0001104659-21-068146.txt : 20210517 0001104659-21-068146.hdr.sgml : 20210517 20210517163118 ACCESSION NUMBER: 0001104659-21-068146 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 50 CONFORMED PERIOD OF REPORT: 20210331 FILED AS OF DATE: 20210517 DATE AS OF CHANGE: 20210517 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Lifesci Acquisition II Corp. CENTRAL INDEX KEY: 0001819113 STANDARD INDUSTRIAL CLASSIFICATION: BLANK CHECKS [6770] IRS NUMBER: 844278203 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-39727 FILM NUMBER: 21931352 BUSINESS ADDRESS: STREET 1: 250 W 55TH ST. STREET 2: #3401 CITY: NEW YORK STATE: NY ZIP: 10019 BUSINESS PHONE: 6468891200 MAIL ADDRESS: STREET 1: 250 W 55TH ST. STREET 2: #3401 CITY: NEW YORK STATE: NY ZIP: 10019 10-Q 1 tm2113988d1_10q.htm FORM 10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2021

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission File No. 001-39727

LIFESCI ACQUISITION II CORP.

(Exact name of registrant as specified in its charter)

Delaware		84-4278203
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification No.)

250 W. 55th St., #3401

New York, NY 10019

(Address of Principal Executive Offices, including zip code)

(646) 899-1200

(Registrant’s telephone number, including area code)

N/A

(Former name, former address and former fiscal year, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Shares of Common Stock, $0.0001 par value		LSAQ		The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes x No ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

¨ Large accelerated filer	¨ Accelerated filer
x Non-accelerated filer	x Smaller reporting company
	x Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act): Yes x No ¨

As of May 14, 2021, there were 10,011,301 shares of common stock, par value $0.0001 per share, issued and outstanding.

LIFESCI ACQUISITION II CORP.

Quarterly Report on Form 10-Q

TABLE OF CONTENTS

		Page
PART 1 – FINANCIAL INFORMATION		1

Item 1.	Unaudited Condensed Financial Statements	1

	Condensed Balance Sheets as of March 31, 2021 (unaudited) and June 30, 2020	1

	Condensed Statements of Operations for the Three Months Ended March 31, 2021(unaudited) and March 31, 2020 (unaudited); Nine Months Ended March 31, 2021 (unaudited) and for the Period from December 18, 2019 (inception) Through March 31, 2020 (unaudited)	2

	Condensed Statements of Changes in Stockholders’ Equity for the Three Months Ended March 31, 2021 and March 31, 2020 (unaudited); Nine Months Ended March 31, 2021 (unaudited) and for the Period from December 18, 2019 (inception) Through March 31, 2020 (unaudited)	3

	Condensed Statements of Cash Flows for the Nine Months Ended March 31, 2021 (unaudited) and for the Period from December 18, 2019 (inception) Through March 31, 2020 (unaudited)	4

	Notes to Condensed Financial Statements (unaudited)	5

Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	13

Item 3.	Quantitative and Qualitative Disclosures about Market Risk	16

Item 4.	Controls and Procedures	16

PART II – OTHER INFORMATION		16

Item 1.	Legal Proceedings	16

Item 1A.	Risk Factors	16

Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	16

Item 3.	Defaults Upon Senior Securities	16

Item 4.	Mine Safety Disclosures	17

Item 5.	Other Information	17

Item 6.	Exhibits	17

SIGNATURES		18

PART 1 – FINANCIAL INFORMATION

ITEM 1. CONDENSED FINANCIAL STATEMENTS

LIFESCI ACQUISITION II CORP.

CONDENSED BALANCE SHEETS

	March 31,			June 30,
	2021			2020
	(unaudited)
ASSETS
Current assets
Cash	$	727,926		$	25,000
Prepaid expenses		153,348			—
Total Current Assets		881,274			25,000

Deferred offering costs		—			28,000
Cash and marketable securities held in Trust Account		80,110,005			—
TOTAL ASSETS	$	80,991,279		$	53,000

LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities
Accounts payable and accrued expenses	$	89,320		$	1,000
Accrued offering costs		—			28,000
Total Liabilities		89,320			29,000

Commitments and Contingencies

Common stock subject to possible redemption, 7,590,195 shares at $10.00 per share		75,901,950			—

Stockholders’ Equity
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; no shares issued and outstanding		—			—
Common stock, $0.0001 par value; 30,000,000 shares authorized; 2,421,106 and 2,156,250 shares issued and outstanding (excluding 7,590,195 and no shares subject to possible redemption) at March 31, 2021 and June 30, 2020, respectively		242			216
Additional paid-in capital		5,186,529			24,784
Accumulated deficit		(186,762	)		(1,000	)
Total Stockholders’ Equity		5,000,009			24,000
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY	$	80,991,279		$	53,000

The accompanying notes are an integral part of the unaudited condensed financial statements.

LIFESCI ACQUISITION II CORP.
CONDENSED STATEMENTS OF OPERATIONS

(Unaudited)

	Three Months ended March 31, 2021			Three Months ended March 31, 2020		Nine Months ended March 31, 2021			For the Period from December 18, 2019 (inception) Through March 31, 2020
Formation and operating costs	$	119,891		$	—	$	205,355		$	1,000
Loss from operations		(119,891	)		—		(205,355	)		(1,000	)

Other income:
Interest earned on marketable securities held in Trust Account		14,752			—		19,593			—

Net loss		(105,139	)		—		(185,762	)		(1,000	)

Weighted average shares outstanding of redeemable common stock		8,009,041			—		8,009,041			—

Basic and diluted net loss per common share		0.00			0.00		0.00			0.00

Weighted average shares outstanding of non-redeemable common stock		1,990,948			1,875,000		1,913,085			1,875,000

Basic and diluted net loss per common share		(0.05	)		0.00		(0.10	)		0.00

The accompanying notes are an integral part of the unaudited condensed financial statements.

LIFESCI ACQUISITION II CORP.

CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY

(Unaudited)

THREE AND NINE MONTHS ENDED MARCH 31, 2021

	Common Stock						Additional Paid in			Accumulated			Total Stockholders’
	Shares			Amount			Capital			Deficit			Equity
Balance — July 1, 2020		2,156,250		$	216		$	24,784		$	(1,000	)	$	24,000

Net loss		—			—			—			(80	)		(80	)

Balance — September 30, 2020		2,156,250			216			24,784			(1,080	)		23,920

Sale of 8,009,041 Public Shares, net of underwriting discounts and offering costs		8,009,041			801			78,231,111			—			78,231,912

Sale of 3,146,454 Private Warrants		—			—			2,831,809			—			2,831,809

Common stock subject to possible redemption		(7,600,709	)		(761	)		(76,006,329	)		—			(76,007,090	)

Net loss		—			—			—			(80,543	)		(80,543	)

Balance — December 31, 2020		2,564,582			256			5,081,375			(81,623	)		5,000,008

Common stock subject to possible redemption		10,514			1			105,139			—			105,140

Forfeiture of Founder Shares		(153,990	)		(15	)		15			—			—

Net loss		—			—			—			(105,139	)		(105,139	)

Balance — March 31, 2021		2,421,106		$	242		$	5,186,529		$	(186,762	)	$	5,000,009

FOR THE THREE MONTHS ENDED MARCH 31, 2020 AND THE PERIOD FROM DECEMBER 18, 2019 (INCEPTION THROUGH MARCH 31, 2020

	Common Stock				Additional Paid in		Accumulated			Total Stockholder’s
	Shares		Amount		Capital		Deficit			Deficit
Balance — December 18, 2019 (inception)		—	$	—	$	—	$	—		$	—

Net loss		—		—		—		(1,000	)		(1,000	)

Balance — December 31, 2019								(1,000	)		(1,000	)

Issuance of common stock to Sponsor		2,156,250		216		24,784		—			25,000

Balance — March 31, 2020		2,156,250	$	216	$	24,784	$	(1,000	)	$	24,000

The accompanying notes are an integral part of the unaudited condensed financial statements.

LIFESCI ACQUISITION II CORP.

CONDENSED STATEMENTS OF CASH FLOWS

(Unaudited)

	Nine Months Ended March 31,			For the Period from December 18, 2019 (Inception) Through March 31,
	2021			2020
Cash Flows from Operating Activities:
Net loss	$	(185,762	)	$	(1,000	)
Adjustments to reconcile net loss to net cash used in operating activities:
Interest earned on marketable securities held in Trust Account		(19,593	)		—
Changes in operating assets and liabilities:
Prepaid expenses		(153,348	)		—
Accounts payable and accrued expenses		88,320			1,000
Net cash used in operating activities		(270,383	)		—

Cash Flows from Investing Activities:
Investment of cash in Trust Account		(80,090,412	)		—
Net cash used in investing activities		(80,090,412	)		—

Cash Flows from Financing Activities:
Proceeds from issuance of common stock to Sponsor		—			25,000
Proceeds from sale of Public Shares, net of underwriting discounts paid		78,488,602			—
Proceeds from sale of Private Warrants		2,831,809			—
Proceeds from promissory note – related party		175,000			—
Repayment of promissory note – related party		(175,000	)		—
Payments of offering costs		(256,690	)		—
Net cash provided by financing activities		81,063,721			25,000

Net Change in Cash		702,926			25,000
Cash – Beginning		25,000			—
Cash – Ending	$	727,926		$	25,000

Non-Cash Investing and Financing Activities:
Initial classification of common stock subject to possible redemption	$	76,087,640		$	—
Change in value of common stock subject to possible redemption	$	(185,690	)	$	—

The accompanying notes are an integral part of the unaudited condensed financial statements.

LIFESCI ACQUISITION II CORP.

NOTES TO CONDENSED FINANCIAL STATEMENTS

MARCH 31, 2021

(Unaudited)

NOTE 1. DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS

LifeSci Acquisition II Corp. (the “Company”) was incorporated in Delaware on December 18, 2019. The Company was formed for the purpose of entering into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business transaction with one or more businesses or entities (a “Business Combination”).

Although the Company is not limited to a particular industry or geographic region for purposes of consummating a Business Combination, the Company intends to focus on businesses operating in North America in the healthcare industry. The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies.

As of March 31, 2021, the Company had not commenced any operations. All activity through March 31, 2021 relates to the Company’s formation and the initial public offering (“Initial Public Offering”), which is described below, and identifying a target company for a Business Combination. The Company will not generate any operating revenues until after the completion of a Business Combination, at the earliest. The Company generates non-operating income in the form of interest income from the proceeds derived from the Initial Public Offering.

The registration statement for the Company’s Initial Public Offering was declared effective on November 20, 2020. On November 24, 2020 the Company consummated the Initial Public Offering of 8,009,041 shares of common stock (the “Public Shares”), which includes the partial exercise by the underwriter of its over-allotment option in the amount of 509,041 Public Shares, at $10.00 per Public Share, generating gross proceeds of $80,090,410 which is described in Note 3.

Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 3,146,454 warrants (the “Private Warrants”) at a price of $0.90 per Private Warrant in a private placement to LifeSci Holdings, LLC (the “Sponsor”), an entity affiliated LifeSci Capital LLC, generating gross proceeds of $2,831,809, which is described in Note 4.

Transaction costs amounted to $1,858,498, consisting of $1,601,808 in cash underwriting fees and $256,690 of other offering costs.

Following the closing of the Initial Public Offering on November 24, 2020, an amount of $80,090,410 ($10.00 per Public Share) from the net proceeds of the sale of the Public Shares in the Initial Public Offering and the sale of the Private Warrants was placed in a trust account (the “Trust Account”), and invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended, or the Investment Company Act, with a maturity of 183 days or less or in any open-ended investment company that holds itself out as a money market fund meeting the conditions of Rule 2a-7 of the Investment Company Act, as determined by the Company, until the earlier of: (i) the consummation of a Business Combination or (ii) the distribution of the funds in the Trust Account as described below.

The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of the Private Warrants, although substantially all of the net proceeds are intended to be applied toward consummating a Business Combination. The Company’s initial Business Combination must be with one or more target businesses that together have a fair market value equal to at least 80% of the balance in the Trust Account (net of amounts previously released to the Company to pay its tax obligations and for working capital purposes, subject to an annual limit of $250,000) at the time of the signing an agreement to enter into a Business Combination. The Company will only complete a Business Combination if the post-Business Combination company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act. There is no assurance that the Company will be able to successfully effect a Business Combination.

The Company will provide its stockholders with the opportunity to redeem all or a portion of their Public Shares sold in the Initial Public Offering upon the completion of a Business Combination either (i) in connection with a stockholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek stockholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The stockholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then on deposit in the Trust Account (initially $10.00 per share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations or for working capital purposes).

The Company will proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001 upon such consummation of a Business Combination and, if the Company seeks stockholder approval, a majority of the outstanding shares voted are voted in favor of the Business Combination. If a stockholder vote is not required by law and the Company does not decide to hold a stockholder vote for business or other legal reasons, the Company will, pursuant to its Amended and Restated Certificate of Incorporation, conduct the redemptions pursuant to the tender offer rules of the Securities and Exchange Commission (“SEC”), and file tender offer documents with the SEC prior to completing a Business Combination. If, however, a stockholder approval of the transaction is required by law, or the Company decides to obtain stockholder approval for business or other legal reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. If the Company seeks stockholder approval in connection with a Business Combination, the Sponsor and other initial stockholders (collectively, the “Initial Stockholders”) have agreed to (a) vote their Founder Shares (as defined in Note 5), and any Public Shares held by them in favor of a Business Combination and (b) not to convert any shares (including Founder Shares) in connection with a stockholder vote to approve a Business Combination or sell any such shares to the Company in a tender offer in connection with a Business Combination. Additionally, each public stockholder may elect to redeem their Public Shares irrespective of whether they vote for or against the proposed transaction.

LIFESCI ACQUISITION II CORP.

NOTES TO CONDENSED FINANCIAL STATEMENTS

MARCH 31, 2021

(Unaudited)

Notwithstanding the foregoing, if the Company seeks stockholder approval of a Business Combination and the Company does not conduct redemptions pursuant to the tender offer rules, a stockholder, together with any affiliate of such stockholder or any other person with whom such stockholder is acting in concert or as a “group” (as defined in Section 13(d)(3) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming their shares with respect to more than an aggregate of 20% of the Public Shares.

The Company will have until November 24, 2022 to consummate a Business Combination (the “Combination Period”). If the Company is unable to complete a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but no more than five business days thereafter, redeem 100% of the outstanding Public Shares, at a per share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned (net of taxes payable), divided by the number of then outstanding Public Shares, which redemption will completely extinguish public stockholders’ rights as stockholders (including the right to receive further liquidation distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining stockholders and the Company’s board of directors, proceed to commence a voluntary liquidation and thereby a formal dissolution of the Company, subject in each case to its obligations to provide for claims of creditors and the requirements of applicable law. The proceeds deposited in the Trust Account could, however, become subject to claims of creditors.

The Sponsor and Chardan Healthcare Investments LLC have agreed to (i) waive their redemption rights with respect to Founder Shares and any Public Shares they may acquire during or after the Initial Public Offering in connection with the consummation of a Business Combination, (ii) to waive their rights to liquidating distributions from the Trust Account with respect to their Founder Shares if the Company fails to consummate a Business Combination within the Combination Period and (iii) not to propose an amendment to the Company’s Amended and Restated Certificate of Incorporation that would affect the substance or timing of the Company’s obligation to redeem 100% of its Public Shares if the Company does not complete a Business Combination, unless the Company provides the public stockholders an opportunity to redeem their Public Shares in conjunction with any such amendment. However, the Sponsor will be entitled to liquidating distributions with respect to any Public Shares acquired if the Company fails to consummate a Business Combination or liquidates within the Combination Period.

In order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent any claims by a vendor for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below $10.00 per share, except as to any claims by a third party who executed a waiver of any right, title, interest or claim of any kind in or to any monies held in the Trust Account or to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (except the Company’s independent registered public accounting firm), prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.

NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of the SEC. Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented.

The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s prospectus for its Initial Public Offering as filed with the SEC on November 23, 2020, as well as the Company’s Current Reports on Form 8-K, as filed with the SEC on November 25, 2020, and December 1, 2020. The interim results for the three and nine months ended March 31, 2021 are not necessarily indicative of the results to be expected for the year ending June 30, 2021 or for any future interim periods.

Emerging Growth Company

The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved.

LIFESCI ACQUISITION II CORP.

NOTES TO CONDENSED FINANCIAL STATEMENTS

MARCH 31, 2021

(Unaudited)

Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

Use of Estimates

The preparation of the unaudited condensed financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods.

Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statement, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.

Cash and Cash Equivalents

The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of March 31, 2021 and June 30, 2020.

Common Stock Subject to Possible Redemption

The Company accounts for its common stock subject to possible redemption in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” Common stock subject to mandatory redemption is classified as a liability instrument and is measured at fair value. Conditionally redeemable common stock (including common stock that features redemption rights that is either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, common stock is classified as stockholders’ equity. The Company’s common stock features certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, at March 31, 2021, common stock subject to possible redemption is presented as temporary equity, outside of the stockholders’ equity section of the Company’s unaudited condensed balance sheet.

Offering Costs

Offering costs consist of legal, accounting, underwriting fees and other costs incurred through the balance sheet date that are directly related to the Initial Public Offering. Offering costs amounting to $1,858,498 were charged to stockholders’ equity upon the completion of the Initial Public Offering.

Income Taxes

The Company complies with the accounting and reporting requirements of ASC Topic 740 “Income Taxes,” which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. As of March 31, 2021, the Company had a deferred tax asset of approximately $39,000, which had a full valuation allowance recorded against it of approximately $39,000.

The Company’s currently taxable income primarily consists of interest income on the Trust Account. The Company’s general and administrative costs are generally considered start-up costs and are not currently deductible. During the three and nine months ended March 31, 2021 the Company recorded no income tax expense. The Company’s effective tax rate for the three and nine months ended March 31, 2021 was zero, which differs from the expected income tax rate due to the start-up costs which are not currently deductible.

LIFESCI ACQUISITION II CORP.

NOTES TO CONDENSED FINANCIAL STATEMENTS

MARCH 31, 2021

(Unaudited)

ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of March 31, 2021 and June 30, 2020. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.

The Company may be subject to potential examination by federal, state and city taxing authorities in the areas of income taxes. These potential examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with federal, state and city tax laws. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months. The Company is subject to income tax examinations by major taxing authorities since inception.

Net Loss Per Common Share

Net loss per common share is computed by dividing net loss by the weighted average number of common shares outstanding for the period. The Company has not considered the effect of warrants sold in connection with the private placement to purchase 3,146,454 shares of common stock in the calculation of diluted loss per common share, since the exercise of the warrants are contingent upon the occurrence of future events and the inclusion of such warrants would be anti-dilutive under the treasury stock method.

The Company’s unaudited condensed statements of operations includes a presentation of loss per share for common shares subject to possible redemption in a manner similar to the two-class method of loss per share. Net income per common share, basic and diluted, for redeemable common stock is calculated by dividing the interest income earned on the Trust Account, less applicable franchise and income taxes, by the weighted average number of redeemable common stock outstanding for the period. Net loss per common share, basic and diluted, for non-redeemable common stock is calculated by dividing the net loss, less income attributable to redeemable common stock, by the weighted average number of non-redeemable common stock outstanding for the period. Weighted average shares were reduced for the effect of an aggregate of 281,250 shares of common stock that were subject to forfeiture if the over-allotment option was not exercised by the underwriters. Non-redeemable common stock includes the Founder Shares as these shares do not have any redemption features and do not participate in the income earned on the Trust Account.

The following table reflects the calculation of basic and diluted net loss per common share (in dollars, except per share amounts):

	Three Months Ended March 31, 2021			Three Months Ended March 31, 2020			Nine Months Ended March 31, 2021			For the Period from December 18, 2019 (inception) Through March 31, 2020
Redeemable Common Stock	$			$			$			$
Numerator: Earnings allocable to Redeemable Common Stock
Interest Income		14,752			—			19,593			—
Income and Franchise Tax		(14,752	)		—			(19,593	)		—
Net earnings		—			—			—			—

Denominator: Weighted Average Redeemable Common Stock Redeemable Common Stock, Basic and Diluted		8,009,041			—			8,009,041			—
Earnings/Basic and Diluted Redeemable Common Stock		0.00			—			0.00			—

Non-Redeemable Common Stock
Numerator: Net Loss minus Redeemable Net Earnings
Net loss		(105,139	)		—			(185,762	)		(1,000	)
Redeemable earnings		—			—			—			—
Non-Redeemable Net Loss		(105,139	)		—			(185,762	)		(1,000	)

Denominator: Weighted Average Non-Redeemable Common Stock Non-Redeemable Common Stock, Basic and Diluted		1,990,948			1,875,000			1,913,085			1,875,000
Loss/Basic and Diluted Non-Redeemable Common Stock		(0.05	)		(0.00	)		(0.10	)		0.00

LIFESCI ACQUISITION II CORP.

NOTES TO CONDENSED FINANCIAL STATEMENTS

MARCH 31, 2021

(Unaudited)

Note: As of March 31, 2021, basic and diluted shares are the same as there are no non-redeemable securities that are dilutive to the Company’s stockholders.

Concentration of Credit Risk

Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.

Fair Value of Financial Instruments

The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurement,” approximates the carrying amounts represented in the accompanying unaudited condensed balance sheets, primarily due to their short-term nature.

Recent Accounting Pronouncements

In August 2020, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2020-06, Debt — Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging — Contracts in Entity’s Own Equity (Subtopic 815-40) (“ASU 2020-06”) to simplify accounting for certain financial instruments. ASU 2020-06 eliminates the current models that require separation of beneficial conversion and cash conversion features from convertible instruments and simplifies the derivative scope exception guidance pertaining to equity classification of contracts in an entity’s own equity. The new standard also introduces additional disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entity’s own equity. ASU 2020-06 amends the diluted earnings per share guidance, including the requirement to use the if-converted method for all convertible instruments. ASU 2020-06 is effective January 1, 2022 and should be applied on a full or modified retrospective basis, with early adoption permitted beginning on January 1, 2021. We are currently assessing the impact, if any, that ASU 2020-06 would have on its financial position, results of operations or cash flows.

Management does not believe that any other recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s unaudited condensed financial statements.

NOTE 3. PUBLIC OFFERING

Pursuant to the Initial Public Offering, the Company sold 8,009,041 Public Shares, which includes the partial exercise by the underwriters of their over-allotment option in the amount of 509,041 Public Shares, at a purchase price of $10.00 per Public Share.

NOTE 4. PRIVATE PLACEMENT

Simultaneously with the closing of the Initial Public Offering, the Sponsor purchased an aggregate of 3,146,454 Private Warrants at a price of $0.90 per Private Warrant for an aggregate purchase price of $2,831,809. Each Private Warrant is exercisable to purchase one share of common stock at an exercise price of $11.50 per warrant. If the Company does not complete a Business Combination within the Combination Period, the proceeds from the sale of the Private Warrants will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law). There will be no redemption rights or liquidating distributions from the Trust Account with respect to the Private Warrants.

NOTE 5. RELATED PARTY TRANSACTIONS

Founder Shares

On January 1, 2020, the Company issued an aggregate of 2,156,250 shares of common stock (the “Founder Shares”) to the Sponsor for an aggregate purchase price of $25,000. On September 30, 2020, LifeSci Holdings LLC transferred 215,625 Founder Shares to Chardan Healthcare Investments LLC, an investor in the Sponsor. The Founder Shares included an aggregate of up to 153,990 shares of common stock that remained subject to forfeiture by the Sponsor, following the underwriters’ election to partially exercise their over-allotment option so that the number of Founder Shares would collectively represent 20% of the Company’s issued and outstanding shares upon the completion of the Initial Public Offering. On January 8, 2021, the underwriters’ election to exercise their remaining over-allotment option expired unexercised, resulting in 127,260 shares no longer subject to forfeiture and the forfeiture of 153,990 shares. Accordingly, as of January 8, 2021, there were 2,002,260 Founder Shares issued and outstanding.

LIFESCI ACQUISITION II CORP.

NOTES TO CONDENSED FINANCIAL STATEMENTS

MARCH 31, 2021

(Unaudited)

The Sponsor and Chardan Healthcare Investments LLC have agreed that, subject to certain limited exceptions, 50% of the Founder Shares will not be transferred, assigned, sold or released from escrow until the earlier of (i) six months after the date of the consummation of a Business Combination or (ii) the date on which the closing price of the Company’s shares of common stock equals or exceeds $12.50 per share (as adjusted for stock splits, stock dividends, reorganizations and recapitalizations) for any 20 trading days within any 30-trading day period commencing after a Business Combination and the remaining 50% of the Founder Shares will not be transferred, assigned, sold or released from escrow until six months after the date of the consummation of a Business Combination, or earlier, in either case, if, subsequent to a Business Combination, the Company consummates a subsequent liquidation, merger, stock exchange or other similar transaction which results in all of the stockholders having the right to exchange their shares of common stock for cash, securities or other property.

Administrative Support Agreement

The Company entered into an agreement, commencing on November 20, 2020 through the earlier of the Company’s consummation of a Business Combination and its liquidation, to pay an affiliate of the Sponsor a total of $10,000 per month for office space, utilities and secretarial support. For the three and nine months ended March 31, 2021, the Company incurred $30,000 and $40,000, respectively, in fees for these services, of which $40,000 is included in accrued expenses in the accompanying unaudited condensed balance sheets.

Promissory Note — Related Party

On June 19, 2020, the Company issued an unsecured promissory note to the Sponsor (the “Promissory Note”), pursuant to which the Company could borrow up to an aggregate principal amount of $175,000. The Promissory Note was non-interest bearing and payable within 15 days of the Sponsor providing the Company with written notice of demand. The outstanding balance under the Promissory Note of $175,000 was repaid at the closing of the Initial Public Offering on November 24, 2020.

Related Party Loans

In order to finance transaction costs in connection with a Business Combination, the Sponsor, an affiliate of the Sponsor, or the Company’s officers and directors may, but are not obligated to, loan the Company funds from time to time or at any time, as may be required (“Working Capital Loans”). Each Working Capital Loan would be evidenced by a promissory note. The Working Capital Loans would be paid upon consummation of a Business Combination, without interest or, at the lender’s discretion, up to $500,000 of such Working Capital Loans may be converted into warrants of the post Business Combination entity at a price of $0.90 per warrant. In the event that a Business Combination does not close, the Company may use a portion of the proceeds held outside the Trust Account to repay the Working Capital Loans, but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. The warrants would be identical to the Private Warrants. As of March 31, 2021 and June 30, 2020, the Company had no outstanding borrowings under the Working Capital Loans.

NOTE 6. COMMITMENTS

Risks and Uncertainties

Management continues to evaluate the impact of the COVID-19 pandemic and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position and/or search for a target company, the specific impact is not readily determinable as of the date of the financial statement. The financial statement does not include any adjustments that might result from the outcome of this uncertainty.

Registration and Stockholder Rights

Pursuant to a registration rights agreement entered into on November 20, 2020, the holders of the Founder Shares and the Private Warrants and any shares that may be issued upon conversion of Working Capital Loans (and all underlying securities) will be entitled to registration and stockholder rights. The holders of a majority of these securities are entitled to make up to two demands that the Company register such securities. The holders of the majority of the Founders Warrants can elect to exercise these registration rights at any time commencing three months prior to the date on which these shares of common stock are to be released from escrow. The holders of a majority of the Private Warrants can elect to exercise these registration rights at any time after the Company consummates a Business Combination. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the consummation of a Business Combination. The Company will bear the expenses incurred in connection with the filing of any such registration statements. The Sponsor and its related persons may not, with respect to the Private Warrants purchased by it, (i) have more than one demand registration right at the Company’s expense, (ii) exercise their demand registration rights more than five (5) years from the effective date of the registration statement of the Initial Public Offering, and (iii) exercise their “piggy-back” registration rights more than seven (7) years from the effective date of the Initial Public Offering, as long as the Sponsor or any of its related persons are beneficial owners of Private Warrants.

Underwriting Agreement

The Company granted the underwriters a 45-day option from the date of the Initial Public Offering to purchase up to 1,125,000 additional Public Shares to cover over-allotments, if any, at the Initial Public Offering price less the underwriting discounts and commissions. As a result of the underwriter’s election to partially exercise the over-allotment option to purchase an additional 509,041 Public Shares, a total of 615,959 Public Shares remained available for purchase at a price of $10.00 per Public Share. On January 8, 2021, the underwriters’ election to exercise their remaining over-allotment option expired unexercised.

LIFESCI ACQUISITION II CORP.

NOTES TO CONDENSED FINANCIAL STATEMENTS

MARCH 31, 2021

(Unaudited)

The underwriters were paid cash underwriting discount of $0.20 per Public Share, or $1,601,808 in the aggregate.

Business Combination Marketing Agreement

The Company has engaged LifeSci Capital LLC and Ladenburg Thalmann & Co. Inc. (“Ladenburg Thalmann “) as advisors in connection with a Business Combination to assist the Company in holding meetings with its stockholders to discuss the potential Business Combination and the target business’ attributes, introduce the Company to potential investors that are interested in purchasing the Company’s securities in connection with a Business Combination, assist the Company in obtaining stockholder approval for the Business Combination and assist the Company with its press releases and public filings in connection with the Business Combination. The Company will pay LifeSci Capital LLC and Ladenburg Thalmann a cash fee for such services upon the consummation of a Business Combination in an amount equal to 3.5% of the gross proceeds of the Initial Public Offering, or $2,803,164, (exclusive of any applicable finders’ fees which might become payable) with 75% of such fee payable to LifeSci Capital LLC and 25% to Ladenburg Thalmann; provided that up to 33% of the fee may be allocated in the Company’s sole discretion to other third parties who are investment banks or financial advisory firms not participating in Initial Public Offering that assist the Company in identifying and consummating a Business Combination.

NOTE 7. STOCKHOLDERS’ EQUITY

Preferred Stock — The Company is authorized to issue 1,000,000 shares of preferred stock with a par value of $0.0001 per share with such designations, voting and other rights and preferences as may be determined from time to time by the Company’s board of directors. At March 31, 2021, there were no shares of preferred stock issued or outstanding.

Common Stock — The Company is authorized to issue 30,000,000 shares of common stock with a par value of $0.0001 per share. Holders of the Company’s common stock are entitled to one vote for each share. At March 31, 2021, there were 2,421,106 shares of common stock issued and outstanding, excluding 7,590,195 shares of common stock subject to possible redemption.

Warrants —The Private Warrants will become exercisable at any time commencing on the later of (1) one year after the closing of the Initial Public Offering or (2) the consummation of a Business Combination; provided that the Company has an effective and current registration statement covering the shares of common stock issuable upon the exercise of the Public Warrants and a current prospectus relating to such shares of common stock.

The Private Warrants purchased by the Sponsor will be exercisable on a cashless basis and not be exercisable more than five years from the commencement of sales of the Initial Public Offering, in accordance with FINRA Rule 5110(g)(8)(A), as long as the Sponsor or any of its related persons beneficially own these Private Warrants.

NOTE 8. FAIR VALUE MEASUREMENTS

The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities:

	Level 1:	Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis.

	Level 2:	Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active.

	Level 3:	Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability.

The Company classifies its U.S. Treasury and equivalent securities as held-to-maturity in accordance with ASC Topic 320 “Investments - Debt and Equity Securities.” Held-to-maturity securities are those securities which the Company has the ability and intent to hold until maturity. Held-to-maturity treasury securities are recorded at amortized cost on the accompanying balance sheets and adjusted for the amortization or accretion of premiums or discounts.

At March 31, 2021, assets held in the Trust Account were comprised of cash of $20,494 and U.S. treasury securities of $80,089,511. During the three and nine months ended March 31, 2021, the Company did not withdraw any interest income from the Trust Account.

LIFESCI ACQUISITION II CORP.

NOTES TO CONDENSED FINANCIAL STATEMENTS

MARCH 31, 2021

(Unaudited)

The following table presents information about the Company’s assets that are measured at fair value on a recurring basis at March 31, 2021 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:

		Held-To-Maturity		Level				Amortized Cost				Unrealized Gain				Fair Value
March 31, 2021		U.S. Treasury Securities (Mature on 6/3/2021)			1			$	80,089,511			$	8,086			$	80,097,597

NOTE 9. SUBSEQUENT EVENTS

The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the unaudited condensed financial statements were issued. Based upon this review, other than as described below, the Company did not identify any subsequent events that would have required adjustment or disclosure in the unaudited condensed financial statements.

On May 6, 2021, the Company entered into an Agreement and Plan of Merger with Science 37, Inc., a company focused on providing customers with a platform to access clinical research. Completion of the transaction is subject to approval of the Company’s stockholders and the satisfaction or waiver of certain other customary closing conditions.

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

References in this report (the “Quarterly Report”) to “we,” “us” or the “Company” refer to LifeSci Acquisition II Corp. References to our “management” or our “management team” refer to our officers and directors, references to the “Sponsor” refer to LifeSci Holdings, LLC. The following discussion and analysis of the Company’s financial condition and results of operations should be read in conjunction with the financial statements and the notes thereto contained elsewhere in this Quarterly Report on Form 10-Q. Certain information contained in the discussion and analysis set forth below includes forward-looking statements that involve risks and uncertainties.

Special Note Regarding Forward-Looking Statements

This Quarterly Report on Form 10-Q includes “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Exchange Act that are not historical facts, and involve risks and uncertainties that could cause actual results to differ materially from those expected and projected. All statements, other than statements of historical fact included in this Quarterly Report on Form 10-Q including, without limitation, statements in this “Management’s Discussion and Analysis of Financial Condition and Results of Operations” regarding the Merger (as defined below), the Company’s financial position and business strategy and the plans and objectives of management for future operations, are forward-looking statements. Words such as “expect,” “believe,” “anticipate,” “intend,” “estimate,” “seek” and variations and similar words and expressions are intended to identify such forward-looking statements. Such forward-looking statements relate to future events or future performance, but reflect management’s current beliefs, based on information currently available. A number of factors could cause actual events, performance or results to differ materially from the events, performance and results discussed in the forward-looking statements. For information identifying important factors that could cause actual results to differ materially from those anticipated in the forward-looking statements, please refer to the Risk Factors section of the Company’s final prospectus for its Initial Public Offering filed with the U.S. Securities and Exchange Commission (the “SEC”). The Company’s securities filings can be accessed on the EDGAR section of the SEC’s website at www.sec.gov. Except as expressly required by applicable securities law, the Company disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.

Overview

We are a blank check company formed under the laws of the State of Delaware on December 18, 2019 for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or other similar Business Combination with one or more businesses. We intend to effectuate our Business Combination using cash from the proceeds of the Initial Public Offering and the sale of the Private Warrants, our capital stock, debt or a combination of cash, stock and debt.

We expect to continue to incur significant costs in the pursuit of our acquisition plans. We cannot assure you that our plans to complete a Business Combination will be successful.

Business Combination Agreement

On May 6, 2021, we entered into an Agreement and Plan of Merger (the “Merger Agreement”) with LifeSci Acquisition II Merger Sub, Inc. (“Merger Sub”), and Science 37, Inc. (“Science 37”), pursuant to which the Merger Sub will merge with and into Science 37, with Science 37 surviving the merger as our wholly-owned subsidiary (the “Merger”). Our board of directors has unanimously (i) approved and declared advisable the Merger Agreement, the Merger and the other transactions contemplated thereby and (ii) resolved to recommend approval of the Merger Agreement and related matters by our stockholders.

Treatment of Science 37 Securities

Preferred Stock. Immediately prior to the effective time of the Merger (the “Effective Time”) and subject to the consent of the holders of a majority of the then outstanding shares of Science 37’s Series A, Series, B, Series C, Series D and Series D-1 preferred stock, par value $0.0001 per share (collectively, the “Science 37 Preferred Stock”), voting together as a single class on an as-converted basis, each issued and outstanding share of Science 37 Preferred Stock will be converted into shares of the common stock, par value $0.0001 per share, of Science 37 (the “Science 37 Common Stock”) at the then-applicable conversion rates (the “Science 37 Preferred Stock Conversion”).

Warrants. At the Effective Time, each outstanding and unexercised warrant to purchase shares of Science 37 capital stock (“Science 37 Warrant”) that is outstanding and unexercised immediately prior to the Effective Time will be converted into a warrant exercisable to receive our common stock, in accordance with its terms. From and after the Effective Time: (i) each Science 37 Warrant assumed by us may be exercised solely for shares of our common stock; (ii) the number of shares of our common stock subject to each Science 37 Warrant assumed by us will be determined by multiplying (A) the number of shares of Science 37 Common Stock, or the number of shares of Science 37 Common Stock issuable upon exercise of the Science 37 Warrant that were subject to such Science 37 Warrant immediately prior to the Effective Time, by (B) the Exchange Ratio, and rounding the resulting number up to the nearest whole number of shares of our common stock; (iii) the per share exercise price for our common stock issuable upon exercise of each Science 37 Warrant assumed by us will be determined by dividing the per share exercise price of Science 37 Common Stock subject to the Science 37 Warrant, as in effect immediately prior to the Effective Time, by the Exchange Ratio and rounding the resulting exercise price up to the nearest whole cent; and (iv) any restriction on any Science 37 Warrant assumed by us will continue in full force and effect and the terms and other provisions of such Science 37 Warrant will otherwise remain unchanged. The Exchange Ratio is defined in the Merger Agreement to be the quotient of (i) 100,000,000 divided by (ii) the number of shares of Science 37’s Fully Diluted Capital Stock (as defined in the Merger Agreement).

Common Stock. At the Effective Time, following the Science 37 Preferred Stock Conversion, each share of Science 37 Common Stock (including shares of Science 37 Common Stock outstanding as a result of the Science 37 Preferred Stock Conversion, but excluding shares the holders of which perfect rights of appraisal under Delaware law) will be converted into the right to receive such number of shares of our common stock equal to the Exchange Ratio (subject to rounding mechanisms as described in the Merger Agreement) and a number of Earn-Out Shares (as defined below).

Stock Options. At the Effective Time, each outstanding option to purchase shares of Science 37 Common Stock, whether or not then vested and exercisable, will be converted automatically (and without any required action on the part of such holder of outstanding option) into an option to purchase shares of our common stock equal to the number of shares subject to such option prior to the Effective Time multiplied by the Exchange Ratio, with the per share exercise price equal to the exercise price prior to the Effective Time divided by the Exchange Ratio.

Earn-Out Shares. Following the closing of the Merger, former holders of shares of Science 37 Common Stock (including shares received as a result of the Science 37 Preferred Stock Conversion) and former holders of Science 37 stock options will be entitled to receive their pro rata share of up to 12,500,000 additional shares of our common stock (the “Earn-Out Shares”) if, within a three-year period following May 6, 2021, the signing date of the Merger Agreement, the closing share price of our common stock equals or exceeds any of two thresholds over any 20 trading days within a 30-day trading period (each, a “Triggering Event”) and, in respect of a former holder of Science 37 stock options, the holder continues to provide services to us or one of our subsidiaries at the time of such Triggering Event.

The Merger Agreement contains customary representations, warranties and covenants of the parties thereto. The consummation of the proposed Merger is subject to certain conditions as further described in the Merger Agreement.

For more information about the Merger Agreement, the Merger and related transactions, see Item 1.01 of our Current Report on Form 8-K filed with the SEC on May 7, 2021.

Results of Operations

We have neither engaged in any operations nor generated any revenues to date. Our only activities since inception have been organizational activities, those necessary to prepare for our Initial Public Offering, and subsequent to our Initial Public Offering, identifying a target for our initial Business Combination. We do not expect to generate any operating revenues until after completion of our initial Business Combination. We generate non-operating income in the form of interest income on investments held in the Trust Account. We incur expenses as a result of being a public company (for legal, financial reporting, accounting and auditing compliance), as well as expenses as we conduct due diligence on prospective Business Combination candidates.

For the three months ended March 31, 2021, we had a net loss of $105,139, which consists of operating costs of $119,891, offset by interest income on investments held in the Trust Account of $14,752.

For the three months ended March 31, 2020, we had no income or loss.

For the nine months ended March 31, 2021, we had a net loss of $185,762, which consists of operating costs of $205,355, offset by interest income on investments held in the Trust Account of $19,593.

For the period from December 18, 2019 (inception) through March 31, 2020, we had a net loss of $1,000, which consists of formation and operating costs.

Liquidity and Capital Resources

Until the consummation of our Initial Public Offering, our only sources of liquidity were an initial purchase of common stock by the Sponsor and loans from our Sponsor.

On November 24, 2020, we consummated the Initial Public Offering of 8,009,041 Public Shares, which includes the partial exercise by the underwriter of its over-allotment option in the amount of 509,041 Public Shares, at a price of $10.00 per Public Share, generating gross proceeds of $80,090,410. Simultaneously with the closing of the Initial Public Offering, we consummated the sale of 3,146,454 Private Warrants to the Sponsor at a price of $0.90 per Private Warrant, generating gross proceeds of $2,831,809.

Following the Initial Public Offering, the partial exercise of the over-allotment option and the sale of the Private Warrants, a total of $80,090,410 was placed in the Trust Account. We incurred $1,858,498 in transaction costs, including $1,601,808 of underwriting fees and $256,690 of other costs.

For the nine months ended March 31, 2021, cash used in operating activities was $270,383. Net loss of $185,762 was affected by interest earned on investments held in the Trust Account of $19,593 and changes in operating assets and liabilities, which used $65,028 of cash from operating activities.

As of March 31, 2021, we had investments of $80,110,005 held in the Trust Account. We intend to use substantially all of the funds held in the Trust Account, including any amounts representing interest earned on the Trust Account (less deferred underwriting commissions) to complete our initial Business Combination. We may withdraw interest to pay taxes. To the extent that our capital stock or debt is used, in whole or in part, as consideration to complete our initial Business Combination, the remaining proceeds held in the Trust Account will be used as working capital to finance the operations of the target business or businesses, make other acquisitions and pursue our growth strategies.

As of March 31, 2021, we had cash of $727,926 outside of the Trust Account. We intend to use the funds held outside the Trust Account primarily to identify and evaluate target businesses, perform business due diligence on prospective target businesses, travel to and from the offices, plants or similar locations of prospective target businesses or their representatives or owners, review corporate documents and material agreements of prospective target businesses, and structure, negotiate and complete our initial Business Combination.

In order to fund working capital deficiencies or finance transaction costs in connection with a Business Combination, the Sponsors, or an affiliate of the Sponsor, or certain of the Company’s officers and directors or their affiliates may, but are not obligated to, loan us funds as may be required. Each Working Capital Loan would be evidenced by a promissory note. If we complete a Business Combination, we would repay the Working Capital Loans out of the proceeds of the Trust Account released to us. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, we may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $500,000 of such Working Capital Loans may be convertible into warrants of the post Business Combination entity. The warrants would be identical to the Private Warrants.

Off-Balance Sheet Financing Arrangements

We have no obligations, assets or liabilities, which would be considered off-balance sheet arrangements as of March 31, 2021. We do not participate in transactions that create relationships with unconsolidated entities or financial partnerships, often referred to as variable interest entities, which would have been established for the purpose of facilitating off-balance sheet arrangements. We have not entered into any off-balance sheet financing arrangements, established any special purpose entities, guaranteed any debt or commitments of other entities, or purchased any non-financial assets.

Contractual Obligations

We do not have any long-term debt, capital lease obligations, operating lease obligations or long-term liabilities, other than an agreement to pay an affiliate of the Sponsor a monthly fee of $10,000 for office space, utilities and secretarial support to the Company. We began incurring these fees on November 20, 2020 and will continue to incur these fees monthly until the earlier of the completion of the Business Combination and the Company’s liquidation.

Critical Accounting Policies

The preparation of condensed financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and income and expenses during the periods reported. Actual results could materially differ from those estimates. We have identified the following critical accounting policies:

Common Stock Subject to Possible Redemption

We account for our common stock subject to possible redemption in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” Common stock subject to mandatory redemption is classified as a liability instrument and is measured at fair value. Conditionally redeemable common stock (including common stock that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within our control) is classified as temporary equity. At all other times, common stock is classified as stockholders’ equity. Our common stock features certain redemption rights that are considered to be outside of our control and subject to occurrence of uncertain future events. Accordingly, the common stock subject to possible redemption is presented as temporary equity, outside of the stockholders’ equity section of our condensed balance sheets.

Net Loss per Common Share

We apply the two-class method in calculating earnings per share. Shares of common stock subject to possible redemption which are not currently redeemable and are not redeemable at fair value, have been excluded from the calculation of basic net loss per share since such shares, if redeemed, only participate in their pro rata share of the Trust Account earnings. Our net income is adjusted for the portion of income that is attributable to common stock subject to possible redemption, as these shares only participate in the earnings of the Trust Account and not our income or losses.

Recent Accounting Standards

In August 2020, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2020-06, Debt — Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging — Contracts in Entity’s Own Equity (Subtopic 815-40) (“ASU 2020-06”) to simplify accounting for certain financial instruments. ASU 2020-06 eliminates the current models that require separation of beneficial conversion and cash conversion features from convertible instruments and simplifies the derivative scope exception guidance pertaining to equity classification of contracts in an entity’s own equity. The new standard also introduces additional disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entity’s own equity. ASU 2020-06 amends the diluted earnings per share guidance, including the requirement to use the if-converted method for all convertible instruments. ASU 2020-06 is effective January 1, 2022 and should be applied on a full or modified retrospective basis, with early adoption permitted beginning on January 1, 2021. We adopted ASU 2020-06 on January 1, 2021. The adoption of ASU 2020-06 did not have an impact on our financial statements.

Management does not believe that any other recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on our condensed financial statements.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Not required for smaller reporting companies.

ITEM 4. CONTROLS AND PROCEDURES

Disclosure controls and procedures are controls and other procedures that are designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, to allow timely decisions regarding required disclosure.

Evaluation of Disclosure Controls and Procedures

As required by Rules 13a-15 and 15d-15 under the Exchange Act, our Chief Executive Officer and Chief Financial Officer carried out an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures as of March 31, 2021. Based upon their evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures (as defined in Rules 13a-15 (e) and 15d-15 (e) under the Exchange Act) were effective.

Changes in Internal Control Over Financial Reporting

During the most recently completed fiscal quarter, there has been no change in our internal control over financial reporting that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

PART II - OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS.

None.

ITEM 1A. RISK FACTORS.

Factors that could cause our actual results to differ materially from those in this Quarterly Report on Form 10-Q include the risk factors described in our final prospectus filed with the SEC on November 23, 2020. As of the date of this Quarterly Report on Form 10-Q, there have been no material changes to the risk factors disclosed in our final prospectus filed with the SEC.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.

On November 24, 2020, we consummated our Initial Public Offering of 8,009,041 Public Shares, which includes the partially exercise by the underwriters of their over-allotment option in the amount of 509,041 Public Shares. The Public Shares were sold at an offering price of $10.00 per Public Share, generating total gross proceeds of $80,090,410. LifeSci Capital LLC and Ladenburg Thalmann & Co. Inc. acted as joint book running managers of the offering. The securities sold in the offering were registered under the Securities Act on registration statements on Form S-1 (No. 333-249480). The SEC declared the registration statements effective on November 20, 2020.

Simultaneously with the consummation of the Initial Public Offering and the partial exercise of the over-allotment option, we consummated a private placement of 3,146,454 Private Warrants to LifeSci Holdings, LLC at a price of $0.90 per Private Warrant, generating total proceeds of $2,831,809. Such securities were issued pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act.

Of the gross proceeds received from the Initial Public Offering, the partial exercise of the over-allotment option and the Private Warrants, $80,090,410 was placed in the Trust Account.

We paid a total of $1,601,808 underwriting discounts and commissions and $256,690 for other costs and expenses related to the Initial Public Offering.

For a description of the use of the proceeds generated in our Initial Public Offering, see Part I, Item 2 of this Quarterly Report on Form 10-Q.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES.

None.

ITEM 4. MINE SAFETY DISCLOSURES.

Not applicable.

ITEM 5. OTHER INFORMATION.

None.

ITEM 6. EXHIBITS.

The following exhibits are filed as part of, or incorporated by reference into, this Quarterly Report on Form 10-Q.

No.		Description of Exhibit
31.1*		Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2*		Certification of Principal Financial Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1**		Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2**		Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.INS*		XBRL Instance Document
101.CAL*		XBRL Taxonomy Extension Calculation Linkbase Document
101.SCH*		XBRL Taxonomy Extension Schema Document
101.DEF*		XBRL Taxonomy Extension Definition Linkbase Document
101.LAB*		XBRL Taxonomy Extension Labels Linkbase Document
101.PRE*		XBRL Taxonomy Extension Presentation Linkbase Document

*	Filed herewith.
**	Furnished.

SIGNATURES

Pursuant to the requirements of Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	LIFESCI ACQUISITION II CORP.

Date: May 17, 2021		/s/ Andrew McDonald
	Name:	Andrew McDonald
	Title:	Chief Executive Officer
		(Principal Executive Officer)

Date: May 17, 2021		/s/ David Dobkin
	Name:	David Dobkin
	Title:	Chief Financial Officer
		(Principal Financial and Accounting Officer)

EX-31.1 2 tm2113988d1_ex31-1.htm EXHIBIT 31.1

Exhibit 31.1

CERTIFICATIONS

I, Andrew McDonald, certify that:

I have reviewed this Quarterly Report on Form 10-Q of LifeSci Acquisition II Corp.;

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(Paragraph omitted pursuant to SEC Release Nos. 33-8238/34-47986 and 33-8392/34-49313);

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 17, 2021	By:	/s/ Andrew McDonald
	Name:	Andrew McDonald
	Title:	Chief Executive Officer
		(Principal Executive Officer)

EX-31.2 3 tm2113988d1_ex31-2.htm EXHIBIT 31.2

Exhibit 31.2

CERTIFICATIONS

I, David Dobkin, certify that:

I have reviewed this Quarterly Report on Form 10-Q of LifeSci Acquisition II Corp.;

(Paragraph omitted pursuant to SEC Release Nos. 33-8238/34-47986 and 33-8392/34-49313);

(a)

(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 17, 2021	By:	/s/ David Dobkin
	Name:	David Dobkin
	Title:	Chief Financial Officer
		(Principal Financial and Accounting Officer)

EX-32.1 4 tm2113988d1_ex32-1.htm EXHIBIT 32.1

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADDED BY

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of LifeSci Acquisition II Corp. (the “Company”) on Form 10-Q for the quarterly period ended March 31, 2021, as filed with the Securities and Exchange Commission (the “Report”), I, Andrew McDonald, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as added by §906 of the Sarbanes-Oxley Act of 2002, that:

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

To my knowledge, the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of and for the period covered by the Report.

Date: May 17, 2021	By:	/s/ Andrew McDonald
	Name:	Andrew McDonald
	Title:	Chief Executive Officer
		(Principal Executive Officer)

EX-32.2 5 tm2113988d1_ex32-2.htm EXHIBIT 32.2

Exhibit 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADDED BY

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of LifeSci Acquisition II Corp. (the “Company”) on Form 10-Q for the quarterly period ended March 31, 2021, as filed with the Securities and Exchange Commission (the “Report”), I, David Dobkin, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as added by §906 of the Sarbanes-Oxley Act of 2002, that:

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

Date: May 17, 2021	By:	/s/ David Dobkin
	Name:	David Dobkin
	Title:	Chief Financial Officer
		(Principal Financial and Accounting Officer)

EX-101.INS 6 lsaq-20210331.xml XBRL INSTANCE DOCUMENT 0001819113 us-gaap:WarrantMember 2021-03-31 0001819113 isaq:CommonStockSubjectToRedemptionMember 2021-03-31 0001819113 isaq:CommonStockSubjectToRedemptionMember 2020-06-30 0001819113 isaq:ChardanHealthcareInvestmentsLlcMember isaq:FounderSharesMember isaq:SponsorMember 2020-09-30 2020-09-30 0001819113 isaq:FounderSharesMember isaq:SponsorMember 2020-01-01 2020-01-01 0001819113 us-gaap:RetainedEarningsMember 2021-03-31 0001819113 us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0001819113 us-gaap:RetainedEarningsMember 2020-12-31 0001819113 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001819113 2020-12-31 0001819113 us-gaap:RetainedEarningsMember 2020-09-30 0001819113 us-gaap:AdditionalPaidInCapitalMember 2020-09-30 0001819113 2020-09-30 0001819113 us-gaap:RetainedEarningsMember 2020-06-30 0001819113 us-gaap:AdditionalPaidInCapitalMember 2020-06-30 0001819113 us-gaap:RetainedEarningsMember 2020-03-31 0001819113 us-gaap:AdditionalPaidInCapitalMember 2020-03-31 0001819113 us-gaap:RetainedEarningsMember 2019-12-31 0001819113 2019-12-31 0001819113 us-gaap:RetainedEarningsMember 2019-12-17 0001819113 us-gaap:AdditionalPaidInCapitalMember 2019-12-17 0001819113 us-gaap:CommonStockMember 2021-03-31 0001819113 us-gaap:CommonStockMember 2020-12-31 0001819113 us-gaap:CommonStockMember 2020-09-30 0001819113 us-gaap:CommonStockMember 2020-06-30 0001819113 us-gaap:CommonStockMember 2020-03-31 0001819113 us-gaap:CommonStockMember 2019-12-17 0001819113 us-gaap:OverAllotmentOptionMember 2020-11-24 0001819113 us-gaap:IPOMember 2020-11-24 0001819113 isaq:PromissoryNoteWithRelatedPartyMember 2020-11-24 2020-11-24 0001819113 isaq:AdministrativeSupportAgreementMember 2021-01-01 2021-03-31 0001819113 isaq:AccruedExpensesExcludingOfferingCostMember isaq:AdministrativeSupportAgreementMember 2020-07-01 2021-03-31 0001819113 isaq:AdministrativeSupportAgreementMember 2020-07-01 2021-03-31 0001819113 isaq:SponsorMember 2019-12-18 2020-03-31 0001819113 us-gaap:RetainedEarningsMember 2021-01-01 2021-03-31 0001819113 us-gaap:RetainedEarningsMember 2020-10-01 2020-12-31 0001819113 us-gaap:RetainedEarningsMember 2020-07-01 2020-09-30 0001819113 2020-07-01 2020-09-30 0001819113 us-gaap:RetainedEarningsMember 2019-12-18 2019-12-31 0001819113 2019-12-18 2019-12-31 0001819113 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasurySecuritiesMember 2021-03-31 0001819113 2019-07-01 2020-06-30 0001819113 isaq:RedeemableCommonStockMember 2020-01-01 2020-03-31 0001819113 isaq:NonRedeemableCommonStockMember 2020-01-01 2020-03-31 0001819113 isaq:RedeemableCommonStockMember 2019-12-18 2020-03-31 0001819113 isaq:RelatedPartyLoansMember 2020-06-30 0001819113 isaq:PromissoryNoteWithRelatedPartyMember 2020-06-19 0001819113 isaq:FounderSharesMember 2021-01-08 0001819113 isaq:PrivateWarrantMember us-gaap:PrivatePlacementMember 2020-11-24 0001819113 2020-03-31 0001819113 2019-12-17 0001819113 us-gaap:USTreasurySecuritiesMember 2021-03-31 0001819113 us-gaap:WarrantMember 2020-07-01 2021-03-31 0001819113 us-gaap:WarrantMember 2020-07-01 2021-03-31 0001819113 us-gaap:OverAllotmentOptionMember 2020-11-24 2020-11-24 0001819113 us-gaap:OverAllotmentOptionMember 2020-07-01 2021-03-31 0001819113 us-gaap:OverAllotmentOptionMember 2021-03-31 0001819113 isaq:RemainingFiftyPercentOfSharesMember isaq:FounderSharesMember 2020-01-01 0001819113 isaq:FirstFiftyPercentOfSharesMember isaq:FounderSharesMember 2020-01-01 0001819113 isaq:FirstFiftyPercentOfSharesMember isaq:FounderSharesMember 2020-01-01 2020-01-01 0001819113 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-03-31 0001819113 us-gaap:CommonStockMember 2020-01-01 2020-03-31 0001819113 2020-11-24 2020-11-24 0001819113 isaq:AdministrativeSupportAgreementMember 2020-11-20 2020-11-20 0001819113 us-gaap:IPOMember 2020-11-24 2020-11-24 0001819113 isaq:PromissoryNoteWithRelatedPartyMember 2020-06-19 2020-06-19 0001819113 isaq:FounderSharesMember 2020-01-01 2020-01-01 0001819113 isaq:LadenburgThalmannMember 2020-07-01 2021-03-31 0001819113 us-gaap:IPOMember 2021-03-31 0001819113 isaq:FounderSharesMember isaq:SponsorMember 2021-01-08 2021-01-08 0001819113 isaq:NonRedeemableCommonStockMember 2021-01-01 2021-03-31 0001819113 isaq:NonRedeemableCommonStockMember 2020-07-01 2021-03-31 0001819113 isaq:NonRedeemableCommonStockMember 2019-12-18 2020-03-31 0001819113 isaq:RelatedPartyLoansMember 2021-03-31 0001819113 isaq:FounderSharesMember isaq:SponsorMember 2020-01-01 0001819113 isaq:RedeemableCommonStockMember 2021-01-01 2021-03-31 0001819113 isaq:RedeemableCommonStockMember 2020-07-01 2021-03-31 0001819113 2020-01-01 2020-03-31 0001819113 isaq:PrivateWarrantMember us-gaap:PrivatePlacementMember 2020-11-24 2020-11-24 0001819113 us-gaap:CommonStockMember 2021-01-01 2021-03-31 0001819113 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-03-31 0001819113 2021-01-01 2021-03-31 0001819113 us-gaap:CommonStockMember 2020-10-01 2020-12-31 0001819113 us-gaap:AdditionalPaidInCapitalMember 2020-10-01 2020-12-31 0001819113 2020-10-01 2020-12-31 0001819113 2019-12-18 2020-03-31 0001819113 2021-03-31 0001819113 isaq:LifesciCapitalLlcMember 2020-07-01 2021-03-31 0001819113 2020-06-30 0001819113 2021-05-14 0001819113 2020-07-01 2021-03-31 isaq:D isaq:item isaq:Vote iso4217:USD xbrli:shares xbrli:pure iso4217:USD xbrli:shares false --06-30 Q3 2021 2021-03-31 10-Q 0001819113 10011301 Yes true false Non-accelerated Filer Yes Lifesci Acquisition II Corp. true true Shares of Common Stock, $0.0001 par value NASDAQ LSAQ 28000 0.035 20494 0 -185690 76007090 76006329 761 -105140 -105139 -1 7600709 -10514 0.90 0.90 1 <div> <div> Common Stock Subject to Possible Redemption The Company accounts for its common stock subject to possible redemption in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” Common stock subject to mandatory redemption is classified as a liability instrument and is measured at fair value. Conditionally redeemable common stock (including common stock that features redemption rights that is either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, common stock is classified as stockholders’ equity. The Company’s common stock features certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, at March 31, 2021, common stock subject to possible redemption is presented as temporary equity, outside of the stockholders’ equity section of the Company’s unaudited condensed balance sheet. <div /></div> </div> 0.20 1601808 <div> <div> Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. <div /></div> </div> 250000 -1000 0 -205355 -119891 -19593 -14752 0 76087640 <div> <div> NOTE 3. PUBLIC OFFERING Pursuant to the Initial Public Offering, the Company sold 8,009,041 Public Shares, which includes the partial exercise by the underwriters of their over-allotment option in the amount of 509,041 Public Shares, at a purchase price of $10.00 per Public Share. <div /></div> </div> 0 80090412 153990 500000 5000001 -1000 -185762 -105139 127260 153990 615959 <div> <div> Offering Costs Offering costs consist of legal, accounting, underwriting fees and other costs incurred through the balance sheet date that are directly related to the Initial Public Offering. Offering costs amounting to $1,858,498 were charged to stockholders’ equity upon the completion of the Initial Public Offering. <div /></div> </div> 1.00 0.25 0.75 0.33 0.20 P15D <div> <div> NOTE 4. PRIVATE PLACEMENT Simultaneously with the closing of the Initial Public Offering, the Sponsor purchased an aggregate of 3,146,454 Private Warrants at a price of $0.90 per Private Warrant for an aggregate purchase price of $2,831,809. Each Private Warrant is exercisable to purchase one share of common stock at an exercise price of $11.50 per warrant. If the Company does not complete a Business Combination within the Combination Period, the proceeds from the sale of the Private Warrants will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law). There will be no redemption rights or liquidating distributions from the Trust Account with respect to the Private Warrants. <div /></div> </div> 80090410 80090410 2 1 P7Y P7Y P3M P5Y P5Y 10000 256690 1858498 1858498 1601808 2156250 25000 24784 216 P5D 0.80 0.50 0.20 P6M 12.50 30 20 0.50 0.50 10.00 509041 8009041 8009041 509041 509041 P1Y 3146454 0.90 281250 250000

1000

89320

24784

5186529

2831809

3146454

53000

80991279

25000

881274

80110005

80089511

25000

727926

25000

727926

25000

702926

11.50

3146454

<div> <div> NOTE 6. COMMITMENTS Risks and Uncertainties Management continues to evaluate the impact of the COVID‑19 pandemic and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position and/or search for a target company, the specific impact is not readily determinable as of the date of the financial statement. The financial statement does not include any adjustments that might result from the outcome of this uncertainty. Registration and Stockholder Rights Pursuant to a registration rights agreement entered into on November 20, 2020, the holders of the Founder Shares and the Private Warrants and any shares that may be issued upon conversion of Working Capital Loans (and all underlying securities) will be entitled to registration and stockholder rights. The holders of a majority of these securities are entitled to make up to two demands that the Company register such securities. The holders of the majority of the Founders Warrants can elect to exercise these registration rights at any time commencing three months prior to the date on which these shares of common stock are to be released from escrow. The holders of a majority of the Private Warrants can elect to exercise these registration rights at any time after the Company consummates a Business Combination. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the consummation of a Business Combination. The Company will bear the expenses incurred in connection with the filing of any such registration statements. The Sponsor and its related persons may not, with respect to the Private Warrants purchased by it, (i) have more than one demand registration right at the Company’s expense, (ii) exercise their demand registration rights more than five  (5) years from the effective date of the registration statement of the Initial Public Offering, and (iii) exercise their “piggy-back” registration rights more than seven  (7) years from the effective date of the Initial Public Offering, as long as the Sponsor or any of its related persons are beneficial owners of Private Warrants. Underwriting Agreement The Company granted the underwriters a 45‑day option from the date of the Initial Public Offering to purchase up to 1,125,000 additional Public Shares to cover over-allotments, if any, at the Initial Public Offering price less the underwriting discounts and commissions. As a result of the underwriter’s election to partially exercise the over-allotment option to purchase an additional 509,041 Public Shares, a total of 615,959 Public Shares remained available for purchase at a price of $10.00 per Public S<a name="_Hlk62733615"></a>hare. On January 8, 2021, the underwriters’ election to exercise their remaining over-allotment option expired unexercised. The underwriters were paid cash underwriting discount of $0.20 per Public Share, or $1,601,808 in the aggregate. Business Combination Marketing Agreement The Company has engaged LifeSci Capital LLC and Ladenburg Thalmann & Co. Inc. (“Ladenburg Thalmann “) as advisors in connection with a Business Combination to assist the Company in holding meetings with its stockholders to discuss the potential Business Combination and the target business’ attributes, introduce the Company to potential investors that are interested in purchasing the Company’s securities in connection with a Business Combination, assist the Company in obtaining stockholder approval for the Business Combination and assist the Company with its press releases and public filings in connection with the Business Combination. The Company will pay LifeSci Capital LLC and Ladenburg Thalmann a cash fee for such services upon the consummation of a Business Combination in an amount equal to 3.5% of the gross proceeds of the Initial Public Offering, or $2,803,164, (exclusive of any applicable finders’ fees which might become payable) with 75% of such fee payable to LifeSci Capital LLC and 25% to Ladenburg Thalmann; provided that up to 33% of the fee may be allocated in the Company’s sole discretion to other third parties who are investment banks or financial advisory firms not participating in Initial Public Offering that assist the Company in identifying and consummating a Business Combination. <div /></div> </div>

0.0001

30000000

1125000

2156250

2002260

2421106

2156250

2002260

2421106

216

242

28000

39000

175000

0.00

-0.10

0.00

-0.05

0.00

<div> <div> Net Loss Per Common Share Net loss per common share is computed by dividing net loss by the weighted average number of common shares outstanding for the period. The Company has not considered the effect of warrants sold in connection with the private placement to purchase 3,146,454 shares of common stock in the calculation of diluted loss per common share, since the exercise of the warrants are contingent upon the occurrence of future events and the inclusion of such warrants would be anti-dilutive under the treasury stock method. The Company’s unaudited condensed statements of operations includes a presentation of loss per share for common shares subject to possible redemption in a manner similar to the two-class method of loss per share. Net income per common share, basic and diluted, for redeemable common stock is calculated by dividing the interest income earned on the Trust Account, less applicable franchise and income taxes, by the weighted average number of redeemable common stock outstanding for the period. Net loss per common share, basic and diluted, for non-redeemable common stock is calculated by dividing the net loss, less income attributable to redeemable common stock, by the weighted average number of non-redeemable common stock outstanding for the period. Weighted average shares were reduced for the effect of an aggregate of 281,250 shares of common stock that were subject to forfeiture if the over-allotment option was not exercised by the underwriters. Non-redeemable common stock includes the Founder Shares as these shares do not have any redemption features and do not participate in the income earned on the Trust Account. The following table reflects the calculation of basic and diluted net loss per common share (in dollars, except per share amounts):   <div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.14%;"> <tr> <td valign="bottom" style="width:54.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:54.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:10.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> For the Period  </td> </tr> <tr> <td valign="bottom" style="width:54.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:10.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> from December 18, </td> </tr> <tr> <td valign="bottom" style="width:54.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:10.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> 2019 </td> </tr> <tr> <td valign="bottom" style="width:54.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Three Months  </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Three Months  </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Nine Months  </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:10.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> (inception)  </td> </tr> <tr> <td valign="bottom" style="width:54.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Ended </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Ended </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Ended </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:10.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Through </td> </tr> <tr> <td valign="bottom" style="width:54.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> March 31,  </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> March 31,  </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> March 31,  </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:10.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> March 31,  </td> </tr> <tr> <td valign="bottom" style="width:54.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> 2021 </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> 2021 </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> 2021 </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:10.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> 2020 </td> </tr> <tr> <td valign="bottom" style="width:54.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Redeemable Common Stock </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">    </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">    </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">    </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:09.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">    </td> </tr> <tr> <td valign="bottom" style="width:54.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Numerator: Earnings allocable to Redeemable Common Stock </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">    </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">    </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">    </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:09.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">    </td> </tr> <tr> <td valign="bottom" style="width:54.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Interest Income </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 14,752 </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">  — </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 19,593 </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">  — </td> </tr> <tr> <td valign="bottom" style="width:54.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Income and Franchise Tax </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> (14,752) </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">  — </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> (19,593) </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:09.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">  — </td> </tr> <tr> <td valign="bottom" style="width:54.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Net earnings </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">  — </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">  — </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">  — </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">  — </td> </tr> <tr> <td valign="bottom" style="width:54.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Denominator: Weighted Average Redeemable Common Stock </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">    </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">    </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">    </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:09.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">    </td> </tr> <tr> <td valign="bottom" style="width:54.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Redeemable Common Stock, Basic and Diluted </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 8,009,041 </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">  — </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 8,009,041 </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">  — </td> </tr> <tr> <td valign="bottom" style="width:54.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Earnings/Basic and Diluted Redeemable Common Stock </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;;font-weight:bold;color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;padding-right:3pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>0.00 </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">  — </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;;font-weight:bold;color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;padding-right:3pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>0.00 </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:09.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">  — </td> </tr> <tr> <td valign="bottom" style="width:54.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:54.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Non-Redeemable Common Stock </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">    </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">    </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">    </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:09.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">    </td> </tr> <tr> <td valign="bottom" style="width:54.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Numerator: Net Loss minus Redeemable Net Earnings </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">    </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">    </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">    </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">    </td> </tr> <tr> <td valign="bottom" style="width:54.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Net loss </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> (105,139) </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">  — </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> (185,762) </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:09.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> (1,000) </td> </tr> <tr> <td valign="bottom" style="width:54.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Redeemable earnings </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> — </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">  — </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> — </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">  — </td> </tr> <tr> <td valign="bottom" style="width:54.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Non-Redeemable Net Loss </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> (105,139) </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">  — </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> (185,762) </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:09.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> (1,000) </td> </tr> <tr> <td valign="bottom" style="width:54.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Denominator: Weighted Average Non-Redeemable Common Stock </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">    </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">    </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">    </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">    </td> </tr> <tr> <td valign="bottom" style="width:54.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Non-Redeemable Common Stock, Basic and Diluted </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 1,990,948 </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 1,875,000 </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 1,913,085 </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:09.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 1,875,000 </td> </tr> <tr> <td valign="bottom" style="width:54.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Loss/Basic and Diluted Non-Redeemable Common Stock </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> (0.05) </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-weight:bold;color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(0.00) </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> (0.10) </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-weight:bold;color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;padding-right:3pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>0.00 </td> </tr> </table></div>   Note: As of March 31, 2021, basic and diluted shares are the same as there are no non-redeemable securities that are dilutive to the Company’s stockholders. <div /></div> </div>

0.00

<div> <div> <div style="width:100%;"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;"> <tr> <td valign="bottom" style="width:13.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:31.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:13.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:31.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:09.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:11.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Amortized </td> <td valign="bottom" style="width:02.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:11.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Unrealized </td> <td valign="bottom" style="width:02.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:11.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:13.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">    </td> <td valign="bottom" style="width:31.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Held-To-Maturity </td> <td valign="bottom" style="width:02.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:09.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Level </td> <td valign="bottom" style="width:02.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:11.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Cost </td> <td valign="bottom" style="width:02.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:11.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Gain </td> <td valign="bottom" style="width:02.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:11.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Fair Value </td> </tr> <tr> <td valign="bottom" style="width:13.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> March 31, 2021 </td> <td valign="bottom" style="width:02.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">      </td> <td valign="bottom" style="width:31.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> U.S. Treasury Securities (Mature on 6/3/2021) </td> <td valign="bottom" style="width:02.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 1 </td> <td valign="bottom" style="width:02.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:09.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">     80,089,511 </td> <td valign="bottom" style="width:02.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:09.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 8,086 </td> <td valign="bottom" style="width:02.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:09.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 80,097,597 </td> </tr> </table></div>   <div /></div> </div>

<div> <div> NOTE 8. FAIR VALUE MEASUREMENTS The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities: Level 1:Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis. Level 2:Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active. Level 3:Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability. The Company classifies its U.S. Treasury and equivalent securities as held-to-maturity in accordance with ASC Topic 320 "Investments - Debt and Equity Securities." Held-to-maturity securities are those securities which the Company has the ability and intent to hold until maturity. Held-to-maturity treasury securities are recorded at amortized cost on the accompanying balance sheets and adjusted for the amortization or accretion of premiums or discounts. At March 31, 2021, assets held in the Trust Account were comprised of cash of $20,494 and U.S. treasury securities of $80, 089,511. During the three and nine months ended March 31, 2021, the Company did not withdraw any interest income from the Trust Account. The following table presents information about the Company’s assets that are measured at fair value on a recurring basis at March 31, 2021 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:   <div style="width:100%;"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;"> <tr> <td valign="bottom" style="width:13.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:31.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:13.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:31.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:09.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:11.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Amortized </td> <td valign="bottom" style="width:02.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:11.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Unrealized </td> <td valign="bottom" style="width:02.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:11.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:13.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">    </td> <td valign="bottom" style="width:31.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Held-To-Maturity </td> <td valign="bottom" style="width:02.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:09.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Level </td> <td valign="bottom" style="width:02.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:11.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Cost </td> <td valign="bottom" style="width:02.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:11.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Gain </td> <td valign="bottom" style="width:02.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:11.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Fair Value </td> </tr> <tr> <td valign="bottom" style="width:13.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> March 31, 2021 </td> <td valign="bottom" style="width:02.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">      </td> <td valign="bottom" style="width:31.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> U.S. Treasury Securities (Mature on 6/3/2021) </td> <td valign="bottom" style="width:02.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 1 </td> <td valign="bottom" style="width:02.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:09.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">     80,089,511 </td> <td valign="bottom" style="width:02.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:09.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 8,086 </td> <td valign="bottom" style="width:02.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:09.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 80,097,597 </td> </tr> </table></div>   <div /></div> </div>

80089511

8086

80097597

1000

88320

153348

19593

14752

29000

89320

53000

80991279

25000

81063721

-80090412

-270383

-1000

-80

-185762

-80543

-105139

2803164

-1000

-205355

-119891

<div> <div> NOTE 1. DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS LifeSci Acquisition II Corp. (the “Company”) was incorporated in Delaware on December 18, 2019. The Company was formed for the purpose of entering into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business transaction with one or more businesses or entities (a “Business Combination”). Although the Company is not limited to a particular industry or geographic region for purposes of consummating a Business Combination, the Company intends to focus on businesses operating in North America in the healthcare industry. The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies. As of March 31, 2021, the Company had not commenced any operations. All activity through March 31, 2021 relates to the Company’s formation and the initial public offering (“Initial Public Offering”), which is described below, and identifying a target company for a Business Combination. The Company will not generate any operating revenues until after the completion of a Business Combination, at the earliest. The Company generates non-operating income in the form of interest income from the proceeds derived from the Initial Public Offering. The registration statement for the Company’s Initial Public Offering was declared effective on November 20, 2020. On November 24, 2020 the Company consummated the Initial Public Offering of 8,009,041 shares of common stock (the “Public Shares”), which includes the partial exercise by the underwriter of its over-allotment option in the amount of 509,041 Public Shares, at $10.00 per Public Share, generating gross proceeds of $80,090,410 which is described in Note 3. Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 3,146,454 warrants (the “Private Warrants”) at a price of $0.90 per Private Warrant in a private placement to LifeSci Holdings, LLC (the “Sponsor”), an entity affiliated LifeSci Capital LLC, generating gross proceeds of $2,831,809, which is described in Note 4. Transaction costs amounted to $1,858,498, consisting of $1,601,808 in cash underwriting fees and $256,690 of other offering costs. Following the closing of the Initial Public Offering on November 24, 2020, an amount of $80,090,410  ($10.00 per Public Share) from the net proceeds of the sale of the Public Shares in the Initial Public Offering and the sale of the Private Warrants was placed in a trust account (the “Trust Account”), and invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended, or the Investment Company Act, with a maturity of 183 days or less or in any open-ended investment company that holds itself out as a money market fund meeting the conditions of Rule 2a‑7 of the Investment Company Act, as determined by the Company, until the earlier of: (i) the consummation of a Business Combination or (ii) the distribution of the funds in the Trust Account as described below. The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of the Private Warrants, although substantially all of the net proceeds are intended to be applied toward consummating a Business Combination. The Company’s initial Business Combination must be with one or more target businesses that together have a fair market value equal to at least 80% of the balance in the Trust Account (net of amounts previously released to the Company to pay its tax obligations and for working capital purposes, subject to an annual limit of $250,000) at the time of the signing an agreement to enter into a Business Combination. The Company will only complete a Business Combination if the post-Business Combination company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act. There is no assurance that the Company will be able to successfully effect a Business Combination. The Company will provide its stockholders with the opportunity to redeem all or a portion of their Public Shares sold in the Initial Public Offering upon the completion of a Business Combination either (i) in connection with a stockholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek stockholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The stockholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then on deposit in the Trust Account (initially $10.00 per share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations or for working capital purposes). The Company will proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001 upon such consummation of a Business Combination and, if the Company seeks stockholder approval, a majority of the outstanding shares voted are voted in favor of the Business Combination. If a stockholder vote is not required by law and the Company does not decide to hold a stockholder vote for business or other legal reasons, the Company will, pursuant to its Amended and Restated Certificate of Incorporation, conduct the redemptions pursuant to the tender offer rules of the Securities and Exchange Commission (“SEC”), and file tender offer documents with the SEC prior to completing a Business Combination. If, however, a stockholder approval of the transaction is required by law, or the Company decides to obtain stockholder approval for business or other legal reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. If the Company seeks stockholder approval in connection with a Business Combination, the Sponsor and other initial stockholders (collectively, the “Initial Stockholders”) have agreed to (a) vote their Founder Shares (as defined in Note 5), and any Public Shares held by them in favor of a Business Combination and (b) not to convert any shares (including Founder Shares) in connection with a stockholder vote to approve a Business Combination or sell any such shares to the Company in a tender offer in connection with a Business Combination. Additionally, each public stockholder may elect to redeem their Public Shares irrespective of whether they vote for or against the proposed transaction. Notwithstanding the foregoing, if the Company seeks stockholder approval of a Business Combination and the Company does not conduct redemptions pursuant to the tender offer rules, a stockholder, together with any affiliate of such stockholder or any other person with whom such stockholder is acting in concert or as a “group” (as defined in Section 13(d)(3) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming their shares with respect to more than an aggregate of 20% of the Public Shares. The Company will have until November 24, 2022 to consummate a Business Combination (the “Combination Period”). If the Company is unable to complete a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but no more than five business days thereafter, redeem 100% of the outstanding Public Shares, at a per share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned (net of taxes payable), divided by the number of then outstanding Public Shares, which redemption will completely extinguish public stockholders’ rights as stockholders (including the right to receive further liquidation distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining stockholders and the Company’s board of directors, proceed to commence a voluntary liquidation and thereby a formal dissolution of the Company, subject in each case to its obligations to provide for claims of creditors and the requirements of applicable law. The proceeds deposited in the Trust Account could, however, become subject to claims of creditors. The Sponsor and Chardan Healthcare Investments LLC have agreed to (i) waive their redemption rights with respect to Founder Shares and any Public Shares they may acquire during or after the Initial Public Offering in connection with the consummation of a Business Combination, (ii) to waive their rights to liquidating distributions from the Trust Account with respect to their Founder Shares if the Company fails to consummate a Business Combination within the Combination Period and (iii) not to propose an amendment to the Company’s Amended and Restated Certificate of Incorporation that would affect the substance or timing of the Company’s obligation to redeem 100% of its Public Shares if the Company does not complete a Business Combination, unless the Company provides the public stockholders an opportunity to redeem their Public Shares in conjunction with any such amendment. However, the Sponsor will be entitled to liquidating distributions with respect to any Public Shares acquired if the Company fails to consummate a Business Combination or liquidates within the Combination Period. In order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent any claims by a vendor for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below $10.00 per share, except as to any claims by a third party who executed a waiver of any right, title, interest or claim of any kind in or to any monies held in the Trust Account or to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (except the Company’s independent registered public accounting firm), prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account. <div /></div> </div>

256690

0.0001

1000000

153348

25000

78488602

2831809

175000

-1000

-185762

40000

30000

<div> <div> NOTE 5. RELATED PARTY TRANSACTIONS Founder Shares On January 1, 2020, the Company issued an aggregate of 2,156,250 shares of common stock (the “Founder Shares”) to the Sponsor for an aggregate purchase price of $25,000. On September 30, 2020, LifeSci Holdings LLC transferred 215,625 Founder Shares to Chardan Healthcare Investments LLC, an investor in the Sponsor. The Founder Shares included an aggregate of up to 153,990 shares of common stock that remained subject to forfeiture by the Sponsor, following the underwriters’ election to partially exercise their over-allotment option so that the number of Founder Shares would collectively represent 20% of the Company’s issued and outstanding shares upon the completion of the Initial Public Offering. On January 8, 2021, the underwriters’ election to exercise their remaining over-allotment option expired unexercised, resulting in 127,260 shares no longer subject to forfeiture and the forfeiture of 153,990 shares. Accordingly, as of January 8, 2021, there were 2,002,260 Founder Shares issued and outstanding. The Sponsor and Chardan Healthcare Investments LLC have agreed that, subject to certain limited exceptions, 50% of the Founder Shares will not be transferred, assigned, sold or released from escrow until the earlier of (i) six months after the date of the consummation of a Business Combination or (ii) the date on which the closing price of the Company’s shares of common stock equals or exceeds $12.50 per share (as adjusted for stock splits, stock dividends, reorganizations and recapitalizations) for any 20 trading days within any 30‑trading day period commencing after a Business Combination and the remaining 50% of the Founder Shares will not be transferred, assigned, sold or released from escrow until six months after the date of the consummation of a Business Combination, or earlier, in either case, if, subsequent to a Business Combination, the Company consummates a subsequent liquidation, merger, stock exchange or other similar transaction which results in all of the stockholders having the right to exchange their shares of common stock for cash, securities or other property. Administrative Support Agreement The Company entered into an agreement, commencing on November 20, 2020 through the earlier of the Company’s consummation of a Business Combination and its liquidation, to pay an affiliate of the Sponsor a total of $10,000 per month for office space, utilities and secretarial support. For the three and nine months ended March 31, 2021, the Company incurred $30,000 and $40,000, respectively, in fees for these services, of which $40,000 is included in accrued expenses in the accompanying unaudited condensed balance sheets. Promissory Note — Related Party On June 19, 2020, the Company issued an unsecured promissory note to the Sponsor (the “Promissory Note”), pursuant to which the Company could borrow up to an aggregate principal amount of $175,000. The Promissory Note was non-interest bearing and payable within 15 days of the Sponsor providing the Company with written notice of demand. The outstanding balance under the Promissory Note of $175,000 was repaid at the closing of the Initial Public Offering on November 24, 2020. Related Party Loans In order to finance transaction costs in connection with a Business Combination, the Sponsor, an affiliate of the Sponsor, or the Company’s officers and directors may, but are not obligated to, loan the Company funds from time to time or at any time, as may be required (“Working Capital Loans”). Each Working Capital Loan would be evidenced by a promissory note. The Working Capital Loans would be paid upon consummation of a Business Combination, without interest or, at the lender’s discretion, up to $500,000 of such Working Capital Loans may be converted into warrants of the post Business Combination entity at a price of $0.90 per warrant. In the event that a Business Combination does not close, the Company may use a portion of the proceeds held outside the Trust Account to repay the Working Capital Loans, but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. The warrants would be identical to the Private Warrants. As of March 31, 2021 and June 30, 2020, the Company had no outstanding borrowings under the Working Capital Loans. <div /></div> </div>

175000

-1000

-186762

<div> <div> The following table reflects the calculation of basic and diluted net loss per common share (in dollars, except per share amounts):   <div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.14%;"> <tr> <td valign="bottom" style="width:54.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:54.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:10.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> For the Period  </td> </tr> <tr> <td valign="bottom" style="width:54.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:10.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> from December 18, </td> </tr> <tr> <td valign="bottom" style="width:54.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:10.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> 2019 </td> </tr> <tr> <td valign="bottom" style="width:54.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Three Months  </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Three Months  </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Nine Months  </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:10.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> (inception)  </td> </tr> <tr> <td valign="bottom" style="width:54.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Ended </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Ended </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Ended </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:10.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Through </td> </tr> <tr> <td valign="bottom" style="width:54.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> March 31,  </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> March 31,  </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> March 31,  </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:10.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> March 31,  </td> </tr> <tr> <td valign="bottom" style="width:54.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> 2021 </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> 2021 </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> 2021 </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:10.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> 2020 </td> </tr> <tr> <td valign="bottom" style="width:54.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Redeemable Common Stock </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">    </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">    </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">    </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:09.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">    </td> </tr> <tr> <td valign="bottom" style="width:54.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Numerator: Earnings allocable to Redeemable Common Stock </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">    </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">    </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">    </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:09.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">    </td> </tr> <tr> <td valign="bottom" style="width:54.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Interest Income </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 14,752 </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">  — </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 19,593 </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">  — </td> </tr> <tr> <td valign="bottom" style="width:54.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Income and Franchise Tax </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> (14,752) </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">  — </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> (19,593) </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:09.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">  — </td> </tr> <tr> <td valign="bottom" style="width:54.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Net earnings </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">  — </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">  — </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">  — </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">  — </td> </tr> <tr> <td valign="bottom" style="width:54.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Denominator: Weighted Average Redeemable Common Stock </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">    </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">    </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">    </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:09.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">    </td> </tr> <tr> <td valign="bottom" style="width:54.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Redeemable Common Stock, Basic and Diluted </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 8,009,041 </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">  — </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 8,009,041 </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">  — </td> </tr> <tr> <td valign="bottom" style="width:54.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Earnings/Basic and Diluted Redeemable Common Stock </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;;font-weight:bold;color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;padding-right:3pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>0.00 </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">  — </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;;font-weight:bold;color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;padding-right:3pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>0.00 </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:09.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">  — </td> </tr> <tr> <td valign="bottom" style="width:54.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:54.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Non-Redeemable Common Stock </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">    </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">    </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">    </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:09.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">    </td> </tr> <tr> <td valign="bottom" style="width:54.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Numerator: Net Loss minus Redeemable Net Earnings </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">    </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">    </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">    </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">    </td> </tr> <tr> <td valign="bottom" style="width:54.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Net loss </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> (105,139) </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">  — </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> (185,762) </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:09.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> (1,000) </td> </tr> <tr> <td valign="bottom" style="width:54.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Redeemable earnings </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> — </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">  — </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> — </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">  — </td> </tr> <tr> <td valign="bottom" style="width:54.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Non-Redeemable Net Loss </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> (105,139) </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">  — </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> (185,762) </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:09.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> (1,000) </td> </tr> <tr> <td valign="bottom" style="width:54.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Denominator: Weighted Average Non-Redeemable Common Stock </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">    </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">    </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">    </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">    </td> </tr> <tr> <td valign="bottom" style="width:54.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Non-Redeemable Common Stock, Basic and Diluted </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 1,990,948 </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 1,875,000 </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 1,913,085 </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:09.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 1,875,000 </td> </tr> <tr> <td valign="bottom" style="width:54.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Loss/Basic and Diluted Non-Redeemable Common Stock </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> (0.05) </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-weight:bold;color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(0.00) </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> (0.10) </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-weight:bold;color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;padding-right:3pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>0.00 </td> </tr> </table></div>   <div /></div> </div>

10.00

2156250

2564582

2421106

<div> <div> NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form 10‑Q and Article 8 of Regulation S-X of the SEC. Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented. The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s prospectus for its Initial Public Offering as filed with the SEC on November 23, 2020, as well as the Company’s Current Reports on Form 8‑K, as filed with the SEC on November 25, 2020, and December 1, 2020. The interim results for the three and nine months ended March 31, 2021 are not necessarily indicative of the results to be expected for the year ending June 30, 2021 or for any future interim periods. Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. Use of Estimates The preparation of the unaudited condensed financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statement, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of March 31, 2021 and June 30, 2020. Common Stock Subject to Possible Redemption The Company accounts for its common stock subject to possible redemption in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” Common stock subject to mandatory redemption is classified as a liability instrument and is measured at fair value. Conditionally redeemable common stock (including common stock that features redemption rights that is either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, common stock is classified as stockholders’ equity. The Company’s common stock features certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, at March 31, 2021, common stock subject to possible redemption is presented as temporary equity, outside of the stockholders’ equity section of the Company’s unaudited condensed balance sheet. Offering Costs Offering costs consist of legal, accounting, underwriting fees and other costs incurred through the balance sheet date that are directly related to the Initial Public Offering. Offering costs amounting to $1,858,498 were charged to stockholders’ equity upon the completion of the Initial Public Offering. Income Taxes The Company complies with the accounting and reporting requirements of ASC Topic 740 “Income Taxes,” which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. As of March 31, 2021, the Company had a deferred tax asset of approximately $39,000, which had a full valuation allowance recorded against it of approximately $39,000. The Company’s currently taxable income primarily consists of interest income on the Trust Account. The Company’s general and administrative costs are generally considered start-up costs and are not currently deductible. During the three and nine months ended March 31, 2021 the Company recorded no income tax expense. The Company’s effective tax rate for the three and nine months ended March 31, 2021 was zero, which differs from the expected income tax rate due to the start-up costs which are not currently deductible. ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of March 31, 2021 and June 30, 2020. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company may be subject to potential examination by federal, state and city taxing authorities in the areas of income taxes. These potential examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with federal, state and city tax laws. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months. The Company is subject to income tax examinations by major taxing authorities since inception. Net Loss Per Common Share Net loss per common share is computed by dividing net loss by the weighted average number of common shares outstanding for the period. The Company has not considered the effect of warrants sold in connection with the private placement to purchase 3,146,454 shares of common stock in the calculation of diluted loss per common share, since the exercise of the warrants are contingent upon the occurrence of future events and the inclusion of such warrants would be anti-dilutive under the treasury stock method. The Company’s unaudited condensed statements of operations includes a presentation of loss per share for common shares subject to possible redemption in a manner similar to the two-class method of loss per share. Net income per common share, basic and diluted, for redeemable common stock is calculated by dividing the interest income earned on the Trust Account, less applicable franchise and income taxes, by the weighted average number of redeemable common stock outstanding for the period. Net loss per common share, basic and diluted, for non-redeemable common stock is calculated by dividing the net loss, less income attributable to redeemable common stock, by the weighted average number of non-redeemable common stock outstanding for the period. Weighted average shares were reduced for the effect of an aggregate of 281,250 shares of common stock that were subject to forfeiture if the over-allotment option was not exercised by the underwriters. Non-redeemable common stock includes the Founder Shares as these shares do not have any redemption features and do not participate in the income earned on the Trust Account. The following table reflects the calculation of basic and diluted net loss per common share (in dollars, except per share amounts):   <div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.14%;"> <tr> <td valign="bottom" style="width:54.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:54.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:10.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> For the Period  </td> </tr> <tr> <td valign="bottom" style="width:54.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:10.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> from December 18, </td> </tr> <tr> <td valign="bottom" style="width:54.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:10.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> 2019 </td> </tr> <tr> <td valign="bottom" style="width:54.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Three Months  </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Three Months  </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Nine Months  </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:10.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> (inception)  </td> </tr> <tr> <td valign="bottom" style="width:54.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Ended </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Ended </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Ended </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:10.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Through </td> </tr> <tr> <td valign="bottom" style="width:54.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> March 31,  </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> March 31,  </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> March 31,  </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:10.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> March 31,  </td> </tr> <tr> <td valign="bottom" style="width:54.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> 2021 </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> 2021 </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> 2021 </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:10.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> 2020 </td> </tr> <tr> <td valign="bottom" style="width:54.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Redeemable Common Stock </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">    </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">    </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">    </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:09.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">    </td> </tr> <tr> <td valign="bottom" style="width:54.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Numerator: Earnings allocable to Redeemable Common Stock </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">    </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">    </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">    </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:09.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">    </td> </tr> <tr> <td valign="bottom" style="width:54.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Interest Income </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 14,752 </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">  — </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 19,593 </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">  — </td> </tr> <tr> <td valign="bottom" style="width:54.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Income and Franchise Tax </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> (14,752) </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">  — </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> (19,593) </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:09.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">  — </td> </tr> <tr> <td valign="bottom" style="width:54.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Net earnings </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">  — </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">  — </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">  — </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">  — </td> </tr> <tr> <td valign="bottom" style="width:54.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Denominator: Weighted Average Redeemable Common Stock </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">    </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">    </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">    </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:09.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">    </td> </tr> <tr> <td valign="bottom" style="width:54.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Redeemable Common Stock, Basic and Diluted </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 8,009,041 </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">  — </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 8,009,041 </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">  — </td> </tr> <tr> <td valign="bottom" style="width:54.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Earnings/Basic and Diluted Redeemable Common Stock </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;;font-weight:bold;color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;padding-right:3pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>0.00 </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">  — </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;;font-weight:bold;color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;padding-right:3pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>0.00 </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:09.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">  — </td> </tr> <tr> <td valign="bottom" style="width:54.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:54.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Non-Redeemable Common Stock </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">    </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">    </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">    </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:09.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">    </td> </tr> <tr> <td valign="bottom" style="width:54.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Numerator: Net Loss minus Redeemable Net Earnings </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">    </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">    </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">    </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">    </td> </tr> <tr> <td valign="bottom" style="width:54.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Net loss </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> (105,139) </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">  — </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> (185,762) </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:09.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> (1,000) </td> </tr> <tr> <td valign="bottom" style="width:54.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Redeemable earnings </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> — </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">  — </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> — </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">  — </td> </tr> <tr> <td valign="bottom" style="width:54.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Non-Redeemable Net Loss </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> (105,139) </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">  — </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> (185,762) </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:09.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> (1,000) </td> </tr> <tr> <td valign="bottom" style="width:54.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Denominator: Weighted Average Non-Redeemable Common Stock </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">    </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">    </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">    </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">    </td> </tr> <tr> <td valign="bottom" style="width:54.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Non-Redeemable Common Stock, Basic and Diluted </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 1,990,948 </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 1,875,000 </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 1,913,085 </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:09.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 1,875,000 </td> </tr> <tr> <td valign="bottom" style="width:54.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Loss/Basic and Diluted Non-Redeemable Common Stock </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> (0.05) </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-weight:bold;color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(0.00) </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> (0.10) </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-weight:bold;color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;padding-right:3pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>0.00 </td> </tr> </table></div>   Note: As of March 31, 2021, basic and diluted shares are the same as there are no non-redeemable securities that are dilutive to the Company’s stockholders. Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account. Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurement,” approximates the carrying amounts represented in the accompanying unaudited condensed balance sheets, primarily due to their short-term nature. Recent Accounting Pronouncements In August 2020, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2020-06, Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity's Own Equity (Subtopic 815-40) ("ASU 2020-06") to simplify accounting for certain financial instruments. ASU 2020-06 eliminates the current models that require separation of beneficial conversion and cash conversion features from convertible instruments and simplifies the derivative scope exception guidance pertaining to equity classification of contracts in an entity's own equity. The new standard also introduces additional disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entity's own equity. ASU 2020-06 amends the diluted earnings per share guidance, including the requirement to use the if-converted method for all convertible instruments. ASU 2020-06 is effective January 1, 2022 and should be applied on a full or modified retrospective basis, with early adoption permitted beginning on January 1, 2021. We are currently assessing the impact, if any, that ASU 2020-06 would have on its financial position, results of operations or cash flows. Management does not believe that any other recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s unaudited condensed financial statements. <div /></div> </div>

-1000

24000

24784

216

-1000

24000

24784

216

-1000

23920

24784

216

-1080

5000008

5081375

256

-81623

5000009

5186529

242

-186762

<div> <div> NOTE 7. STOCKHOLDERS’ EQUITY Preferred Stock — The Company is authorized to issue 1,000,000 shares of preferred stock with a par value of $0.0001 per share with such designations, voting and other rights and preferences as may be determined from time to time by the Company’s board of directors. At March 31, 2021, there were no shares of preferred stock issued or outstanding. Common Stock — The Company is authorized to issue 30,000,000 shares of common stock with a par value of $0.0001 per share. Holders of the Company’s common stock are entitled to one vote for each share. At March 31, 2021, there were 2,421,106 shares of common stock issued and outstanding, excluding 7,590,195 shares of common stock subject to possible redemption. Warrants —The Private Warrants will become exercisable at any time commencing on the later of (1) one year after the closing of the Initial Public Offering or (2) the consummation of a Business Combination; provided that the Company has an effective and current registration statement covering the shares of common stock issuable upon the exercise of the Public Warrants and a current prospectus relating to such shares of common stock. The Private Warrants purchased by the Sponsor will be exercisable on a cashless basis and not be exercisable more than five years from the commencement of sales of the Initial Public Offering, in accordance with FINRA Rule 5110(g)(8)(A), as long as the Sponsor or any of its related persons beneficially own these Private Warrants. <div /></div> </div>

2156250

215625

8009041

25000

78231912

78231111

801

153990

-15

<div> <div> NOTE 9. SUBSEQUENT EVENTS The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the unaudited condensed financial statements were issued. Based upon this review, other than as described below, the Company did not identify any subsequent events that would have required adjustment or disclosure in the unaudited condensed financial statements. On May 6, 2021, the Company entered into an Agreement and Plan of Merger with Science 37, Inc., a company focused on providing customers with a platform to access clinical research. Completion of the transaction is subject to approval of the Company's stockholders and the satisfaction or waiver of certain other customary closing conditions. <div /></div> </div>

75901950

10.00

7590195

P5Y

1875000

1913085

8009041

1990948

8009041

EX-101.SCH 7 lsaq-20210331.xsd XBRL TAXONOMY EXTENSION SCHEMA 00100 - Statement - CONDENSED BALANCE SHEET link:presentationLink link:calculationLink link:definitionLink 00200 - Statement - CONDENSED STATEMENTS OF OPERATIONS link:presentationLink link:calculationLink link:definitionLink 00400 - Statement - CONDENSED STATEMENT OF CASH FLOWS link:presentationLink link:calculationLink link:definitionLink 40202 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Net Income (Loss) Per Common Share (Details) link:presentationLink link:calculationLink link:definitionLink 40801 - Disclosure - FAIR VALUE MEASUREMENTS - Gross holding gains and fair value of held-to-maturity securities (Details) link:presentationLink link:calculationLink link:definitionLink 00090 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 00105 - Statement - CONDENSED BALANCE SHEET (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00300 - Statement - CONDENSED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY link:presentationLink link:calculationLink link:definitionLink 00305 - Statement - CONDENSED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 10401 - Disclosure - PRIVATE PLACEMENT link:presentationLink link:calculationLink link:definitionLink 10501 - Disclosure - RELATED PARTY TRANSACTIONS link:presentationLink link:calculationLink link:definitionLink 40101 - Disclosure - DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 40201 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Class A Common Stock Subject to Possible Redemption (Details) link:presentationLink link:calculationLink link:definitionLink 40301 - Disclosure - PUBLIC OFFERING (Details) link:presentationLink link:calculationLink link:definitionLink 40401 - Disclosure - PRIVATE PLACEMENT (Details) link:presentationLink link:calculationLink link:definitionLink 40501 - Disclosure - RELATED PARTY TRANSACTIONS - Founder Shares (Details) link:presentationLink link:calculationLink link:definitionLink 40502 - Disclosure - RELATED PARTY TRANSACTIONS - Additional information (Details) link:presentationLink link:calculationLink link:definitionLink 40602 - Disclosure - COMMITMENTS - Underwriting Agreement (Details) link:presentationLink link:calculationLink link:definitionLink 40603 - Disclosure - COMMITMENTS - Business combination marketing agreement (Details) link:presentationLink link:calculationLink link:definitionLink 40702 - Disclosure - STOCKHOLDERS' EQUITY - Common Stock Shares (Details) link:presentationLink link:calculationLink link:definitionLink 40703 - Disclosure - STOCKHOLDERS' EQUITY - Warrants (Details) link:presentationLink link:calculationLink link:definitionLink 10101 - Disclosure - DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS link:presentationLink link:calculationLink link:definitionLink 10201 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES link:presentationLink link:calculationLink link:definitionLink 10301 - Disclosure - PUBLIC OFFERING link:presentationLink link:calculationLink link:definitionLink 10601 - Disclosure - COMMITMENTS link:presentationLink link:calculationLink link:definitionLink 10701 - Disclosure - STOCKHOLDERS' EQUITY link:presentationLink link:calculationLink link:definitionLink 10801 - Disclosure - FAIR VALUE MEASUREMENTS link:presentationLink link:calculationLink link:definitionLink 10901 - Disclosure - SUBSEQUENT EVENTS link:presentationLink link:calculationLink link:definitionLink 20202 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) link:presentationLink link:calculationLink link:definitionLink 30203 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) link:presentationLink link:calculationLink link:definitionLink 30803 - Disclosure - FAIR VALUE MEASUREMENTS (Tables) link:presentationLink link:calculationLink link:definitionLink 40203 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) link:presentationLink link:calculationLink link:definitionLink 40601 - Disclosure - COMMITMENTS - Registration and Stockholder Rights (Details) link:presentationLink link:calculationLink link:definitionLink 40701 - Disclosure - STOCKHOLDERS' EQUITY - Preferred Stock Shares (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 8 lsaq-20210331_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 9 lsaq-20210331_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 10 lsaq-20210331_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Document and Entity Information Document Information [Table] Document Information [Line Items] Document Type Document Period End Date Entity Registrant Name Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Entity Ex Transition Period Entity Shell Company Entity Common Stock, Shares Outstanding Entity Central Index Key Current Fiscal Year End Date Document Fiscal Year Focus Document Fiscal Period Focus Amendment Flag Trading Symbol Title of 12(b) Security Security Exchange Name CONDENSED BALANCE SHEET Statement [Table] Statement [Line Items] Assets [Abstract] ASSETS Assets, Current [Abstract] Current assets Cash and Cash Equivalents, at Carrying Value Cash Prepaid Expense, Current Prepaid expenses Assets, Current Total Current Assets Deferred Costs, Noncurrent Deferred offering costs Assets Held-in-trust, Noncurrent Cash and marketable securities held in Trust Account Assets held in the Trust Account Assets TOTAL ASSETS Liabilities and Equity [Abstract] LIABILITIES AND STOCKHOLDERS' EQUITY Liabilities, Current [Abstract] Current liabilities Accounts Payable and Accrued Liabilities, Current Accounts payable and accrued expenses Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to offering costs (due within one year or within the normal operating cycle if longer). Accrued Offering Costs, Current Accrued offering costs Liabilities Total Liabilities Commitments and Contingencies. Commitments and Contingencies Temporary Equity, Carrying Amount, Attributable to Parent Common stock subject to possible redemption, 7,590,195 shares at $10.00 per share Stockholders' Equity Attributable to Parent [Abstract] Stockholders' Equity Preferred Stock, Value, Issued Preferred stock, $0.0001 par value; 1,000,000 shares authorized; no shares issued and outstanding Common Stock, Value, Issued Common stock, $0.0001 par value; 30,000,000 shares authorized; 2,421,106 and 2,156,250 shares issued and outstanding (excluding 7,590,195 and no shares subject to possible redemption) at March 31, 2021 and June 30, 2020, respectively Additional Paid in Capital Additional paid-in capital Retained Earnings (Accumulated Deficit) Accumulated deficit Stockholders' Equity Attributable to Parent Balance at the end Balance at the beginning Total Stockholders' Equity Liabilities and Equity TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY Class of Stock [Axis] Class Of Stock [Domain] Class of Stock [Domain] Represents information pertaining to common stock subject to redemption. Common Stock Subject To Redemption [Member] Common stock subject to possible redemption Temporary Equity, Shares Outstanding Shares subject to possible redemption Temporary Equity, Par or Stated Value Per Share Shares subject to possible redemption, par value per share Preferred Stock, Par or Stated Value Per Share Preferred stock, par value Preferred shares, par value Preferred Stock, Shares Authorized Preferred stock, shares authorized Preferred shares, shares authorized Preferred Stock, Shares Issued Preferred stock, shares issued Preferred shares, shares issued Preferred Stock, Shares Outstanding Preferred stock, shares outstanding Preferred shares, shares outstanding Common Stock, Par or Stated Value Per Share Common stock, par value Common shares, par value (in dollars per share) Common Stock, Shares Authorized Common stock, shares authorized Common shares, shares authorized (in shares) Common Stock, Shares, Issued Common stock, shares issued Common shares, shares issued (in shares) Common Stock, Shares, Outstanding Common stock, shares outstanding Common shares, shares outstanding (in shares) Represents the maximum number of common stock shares subject to forfeiture. Maximum Common Stock, Shares Subject To Forfeiture Maximum shares subject to forfeiture Maximum shares subject to forfeiture (in shares) CONDENSED STATEMENTS OF OPERATIONS Represents member information pertaining to redeemable common stock. Redeemable Common Stock [Member] Redeemable common stock Represents member information pertaining to non-redeemable common stock. Non Redeemable Common Stock [Member] Non-redeemable common stock Amount of formation and operating costs incurred during the period. Formation And Operating Costs Formation and operating costs Operating Income (Loss) Loss from operations Nonoperating Income (Expense) [Abstract] Other income: Investment Income, Interest Interest earned on marketable securities held in Trust Account Interest earned on marketable securities held in Trust Account Interest Income Net Income (Loss) Attributable to Parent Net loss Net loss Weighted Average Number of Shares Outstanding, Basic and Diluted Weighted average shares outstanding of common stock Weighted average shares outstanding of common stock, Basic and Diluted Earnings Per Share, Basic and Diluted Basic and diluted net loss per common share CONDENSED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY Equity Components [Axis] Equity Component [Domain] Equity Component [Domain] Common Stock [Member] Common Stock Additional Paid In Capital [Member] Additional Paid-in Capital Retained Earnings [Member] Accumulated Deficit Increase (Decrease) in Stockholders' Equity [Roll Forward] Shares, Issued Balance at the end (in shares) Balance at the beginning (in shares) Stock Issued During Period, Value, New Issues Aggregate purchase price Stock Issued During Period, Shares, New Issues Sale of Public Shares (in shares) Adjustments to Additional Paid in Capital, Warrant Issued Sale of 3,146,454 Private Warrants This represents classification of stock to temporary equity. Classification of Stock to Temporary Equity Common stock subject to possible redemption This represents Classification of stock to temporary equity shares Classification of Stock to Temporary Equity Shares Common stock subject to possible redemption (in shares) Stock Repurchased and Retired During Period, Value Forfeiture of Founder Shares Stock Repurchased and Retired During Period, Shares Forfeiture of Founder Shares (in shares) Amount of common stock to sponsor. Stock Issued During Period, Value, Common Stock To Sponsor Issuance of common stock to Sponsor Number of common stock to sponsor. Stock Issued During Period, Shares, Common Stock To Sponsor Issuance of common stock to Sponsor (in shares) Number of new warrants issued during the period. Warrants issued During Period, Shares, New Issues Sale of warrants (in shares) CONDENSED STATEMENT OF CASH FLOWS Cash Flows from Operating Activities: Net loss Net loss Adjustments to reconcile net loss to net cash used in operating activities: Changes in operating assets and liabilities: Increase (Decrease) in Prepaid Expense Prepaid expenses Increase (Decrease) in Accounts Payable and Accrued Liabilities Accounts payable and accrued expenses Net Cash Provided by (Used in) Operating Activities Net cash used in operating activities Cash Flows from Investing Activities: Represents the investment of cash into trust account. Investment of Cash into Trust Account Investment of cash in Trust Account Net Cash Provided by (Used in) Investing Activities Net cash used in investing activities Cash Flows from Financing Activities: Proceeds from Issuance of Common Stock Proceeds from sale of common stock Proceeds from Issuance of Warrants Proceeds from sale of Private Warrants Aggregate purchase price Proceeds from Related Party Debt Proceeds from promissory note - related party Repayments of Related Party Debt Repayment of promissory note - related party Repayment of promissory note - related party Payments of Stock Issuance Costs Payments of offering costs Net Cash Provided by (Used in) Financing Activities Net cash provided by financing activities Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Net Change in Cash Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Cash - Ending Cash - Beginning Supplemental Disclosure of Non-Cash Investing and Financing Activities: Non-Cash Investing and Financing Activities: Represents the amount of initial classification of common stock subject to possible redemption in a non cash investing and financing activities. Initial Classification Of Common Stock Subject To Possible Redemption Initial classification of common stock subject to possible redemption Represents the amount of change in value of common stock subject to possible redemption in a non cash investing and financing activities. Change In Value Of Common Stock Subject To Possible Redemption Change in value of common stock subject to possible redemption DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Significant Accounting Policies [Text Block] SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES No definition available. PUBLIC OFFERING The entire disclosure on information about initial public offering. Initial Public Offering [Text Block] PUBLIC OFFERING No definition available. PRIVATE PLACEMENT The entire disclosure on information about private placement. Private Placement [Text Block] PRIVATE PLACEMENT RELATED PARTY TRANSACTIONS Related Party Transactions Disclosure [Text Block] RELATED PARTY TRANSACTIONS COMMITMENTS Commitments and Contingencies Disclosure [Text Block] COMMITMENTS STOCKHOLDERS' EQUITY Stockholders' Equity Note Disclosure [Text Block] STOCKHOLDERS' EQUITY FAIR VALUE MEASUREMENTS Fair Value Disclosures [Text Block] FAIR VALUE MEASUREMENTS SUBSEQUENT EVENTS Subsequent Events [Text Block] SUBSEQUENT EVENTS Basis of Accounting, Policy [Policy Text Block] Basis of Presentation Represents the accounting policy on Emerging Growth Company. Emerging Growth Company [Policy Text Block] Emerging Growth Company Use of Estimates, Policy [Policy Text Block] Use of Estimates Cash and Cash Equivalents, Policy [Policy Text Block] Cash and Cash Equivalents Represents the accounting policy on common stock subject to possible redemption. Common Stock Subject to Possible Redemption [Policy Text Block] Common Stock Subject to Possible Redemption Represents the accounting policy on offering costs. Offering Costs [Policy Text Block] Offering Costs Income Tax, Policy [Policy Text Block] Income Taxes Earnings Per Share, Policy [Policy Text Block] Net Loss Per Common Share Concentration Risk, Credit Risk, Policy [Policy Text Block] Concentration of Credit Risk Fair Value of Financial Instruments, Policy [Policy Text Block] Fair Value of Financial Instruments New Accounting Pronouncements, Policy [Policy Text Block] Recent Accounting Standards Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Summary of the calculation of basic and diluted net loss per common share Fair Value, Assets Measured on Recurring Basis [Table Text Block] Summary of assets that are measured at fair value on a recurring basis Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table] Sale of Stock [Axis] Sale Of Stock Name Of Transaction [Domain] Sale of Stock [Domain] I P O [Member] Initial Public Offering Over Allotment Option [Member] Over-allotment Private Placement [Member] Private Placement Subsidiary, Sale of Stock [Line Items] Number of new units issued during the period. Units Issued During Period, Shares, New Issues Number of units issued Share Price Share price per share Price per share This represents Proceeds from Sale of Units. Proceeds From Sale Of Units Gross proceeds from sale of units Class of Warrant or Right, Number of Securities Called by Warrants or Rights Number of warrants issued Price per share or per unit of warrants or rights outstanding. Class of Warrant or Right, Price of Warrants or Rights Price of warrants Exercise price of warrants Represents the amount of transaction costs incurred on sale of stock. Sale of Stock, Transaction Costs Transaction costs Represents the amount of underwriting fees incurred on sale of stock. Sale of Stock, Underwriting fees Cash underwriting fees Represents the amount of other offering costs incurred on sale of stock. Sale of Stock, Other Offering Costs Other offering costs Represents the threshold minimum aggregate fair market value as a percentage of the assets held in the Trust Account. Threshold Minimum Aggregate Fair Market Value As A Percentage Of The Assets Held In The Trust Account Threshold minimum aggregate fair market value as a percentage of the assets held in the Trust Account Represents the threshold percentage of outstanding voting securities of the target to be acquired by post-transaction company to complete business combination. Threshold Percentage Of Outstanding Voting Securities Of The Target To Be Acquired By Post-Transaction Company To Complete Business Combination Threshold percentage of outstanding voting securities of the target to be acquired by post-transaction company to complete business combination Amount of working capital subject to annual limit. Working Capital Subject to Annual Limit Working capital subject to annual limit Represents the minimum net tangible assets upon consummation of the Business Combination. Minimum Net Tangible Assets Upon Consummation Of Business Combination Minimum net tangible assets upon consummation of the Business Combination This represents threshold percentage of Public Shares subject to redemption without the Company's prior written consent Threshold Percentage of Public Shares Subject to Redemption Without the Company's Prior Written Consent Threshold percentage of Public Shares subject to redemption without the Company's prior written consent Represents the threshold percentage of Obligation to redeem Public Shares if entity does not complete a Business Combination. Percentage Obligation To Redeem Public Shares If Entity Does Not Complete A Business Combination Obligation to redeem Public Shares if entity does not complete a Business Combination (as a percent) Represents the threshold business days for redemption of public shares. Threshold Business Days for Redemption of Public Shares Threshold business days for redemption of public shares Deferred Tax Assets, Gross Deferred tax asset Deferred Tax Assets, Valuation Allowance Valuation allowance on deferred tax asset Income Tax Expense (Benefit) Income tax expense Effective Income Tax Rate Reconciliation, Percent Effective tax rate (as a percent) Unrecognized Tax Benefits Unrecognized tax benefits Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued Unrecognized tax benefits accrued for interest and penalties Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Shares excluded since their inclusion would be anti-dilutive Number of shares of common stock subject to forfeiture. Weighted Average Number of Shares, Common Stock Subject to Forfeiture Common stock that were subject to forfeiture n/a Redeemable Common Stock [Abstract] Redeemable Common Stock The amount of income and franchise tax. Income And Franchise Tax Income and Franchise Tax The amount of redeemable net earnings (loss). Redeemable Net Earnings Loss Redeemable Net Earnings Net earnings n/a Non-Redeemable Common Stock [Abstract] Non-Redeemable Common Stock The amount of non-redeemable net earnings (loss). Non Redeemable Net Earnings Loss Non-Redeemable Net Loss Amount of federal depository insurance coverage. Federal Depository Insurance Coverage Federal Depository Insurance Coverage Class of Warrant or Right, Number of Securities Called by Each Warrant or Right Number of shares per warrant Class of Warrant or Right, Exercise Price of Warrants or Rights Exercise price of warrant Schedule of Related Party Transactions, by Related Party [Table] Related Party [Axis] Related Party [Domain] Related Party [Domain] This member stands for sponsor. Sponsor [Member] Sponsor Related Party Transaction [Axis] Related Party Transaction [Domain] Related Party Transaction [Domain] This represents Founder Shares member. Founder Shares [Member] Founder Shares Related Party Transaction [Line Items] Represents the percentage of issued and outstanding shares after the Initial Public Offering collectively held by initial stockholders. Percentage Of Issued And Outstanding Shares After The Initial Public Offering Collectively Held By Initial Stockholders Percentage of issued and outstanding shares after the Initial Public Offering collectively held by initial stockholders Number of shares of the company that are subject to forfeiture during the period. Number Of Shares Subject To Forfeiture Number of shares subject to forfeiture (in shares) Number of shares if the company that are cease to be subject to forfeiture during the period. Number Of Shares Not Subject To Forfeiture Number of shares not subject to forfeiture EX-101.PRE 11 lsaq-20210331_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 12 R1.htm IDEA: XBRL DOCUMENT

Document and Entity Information - shares	9 Months Ended
Document and Entity Information - shares	Mar. 31, 2021	May 14, 2021
Document and Entity Information
Document Type	10-Q
Document Period End Date	Mar. 31, 2021
Entity Registrant Name	Lifesci Acquisition II Corp.
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Shell Company	true
Entity Common Stock, Shares Outstanding		10,011,301
Entity Central Index Key	0001819113
Current Fiscal Year End Date	--06-30
Document Fiscal Year Focus	2021
Document Fiscal Period Focus	Q3
Amendment Flag	false
Trading Symbol	LSAQ
Title of 12(b) Security	Shares of Common Stock, $0.0001 par value
Security Exchange Name	NASDAQ

XML 13 R2.htm IDEA: XBRL DOCUMENT

CONDENSED BALANCE SHEET - USD ($)	Mar. 31, 2021	Jun. 30, 2020
Current assets
Cash	$ 727,926	$ 25,000
Prepaid expenses	153,348
Total Current Assets	881,274	25,000
Deferred offering costs		28,000
Cash and marketable securities held in Trust Account	80,110,005
TOTAL ASSETS	80,991,279	53,000
Current liabilities
Accounts payable and accrued expenses	89,320	1,000
Accrued offering costs		28,000
Total Liabilities	89,320	29,000
Commitments and Contingencies
Common stock subject to possible redemption, 7,590,195 shares at $10.00 per share	75,901,950
Stockholders' Equity
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; no shares issued and outstanding
Common stock, $0.0001 par value; 30,000,000 shares authorized; 2,421,106 and 2,156,250 shares issued and outstanding (excluding 7,590,195 and no shares subject to possible redemption) at March 31, 2021 and June 30, 2020, respectively	242	216
Additional paid-in capital	5,186,529	24,784
Accumulated deficit	(186,762)	(1,000)
Total Stockholders' Equity	5,000,009	24,000
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	$ 80,991,279	$ 53,000

XML 14 R3.htm IDEA: XBRL DOCUMENT

CONDENSED BALANCE SHEET (Parenthetical) - $ / shares	Mar. 31, 2021	Jun. 30, 2020
Shares subject to possible redemption	7,590,195	0
Preferred stock, par value	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	1,000,000	1,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value	$ 0.0001	$ 0.0001
Common stock, shares authorized	30,000,000	30,000,000
Common stock, shares issued	2,421,106	2,156,250
Common stock, shares outstanding	2,421,106	2,156,250
Common stock subject to possible redemption
Shares subject to possible redemption	7,590,195	7,590,195
Shares subject to possible redemption, par value per share	$ 10.00	$ 10.00

XML 15 R4.htm IDEA: XBRL DOCUMENT

CONDENSED STATEMENTS OF OPERATIONS - USD ($)	3 Months Ended			9 Months Ended
CONDENSED STATEMENTS OF OPERATIONS - USD ($)	Mar. 31, 2021	Mar. 31, 2020	Mar. 31, 2020	Mar. 31, 2021
Formation and operating costs	$ 119,891	$ 0	$ 1,000	$ 205,355
Loss from operations	(119,891)	0	(1,000)	(205,355)
Other income:
Interest earned on marketable securities held in Trust Account	14,752	0	0	19,593
Net loss	(105,139)	$ 0	$ (1,000)	(185,762)
Redeemable common stock
Other income:
Interest earned on marketable securities held in Trust Account	$ 14,752			$ 19,593
Weighted average shares outstanding of common stock	8,009,041			8,009,041
Basic and diluted net loss per common share	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Non-redeemable common stock
Other income:
Net loss	$ (105,139)		$ (1,000)	$ (185,762)
Weighted average shares outstanding of common stock	1,990,948	1,875,000	1,875,000	1,913,085
Basic and diluted net loss per common share	$ (0.05)	$ 0.00	$ 0.00	$ (0.10)

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1A
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(22))
-URI http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22595-107794

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1B
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599

Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(18))
-URI http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263

Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(20))
-URI http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227

Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)(2)
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 28
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 60B
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22658-107794

+ Details

XML 16 R5.htm IDEA: XBRL DOCUMENT

CONDENSED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Total
Balance at the beginning at Dec. 17, 2019
Balance at the beginning (in shares) at Dec. 17, 2019
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss			(1,000)	(1,000)
Balance at the end at Dec. 31, 2019			(1,000)	(1,000)
Balance at the beginning at Dec. 17, 2019
Balance at the beginning (in shares) at Dec. 17, 2019
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss				(1,000)
Balance at the end at Mar. 31, 2020	$ 216	24,784	(1,000)	24,000
Balance at the end (in shares) at Mar. 31, 2020	2,156,250
Balance at the beginning at Dec. 31, 2019			(1,000)	(1,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock to Sponsor	$ 216	24,784		25,000
Issuance of common stock to Sponsor (in shares)	2,156,250
Net loss				0
Balance at the end at Mar. 31, 2020	$ 216	24,784	(1,000)	24,000
Balance at the end (in shares) at Mar. 31, 2020	2,156,250
Balance at the beginning at Jun. 30, 2020	$ 216	24,784	(1,000)	24,000
Balance at the beginning (in shares) at Jun. 30, 2020	2,156,250
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss			(80)	(80)
Balance at the end at Sep. 30, 2020	$ 216	24,784	(1,080)	23,920
Balance at the end (in shares) at Sep. 30, 2020	2,156,250
Balance at the beginning at Jun. 30, 2020	$ 216	24,784	(1,000)	24,000
Balance at the beginning (in shares) at Jun. 30, 2020	2,156,250
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss				(185,762)
Balance at the end at Mar. 31, 2021	$ 242	5,186,529	(186,762)	5,000,009
Balance at the end (in shares) at Mar. 31, 2021	2,421,106
Balance at the beginning at Sep. 30, 2020	$ 216	24,784	(1,080)	23,920
Balance at the beginning (in shares) at Sep. 30, 2020	2,156,250
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Aggregate purchase price	$ 801	78,231,111		$ 78,231,912
Sale of Public Shares (in shares)	8,009,041			8,009,041
Sale of 3,146,454 Private Warrants		2,831,809		$ 2,831,809
Common stock subject to possible redemption	$ (761)	(76,006,329)		(76,007,090)
Common stock subject to possible redemption (in shares)	(7,600,709)
Net loss			(80,543)	(80,543)
Balance at the end at Dec. 31, 2020	$ 256	5,081,375	(81,623)	5,000,008
Balance at the end (in shares) at Dec. 31, 2020	2,564,582
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock subject to possible redemption	$ 1	105,139		105,140
Common stock subject to possible redemption (in shares)	10,514
Forfeiture of Founder Shares	$ (15)	15
Forfeiture of Founder Shares (in shares)	(153,990)
Net loss			(105,139)	(105,139)
Balance at the end at Mar. 31, 2021	$ 242	$ 5,186,529	$ (186,762)	$ 5,000,009
Balance at the end (in shares) at Mar. 31, 2021	2,421,106

XML 17 R6.htm IDEA: XBRL DOCUMENT

CONDENSED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (Parenthetical)	3 Months Ended
	Dec. 31, 2020 shares
CONDENSED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY
Sale of Public Shares (in shares)	8,009,041
Sale of warrants (in shares)	3,146,454

XML 18 R7.htm IDEA: XBRL DOCUMENT

CONDENSED STATEMENT OF CASH FLOWS - USD ($)	3 Months Ended	9 Months Ended
CONDENSED STATEMENT OF CASH FLOWS - USD ($)	Mar. 31, 2020	Mar. 31, 2021
Cash Flows from Operating Activities:
Net loss	$ (1,000)	$ (185,762)
Adjustments to reconcile net loss to net cash used in operating activities:
Interest earned on marketable securities held in Trust Account	0	(19,593)
Changes in operating assets and liabilities:
Prepaid expenses	0	(153,348)
Accounts payable and accrued expenses	1,000	88,320
Net cash used in operating activities	0	(270,383)
Cash Flows from Investing Activities:
Investment of cash in Trust Account	0	(80,090,412)
Net cash used in investing activities	0	(80,090,412)
Cash Flows from Financing Activities:
Proceeds from sale of common stock	0	78,488,602
Proceeds from sale of Private Warrants	0	2,831,809
Proceeds from promissory note - related party	0	175,000
Repayment of promissory note - related party	0	(175,000)
Payments of offering costs	0	(256,690)
Net cash provided by financing activities	25,000	81,063,721
Net Change in Cash	25,000	702,926
Cash - Beginning	0	25,000
Cash - Ending	25,000	727,926
Non-Cash Investing and Financing Activities:
Initial classification of common stock subject to possible redemption	0	76,087,640
Change in value of common stock subject to possible redemption	0	$ (185,690)
Sponsor
Cash Flows from Financing Activities:
Proceeds from sale of common stock	$ 25,000

XML 19 R8.htm IDEA: XBRL DOCUMENT

DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS	9 Months Ended
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS	Mar. 31, 2021
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS	NOTE 1. DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS LifeSci Acquisition II Corp. (the “Company”) was incorporated in Delaware on December 18, 2019. The Company was formed for the purpose of entering into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business transaction with one or more businesses or entities (a “Business Combination”). Although the Company is not limited to a particular industry or geographic region for purposes of consummating a Business Combination, the Company intends to focus on businesses operating in North America in the healthcare industry. The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies. As of March 31, 2021, the Company had not commenced any operations. All activity through March 31, 2021 relates to the Company’s formation and the initial public offering (“Initial Public Offering”), which is described below, and identifying a target company for a Business Combination. The Company will not generate any operating revenues until after the completion of a Business Combination, at the earliest. The Company generates non-operating income in the form of interest income from the proceeds derived from the Initial Public Offering. The registration statement for the Company’s Initial Public Offering was declared effective on November 20, 2020. On November 24, 2020 the Company consummated the Initial Public Offering of 8,009,041 shares of common stock (the “Public Shares”), which includes the partial exercise by the underwriter of its over-allotment option in the amount of 509,041 Public Shares, at $10.00 per Public Share, generating gross proceeds of $80,090,410 which is described in Note 3. Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 3,146,454 warrants (the “Private Warrants”) at a price of $0.90 per Private Warrant in a private placement to LifeSci Holdings, LLC (the “Sponsor”), an entity affiliated LifeSci Capital LLC, generating gross proceeds of $2,831,809, which is described in Note 4. Transaction costs amounted to $1,858,498, consisting of $1,601,808 in cash underwriting fees and $256,690 of other offering costs. Following the closing of the Initial Public Offering on November 24, 2020, an amount of $80,090,410 ($10.00 per Public Share) from the net proceeds of the sale of the Public Shares in the Initial Public Offering and the sale of the Private Warrants was placed in a trust account (the “Trust Account”), and invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended, or the Investment Company Act, with a maturity of 183 days or less or in any open-ended investment company that holds itself out as a money market fund meeting the conditions of Rule 2a‑7 of the Investment Company Act, as determined by the Company, until the earlier of: (i) the consummation of a Business Combination or (ii) the distribution of the funds in the Trust Account as described below. The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of the Private Warrants, although substantially all of the net proceeds are intended to be applied toward consummating a Business Combination. The Company’s initial Business Combination must be with one or more target businesses that together have a fair market value equal to at least 80% of the balance in the Trust Account (net of amounts previously released to the Company to pay its tax obligations and for working capital purposes, subject to an annual limit of $250,000) at the time of the signing an agreement to enter into a Business Combination. The Company will only complete a Business Combination if the post-Business Combination company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act. There is no assurance that the Company will be able to successfully effect a Business Combination. The Company will provide its stockholders with the opportunity to redeem all or a portion of their Public Shares sold in the Initial Public Offering upon the completion of a Business Combination either (i) in connection with a stockholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek stockholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The stockholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then on deposit in the Trust Account (initially $10.00 per share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations or for working capital purposes). The Company will proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001 upon such consummation of a Business Combination and, if the Company seeks stockholder approval, a majority of the outstanding shares voted are voted in favor of the Business Combination. If a stockholder vote is not required by law and the Company does not decide to hold a stockholder vote for business or other legal reasons, the Company will, pursuant to its Amended and Restated Certificate of Incorporation, conduct the redemptions pursuant to the tender offer rules of the Securities and Exchange Commission (“SEC”), and file tender offer documents with the SEC prior to completing a Business Combination. If, however, a stockholder approval of the transaction is required by law, or the Company decides to obtain stockholder approval for business or other legal reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. If the Company seeks stockholder approval in connection with a Business Combination, the Sponsor and other initial stockholders (collectively, the “Initial Stockholders”) have agreed to (a) vote their Founder Shares (as defined in Note 5), and any Public Shares held by them in favor of a Business Combination and (b) not to convert any shares (including Founder Shares) in connection with a stockholder vote to approve a Business Combination or sell any such shares to the Company in a tender offer in connection with a Business Combination. Additionally, each public stockholder may elect to redeem their Public Shares irrespective of whether they vote for or against the proposed transaction. Notwithstanding the foregoing, if the Company seeks stockholder approval of a Business Combination and the Company does not conduct redemptions pursuant to the tender offer rules, a stockholder, together with any affiliate of such stockholder or any other person with whom such stockholder is acting in concert or as a “group” (as defined in Section 13(d)(3) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming their shares with respect to more than an aggregate of 20% of the Public Shares. The Company will have until November 24, 2022 to consummate a Business Combination (the “Combination Period”). If the Company is unable to complete a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but no more than five business days thereafter, redeem 100% of the outstanding Public Shares, at a per share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned (net of taxes payable), divided by the number of then outstanding Public Shares, which redemption will completely extinguish public stockholders’ rights as stockholders (including the right to receive further liquidation distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining stockholders and the Company’s board of directors, proceed to commence a voluntary liquidation and thereby a formal dissolution of the Company, subject in each case to its obligations to provide for claims of creditors and the requirements of applicable law. The proceeds deposited in the Trust Account could, however, become subject to claims of creditors. The Sponsor and Chardan Healthcare Investments LLC have agreed to (i) waive their redemption rights with respect to Founder Shares and any Public Shares they may acquire during or after the Initial Public Offering in connection with the consummation of a Business Combination, (ii) to waive their rights to liquidating distributions from the Trust Account with respect to their Founder Shares if the Company fails to consummate a Business Combination within the Combination Period and (iii) not to propose an amendment to the Company’s Amended and Restated Certificate of Incorporation that would affect the substance or timing of the Company’s obligation to redeem 100% of its Public Shares if the Company does not complete a Business Combination, unless the Company provides the public stockholders an opportunity to redeem their Public Shares in conjunction with any such amendment. However, the Sponsor will be entitled to liquidating distributions with respect to any Public Shares acquired if the Company fails to consummate a Business Combination or liquidates within the Combination Period. In order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent any claims by a vendor for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below $10.00 per share, except as to any claims by a third party who executed a waiver of any right, title, interest or claim of any kind in or to any monies held in the Trust Account or to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (except the Company’s independent registered public accounting firm), prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.

XML 20 R9.htm IDEA: XBRL DOCUMENT

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

9 Months Ended

Mar. 31, 2021

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form 10‑Q and Article 8 of Regulation S-X of the SEC. Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented.

The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s prospectus for its Initial Public Offering as filed with the SEC on November 23, 2020, as well as the Company’s Current Reports on Form 8‑K, as filed with the SEC on November 25, 2020, and December 1, 2020. The interim results for the three and nine months ended March 31, 2021 are not necessarily indicative of the results to be expected for the year ending June 30, 2021 or for any future interim periods.

Emerging Growth Company

Use of Estimates

Cash and Cash Equivalents

Common Stock Subject to Possible Redemption

Offering Costs

Income Taxes

Net Loss Per Common Share

The following table reflects the calculation of basic and diluted net loss per common share (in dollars, except per share amounts):


							For the Period
							from December 18,
							2019
	Three Months		Three Months		Nine Months		(inception)
	Ended		Ended		Ended		Through
	March 31,		March 31,		March 31,		March 31,
	2021		2021		2021		2020
Redeemable Common Stock	$		$		$		$
Numerator: Earnings allocable to Redeemable Common Stock
Interest Income		14,752		—		19,593		—
Income and Franchise Tax		(14,752)		—		(19,593)		—
Net earnings		—		—		—		—
Denominator: Weighted Average Redeemable Common Stock
Redeemable Common Stock, Basic and Diluted		8,009,041		—		8,009,041		—
Earnings/Basic and Diluted Redeemable Common Stock		0.00		—		0.00		—

Non-Redeemable Common Stock
Numerator: Net Loss minus Redeemable Net Earnings
Net loss		(105,139)		—		(185,762)		(1,000)
Redeemable earnings		—		—		—		—
Non-Redeemable Net Loss		(105,139)		—		(185,762)		(1,000)
Denominator: Weighted Average Non-Redeemable Common Stock
Non-Redeemable Common Stock, Basic and Diluted		1,990,948		1,875,000		1,913,085		1,875,000
Loss/Basic and Diluted Non-Redeemable Common Stock		(0.05)		(0.00)		(0.10)		0.00

Note: As of March 31, 2021, basic and diluted shares are the same as there are no non-redeemable securities that are dilutive to the Company’s stockholders.

Concentration of Credit Risk

Fair Value of Financial Instruments

Recent Accounting Pronouncements

In August 2020, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2020-06, Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity's Own Equity (Subtopic 815-40) ("ASU 2020-06") to simplify accounting for certain financial instruments. ASU 2020-06 eliminates the current models that require separation of beneficial conversion and cash conversion features from convertible instruments and simplifies the derivative scope exception guidance pertaining to equity classification of contracts in an entity's own equity. The new standard also introduces additional disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entity's own equity. ASU 2020-06 amends the diluted earnings per share guidance, including the requirement to use the if-converted method for all convertible instruments. ASU 2020-06 is effective January 1, 2022 and should be applied on a full or modified retrospective basis, with early adoption permitted beginning on January 1, 2021. We are currently assessing the impact, if any, that ASU 2020-06 would have on its financial position, results of operations or cash flows.

XML 21 R10.htm IDEA: XBRL DOCUMENT

PUBLIC OFFERING	9 Months Ended
PUBLIC OFFERING	Mar. 31, 2021
PUBLIC OFFERING
PUBLIC OFFERING	NOTE 3. PUBLIC OFFERING Pursuant to the Initial Public Offering, the Company sold 8,009,041 Public Shares, which includes the partial exercise by the underwriters of their over-allotment option in the amount of 509,041 Public Shares, at a purchase price of $10.00 per Public Share.

XML 22 R11.htm IDEA: XBRL DOCUMENT

PRIVATE PLACEMENT	9 Months Ended
PRIVATE PLACEMENT	Mar. 31, 2021
PRIVATE PLACEMENT
PRIVATE PLACEMENT	NOTE 4. PRIVATE PLACEMENT Simultaneously with the closing of the Initial Public Offering, the Sponsor purchased an aggregate of 3,146,454 Private Warrants at a price of $0.90 per Private Warrant for an aggregate purchase price of $2,831,809. Each Private Warrant is exercisable to purchase one share of common stock at an exercise price of $11.50 per warrant. If the Company does not complete a Business Combination within the Combination Period, the proceeds from the sale of the Private Warrants will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law). There will be no redemption rights or liquidating distributions from the Trust Account with respect to the Private Warrants.

XML 23 R12.htm IDEA: XBRL DOCUMENT

RELATED PARTY TRANSACTIONS	9 Months Ended
RELATED PARTY TRANSACTIONS	Mar. 31, 2021
RELATED PARTY TRANSACTIONS
RELATED PARTY TRANSACTIONS	NOTE 5. RELATED PARTY TRANSACTIONS Founder Shares On January 1, 2020, the Company issued an aggregate of 2,156,250 shares of common stock (the “Founder Shares”) to the Sponsor for an aggregate purchase price of $25,000. On September 30, 2020, LifeSci Holdings LLC transferred 215,625 Founder Shares to Chardan Healthcare Investments LLC, an investor in the Sponsor. The Founder Shares included an aggregate of up to 153,990 shares of common stock that remained subject to forfeiture by the Sponsor, following the underwriters’ election to partially exercise their over-allotment option so that the number of Founder Shares would collectively represent 20% of the Company’s issued and outstanding shares upon the completion of the Initial Public Offering. On January 8, 2021, the underwriters’ election to exercise their remaining over-allotment option expired unexercised, resulting in 127,260 shares no longer subject to forfeiture and the forfeiture of 153,990 shares. Accordingly, as of January 8, 2021, there were 2,002,260 Founder Shares issued and outstanding. The Sponsor and Chardan Healthcare Investments LLC have agreed that, subject to certain limited exceptions, 50% of the Founder Shares will not be transferred, assigned, sold or released from escrow until the earlier of (i) six months after the date of the consummation of a Business Combination or (ii) the date on which the closing price of the Company’s shares of common stock equals or exceeds $12.50 per share (as adjusted for stock splits, stock dividends, reorganizations and recapitalizations) for any 20 trading days within any 30‑trading day period commencing after a Business Combination and the remaining 50% of the Founder Shares will not be transferred, assigned, sold or released from escrow until six months after the date of the consummation of a Business Combination, or earlier, in either case, if, subsequent to a Business Combination, the Company consummates a subsequent liquidation, merger, stock exchange or other similar transaction which results in all of the stockholders having the right to exchange their shares of common stock for cash, securities or other property. Administrative Support Agreement The Company entered into an agreement, commencing on November 20, 2020 through the earlier of the Company’s consummation of a Business Combination and its liquidation, to pay an affiliate of the Sponsor a total of $10,000 per month for office space, utilities and secretarial support. For the three and nine months ended March 31, 2021, the Company incurred $30,000 and $40,000, respectively, in fees for these services, of which $40,000 is included in accrued expenses in the accompanying unaudited condensed balance sheets. Promissory Note — Related Party On June 19, 2020, the Company issued an unsecured promissory note to the Sponsor (the “Promissory Note”), pursuant to which the Company could borrow up to an aggregate principal amount of $175,000. The Promissory Note was non-interest bearing and payable within 15 days of the Sponsor providing the Company with written notice of demand. The outstanding balance under the Promissory Note of $175,000 was repaid at the closing of the Initial Public Offering on November 24, 2020. Related Party Loans In order to finance transaction costs in connection with a Business Combination, the Sponsor, an affiliate of the Sponsor, or the Company’s officers and directors may, but are not obligated to, loan the Company funds from time to time or at any time, as may be required (“Working Capital Loans”). Each Working Capital Loan would be evidenced by a promissory note. The Working Capital Loans would be paid upon consummation of a Business Combination, without interest or, at the lender’s discretion, up to $500,000 of such Working Capital Loans may be converted into warrants of the post Business Combination entity at a price of $0.90 per warrant. In the event that a Business Combination does not close, the Company may use a portion of the proceeds held outside the Trust Account to repay the Working Capital Loans, but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. The warrants would be identical to the Private Warrants. As of March 31, 2021 and June 30, 2020, the Company had no outstanding borrowings under the Working Capital Loans.

XML 24 R13.htm IDEA: XBRL DOCUMENT

COMMITMENTS	9 Months Ended
COMMITMENTS	Mar. 31, 2021
COMMITMENTS
COMMITMENTS	NOTE 6. COMMITMENTS Risks and Uncertainties Management continues to evaluate the impact of the COVID‑19 pandemic and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position and/or search for a target company, the specific impact is not readily determinable as of the date of the financial statement. The financial statement does not include any adjustments that might result from the outcome of this uncertainty. Registration and Stockholder Rights Pursuant to a registration rights agreement entered into on November 20, 2020, the holders of the Founder Shares and the Private Warrants and any shares that may be issued upon conversion of Working Capital Loans (and all underlying securities) will be entitled to registration and stockholder rights. The holders of a majority of these securities are entitled to make up to two demands that the Company register such securities. The holders of the majority of the Founders Warrants can elect to exercise these registration rights at any time commencing three months prior to the date on which these shares of common stock are to be released from escrow. The holders of a majority of the Private Warrants can elect to exercise these registration rights at any time after the Company consummates a Business Combination. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the consummation of a Business Combination. The Company will bear the expenses incurred in connection with the filing of any such registration statements. The Sponsor and its related persons may not, with respect to the Private Warrants purchased by it, (i) have more than one demand registration right at the Company’s expense, (ii) exercise their demand registration rights more than five (5) years from the effective date of the registration statement of the Initial Public Offering, and (iii) exercise their “piggy-back” registration rights more than seven (7) years from the effective date of the Initial Public Offering, as long as the Sponsor or any of its related persons are beneficial owners of Private Warrants. Underwriting Agreement The Company granted the underwriters a 45‑day option from the date of the Initial Public Offering to purchase up to 1,125,000 additional Public Shares to cover over-allotments, if any, at the Initial Public Offering price less the underwriting discounts and commissions. As a result of the underwriter’s election to partially exercise the over-allotment option to purchase an additional 509,041 Public Shares, a total of 615,959 Public Shares remained available for purchase at a price of $10.00 per Public Share. On January 8, 2021, the underwriters’ election to exercise their remaining over-allotment option expired unexercised. The underwriters were paid cash underwriting discount of $0.20 per Public Share, or $1,601,808 in the aggregate. Business Combination Marketing Agreement The Company has engaged LifeSci Capital LLC and Ladenburg Thalmann & Co. Inc. (“Ladenburg Thalmann “) as advisors in connection with a Business Combination to assist the Company in holding meetings with its stockholders to discuss the potential Business Combination and the target business’ attributes, introduce the Company to potential investors that are interested in purchasing the Company’s securities in connection with a Business Combination, assist the Company in obtaining stockholder approval for the Business Combination and assist the Company with its press releases and public filings in connection with the Business Combination. The Company will pay LifeSci Capital LLC and Ladenburg Thalmann a cash fee for such services upon the consummation of a Business Combination in an amount equal to 3.5% of the gross proceeds of the Initial Public Offering, or $2,803,164, (exclusive of any applicable finders’ fees which might become payable) with 75% of such fee payable to LifeSci Capital LLC and 25% to Ladenburg Thalmann; provided that up to 33% of the fee may be allocated in the Company’s sole discretion to other third parties who are investment banks or financial advisory firms not participating in Initial Public Offering that assist the Company in identifying and consummating a Business Combination.

XML 25 R14.htm IDEA: XBRL DOCUMENT

STOCKHOLDERS' EQUITY	9 Months Ended
STOCKHOLDERS' EQUITY	Mar. 31, 2021
STOCKHOLDERS' EQUITY
STOCKHOLDERS' EQUITY	NOTE 7. STOCKHOLDERS’ EQUITY Preferred Stock — The Company is authorized to issue 1,000,000 shares of preferred stock with a par value of $0.0001 per share with such designations, voting and other rights and preferences as may be determined from time to time by the Company’s board of directors. At March 31, 2021, there were no shares of preferred stock issued or outstanding. Common Stock — The Company is authorized to issue 30,000,000 shares of common stock with a par value of $0.0001 per share. Holders of the Company’s common stock are entitled to one vote for each share. At March 31, 2021, there were 2,421,106 shares of common stock issued and outstanding, excluding 7,590,195 shares of common stock subject to possible redemption. Warrants —The Private Warrants will become exercisable at any time commencing on the later of (1) one year after the closing of the Initial Public Offering or (2) the consummation of a Business Combination; provided that the Company has an effective and current registration statement covering the shares of common stock issuable upon the exercise of the Public Warrants and a current prospectus relating to such shares of common stock. The Private Warrants purchased by the Sponsor will be exercisable on a cashless basis and not be exercisable more than five years from the commencement of sales of the Initial Public Offering, in accordance with FINRA Rule 5110(g)(8)(A), as long as the Sponsor or any of its related persons beneficially own these Private Warrants.

XML 26 R15.htm IDEA: XBRL DOCUMENT

FAIR VALUE MEASUREMENTS

9 Months Ended

Mar. 31, 2021

FAIR VALUE MEASUREMENTS

FAIR VALUE MEASUREMENTS

NOTE 8. FAIR VALUE MEASUREMENTS

Level 1:Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis.

Level 2:Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active.

Level 3:Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability.

The Company classifies its U.S. Treasury and equivalent securities as held-to-maturity in accordance with ASC Topic 320 "Investments - Debt and Equity Securities." Held-to-maturity securities are those securities which the Company has the ability and intent to hold until maturity. Held-to-maturity treasury securities are recorded at amortized cost on the accompanying balance sheets and adjusted for the amortization or accretion of premiums or discounts.

At March 31, 2021, assets held in the Trust Account were comprised of cash of $20,494 and U.S. treasury securities of $80, 089,511. During the three and nine months ended March 31, 2021, the Company did not withdraw any interest income from the Trust Account.


			Amortized		Unrealized
	Held-To-Maturity	Level	Cost		Gain		Fair Value
March 31, 2021	U.S. Treasury Securities (Mature on 6/3/2021)	1	$	80,089,511	$	8,086	$	80,097,597

- Definition

The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.

+ References + Details

XML 27 R16.htm IDEA: XBRL DOCUMENT

SUBSEQUENT EVENTS	9 Months Ended
SUBSEQUENT EVENTS	Mar. 31, 2021
SUBSEQUENT EVENTS
SUBSEQUENT EVENTS	NOTE 9. SUBSEQUENT EVENTS The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the unaudited condensed financial statements were issued. Based upon this review, other than as described below, the Company did not identify any subsequent events that would have required adjustment or disclosure in the unaudited condensed financial statements. On May 6, 2021, the Company entered into an Agreement and Plan of Merger with Science 37, Inc., a company focused on providing customers with a platform to access clinical research. Completion of the transaction is subject to approval of the Company's stockholders and the satisfaction or waiver of certain other customary closing conditions.

XML 28 R17.htm IDEA: XBRL DOCUMENT

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)

9 Months Ended

Mar. 31, 2021

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form 10‑Q and Article 8 of Regulation S-X of the SEC. Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented.

The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s prospectus for its Initial Public Offering as filed with the SEC on November 23, 2020, as well as the Company’s Current Reports on Form 8‑K, as filed with the SEC on November 25, 2020, and December 1, 2020. The interim results for the three and nine months ended March 31, 2021 are not necessarily indicative of the results to be expected for the year ending June 30, 2021 or for any future interim periods.

Emerging Growth Company

Use of Estimates

Cash and Cash Equivalents

Common Stock Subject to Possible Redemption

Offering Costs

Income Taxes

Net Loss Per Common Share

The following table reflects the calculation of basic and diluted net loss per common share (in dollars, except per share amounts):


							For the Period
							from December 18,
							2019
	Three Months		Three Months		Nine Months		(inception)
	Ended		Ended		Ended		Through
	March 31,		March 31,		March 31,		March 31,
	2021		2021		2021		2020
Redeemable Common Stock	$		$		$		$
Numerator: Earnings allocable to Redeemable Common Stock
Interest Income		14,752		—		19,593		—
Income and Franchise Tax		(14,752)		—		(19,593)		—
Net earnings		—		—		—		—
Denominator: Weighted Average Redeemable Common Stock
Redeemable Common Stock, Basic and Diluted		8,009,041		—		8,009,041		—
Earnings/Basic and Diluted Redeemable Common Stock		0.00		—		0.00		—

Non-Redeemable Common Stock
Numerator: Net Loss minus Redeemable Net Earnings
Net loss		(105,139)		—		(185,762)		(1,000)
Redeemable earnings		—		—		—		—
Non-Redeemable Net Loss		(105,139)		—		(185,762)		(1,000)
Denominator: Weighted Average Non-Redeemable Common Stock
Non-Redeemable Common Stock, Basic and Diluted		1,990,948		1,875,000		1,913,085		1,875,000
Loss/Basic and Diluted Non-Redeemable Common Stock		(0.05)		(0.00)		(0.10)		0.00

Note: As of March 31, 2021, basic and diluted shares are the same as there are no non-redeemable securities that are dilutive to the Company’s stockholders.

Concentration of Credit Risk

Fair Value of Financial Instruments

Recent Accounting Standards

Recent Accounting Pronouncements

XML 29 R18.htm IDEA: XBRL DOCUMENT

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)

9 Months Ended

Mar. 31, 2021

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Summary of the calculation of basic and diluted net loss per common share

The following table reflects the calculation of basic and diluted net loss per common share (in dollars, except per share amounts):


							For the Period
							from December 18,
							2019
	Three Months		Three Months		Nine Months		(inception)
	Ended		Ended		Ended		Through
	March 31,		March 31,		March 31,		March 31,
	2021		2021		2021		2020
Redeemable Common Stock	$		$		$		$
Numerator: Earnings allocable to Redeemable Common Stock
Interest Income		14,752		—		19,593		—
Income and Franchise Tax		(14,752)		—		(19,593)		—
Net earnings		—		—		—		—
Denominator: Weighted Average Redeemable Common Stock
Redeemable Common Stock, Basic and Diluted		8,009,041		—		8,009,041		—
Earnings/Basic and Diluted Redeemable Common Stock		0.00		—		0.00		—

Non-Redeemable Common Stock
Numerator: Net Loss minus Redeemable Net Earnings
Net loss		(105,139)		—		(185,762)		(1,000)
Redeemable earnings		—		—		—		—
Non-Redeemable Net Loss		(105,139)		—		(185,762)		(1,000)
Denominator: Weighted Average Non-Redeemable Common Stock
Non-Redeemable Common Stock, Basic and Diluted		1,990,948		1,875,000		1,913,085		1,875,000
Loss/Basic and Diluted Non-Redeemable Common Stock		(0.05)		(0.00)		(0.10)		0.00

XML 30 R19.htm IDEA: XBRL DOCUMENT

FAIR VALUE MEASUREMENTS (Tables)

9 Months Ended

Mar. 31, 2021

FAIR VALUE MEASUREMENTS

Summary of assets that are measured at fair value on a recurring basis


			Amortized		Unrealized
	Held-To-Maturity	Level	Cost		Gain		Fair Value
March 31, 2021	U.S. Treasury Securities (Mature on 6/3/2021)	1	$	80,089,511	$	8,086	$	80,097,597

XML 31 R20.htm IDEA: XBRL DOCUMENT

DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS - Additional Information (Details) - USD ($)		3 Months Ended	9 Months Ended
	Nov. 24, 2020	Mar. 31, 2020	Mar. 31, 2021
Subsidiary, Sale of Stock [Line Items]
Proceeds from sale of Private Warrants		$ 0	$ 2,831,809
Sale of Stock, Transaction Costs	$ 1,858,498
Cash underwriting fees	1,601,808
Other offering costs	$ 256,690
Threshold minimum aggregate fair market value as a percentage of the assets held in the Trust Account			80.00%
Threshold percentage of outstanding voting securities of the target to be acquired by post-transaction company to complete business combination			50.00%
Working capital subject to annual limit			$ 250,000
Minimum net tangible assets upon consummation of the Business Combination			$ 5,000,001
Threshold percentage of Public Shares subject to redemption without the Company's prior written consent			20.00%
Obligation to redeem Public Shares if entity does not complete a Business Combination (as a percent)			100.00%
Threshold business days for redemption of public shares			5 days
Initial Public Offering
Subsidiary, Sale of Stock [Line Items]
Number of units issued	8,009,041
Share price per share	$ 10.00
Gross proceeds from sale of units	$ 80,090,410
Over-allotment
Subsidiary, Sale of Stock [Line Items]
Number of units issued	509,041		509,041
Share price per share	$ 10.00
Private Placement \| Private Warrant
Subsidiary, Sale of Stock [Line Items]
Number of warrants issued	3,146,454
Exercise price of warrants	$ 0.90
Proceeds from sale of Private Warrants	$ 2,831,809

XML 32 R21.htm IDEA: XBRL DOCUMENT

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Class A Common Stock Subject to Possible Redemption (Details) - USD ($)		9 Months Ended	12 Months Ended
	Nov. 24, 2020	Mar. 31, 2021	Jun. 30, 2020
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Temporary Equity, Shares Outstanding		7,590,195	0
Transaction costs	$ 1,858,498
Deferred tax asset		$ 39,000
Valuation allowance on deferred tax asset		39,000
Income tax expense		$ 0	$ 0
Effective tax rate (as a percent)		0.00%	0.00%
Unrecognized tax benefits		$ 0	$ 0
Unrecognized tax benefits accrued for interest and penalties		$ 0	$ 0

- Definition

Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.

+ References + Details

XML 33 R22.htm IDEA: XBRL DOCUMENT

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Net Income (Loss) Per Common Share (Details) - USD ($)		3 Months Ended					9 Months Ended
	Dec. 31, 2019	Mar. 31, 2021	Dec. 31, 2020	Sep. 30, 2020	Mar. 31, 2020	Mar. 31, 2020	Mar. 31, 2021
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Common stock that were subject to forfeiture							281,250
Redeemable Common Stock
Interest Income		$ 14,752			$ 0	$ 0	$ 19,593
Non-Redeemable Common Stock
Net loss	$ (1,000)	(105,139)	$ (80,543)	$ (80)	$ 0	$ (1,000)	(185,762)
Redeemable common stock
Redeemable Common Stock
Interest Income		14,752					19,593
Income and Franchise Tax		$ (14,752)					$ (19,593)
Non-Redeemable Common Stock
Weighted average shares outstanding of common stock, Basic and Diluted		8,009,041					8,009,041
Basic and diluted net loss per common share		$ 0.00			$ 0.00	$ 0.00	$ 0.00
Non-redeemable common stock
Non-Redeemable Common Stock
Net loss		$ (105,139)				$ (1,000)	$ (185,762)
Non-Redeemable Net Loss		$ (105,139)				$ (1,000)	$ (185,762)
Weighted average shares outstanding of common stock, Basic and Diluted		1,990,948			1,875,000	1,875,000	1,913,085
Basic and diluted net loss per common share		$ (0.05)			$ 0.00	$ 0.00	$ (0.10)
Redeemable warrants
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Shares excluded since their inclusion would be anti-dilutive							3,146,454

XML 34 R23.htm IDEA: XBRL DOCUMENT

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)	9 Months Ended
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)	Mar. 31, 2021 USD ($)
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Federal Depository Insurance Coverage	$ 250,000

XML 35 R24.htm IDEA: XBRL DOCUMENT

PUBLIC OFFERING (Details) - $ / shares		9 Months Ended
PUBLIC OFFERING (Details) - $ / shares	Nov. 24, 2020	Mar. 31, 2021
Initial Public Offering
Subsidiary, Sale of Stock [Line Items]
Number of units issued	8,009,041
Price per share	$ 10.00
Over-allotment
Subsidiary, Sale of Stock [Line Items]
Number of units issued	509,041	509,041
Price per share	$ 10.00

XML 36 R25.htm IDEA: XBRL DOCUMENT

PRIVATE PLACEMENT (Details) - USD ($)		3 Months Ended	9 Months Ended
PRIVATE PLACEMENT (Details) - USD ($)	Nov. 24, 2020	Mar. 31, 2020	Mar. 31, 2021
Subsidiary, Sale of Stock [Line Items]
Aggregate purchase price		$ 0	$ 2,831,809
Private Placement \| Private Warrant
Subsidiary, Sale of Stock [Line Items]
Number of warrants issued	3,146,454
Price of warrants	$ 0.90
Aggregate purchase price	$ 2,831,809
Number of shares per warrant	1
Exercise price of warrant	$ 11.50

XML 37 R26.htm IDEA: XBRL DOCUMENT

RELATED PARTY TRANSACTIONS - Founder Shares (Details)				3 Months Ended
RELATED PARTY TRANSACTIONS - Founder Shares (Details)	Jan. 08, 2021 shares	Sep. 30, 2020 shares	Jan. 01, 2020 USD ($) D $ / shares shares	Dec. 31, 2020 USD ($) shares	Mar. 31, 2021 shares	Jun. 30, 2020 shares
Related Party Transaction [Line Items]
Sale of Public Shares (in shares)				8,009,041
Aggregate purchase price \| $				$ 78,231,912
Common stock, shares issued					2,421,106	2,156,250
Common stock, shares outstanding					2,421,106	2,156,250
Founder Shares
Related Party Transaction [Line Items]
Percentage of issued and outstanding shares after the Initial Public Offering collectively held by initial stockholders			20.00%
Common stock, shares issued	2,002,260
Common stock, shares outstanding	2,002,260
Founder Shares \| First Fifty Percent Of Shares
Related Party Transaction [Line Items]
Percentage of shares or warrants agreed not be transferred, assigned, sold or released from escrow			50.00%
Threshold period for not to transfer, assign or sell any of their shares or warrants after the completion of the initial business combination			6 months
Stock price trigger to transfer, assign or sell any shares or warrants of the company, after the completion of the initial business combination (in dollars per share) \| $ / shares			$ 12.50
Threshold trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination \| D			20
Threshold consecutive trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination \| D			30
Founder Shares \| Remaining Fifty Percent Of Shares
Related Party Transaction [Line Items]
Percentage of shares or warrants agreed not be transferred, assigned, sold or released from escrow			50.00%
Sponsor \| Founder Shares
Related Party Transaction [Line Items]
Sale of Public Shares (in shares)			2,156,250
Aggregate purchase price \| $			$ 25,000
Maximum shares subject to forfeiture (in shares)			153,990
Number of shares subject to forfeiture (in shares)	153,990
Number of shares not subject to forfeiture	127,260
Sponsor \| Chardan Healthcare Investments LLC \| Founder Shares
Related Party Transaction [Line Items]
Sale of Public Shares (in shares)		215,625

XML 38 R27.htm IDEA: XBRL DOCUMENT

RELATED PARTY TRANSACTIONS - Additional information (Details) - USD ($)				3 Months Ended		9 Months Ended
	Nov. 24, 2020	Nov. 20, 2020	Jun. 19, 2020	Mar. 31, 2021	Mar. 31, 2020	Mar. 31, 2021	Jun. 30, 2020
Related Party Transaction [Line Items]
Repayment of promissory note - related party					$ 0	$ 175,000
Administrative Support Agreement
Related Party Transaction [Line Items]
Expenses per month		$ 10,000
Expenses incurred				$ 30,000		40,000
Administrative Support Agreement \| Accrued expenses
Related Party Transaction [Line Items]
Expenses incurred						40,000
Promissory Note with Related Party
Related Party Transaction [Line Items]
Outstanding borrowings			$ 175,000
Period To Repay Debt After Receiving Written Notice Of Demand			15 days
Repayment of promissory note - related party	$ 175,000
Related Party Loans
Related Party Transaction [Line Items]
Outstanding borrowings				0		0	$ 0
Maximum loans convertible into warrants				$ 500,000		$ 500,000
Price of warrants (in dollars per share)				$ 0.90		$ 0.90

XML 39 R28.htm IDEA: XBRL DOCUMENT

COMMITMENTS - Registration and Stockholder Rights (Details)	9 Months Ended
	Mar. 31, 2021 item
COMMITMENTS
Maximum demands that entity register on securities	2
Threshold period to exercise registration rights	3 months
Maximum demand registration right at entity's expense	1
Threshold period to exercise registration rights from the effective date of registration statement of Initial Public Offering	5 years
Threshold period to exercise "piggy-back" registration rights from the effective date of registration statement of Initial Public Offering	7 years

XML 40 R29.htm IDEA: XBRL DOCUMENT

COMMITMENTS - Underwriting Agreement (Details) - USD ($)		9 Months Ended
	Nov. 24, 2020	Mar. 31, 2021	Jun. 30, 2020
Commitments And Contingencies [Line Items]
Common Stock, Shares Authorized		30,000,000	30,000,000
Deferred fee per unit		$ 0.20
Deferred underwriting fee payable		$ 1,601,808
Initial Public Offering
Commitments And Contingencies [Line Items]
Common Stock, Shares Authorized		1,125,000
Number of units issued	8,009,041
Number of units available		615,959
Over-allotment
Commitments And Contingencies [Line Items]
Number of units issued	509,041	509,041
Unit price		$ 10.00

XML 41 R30.htm IDEA: XBRL DOCUMENT

COMMITMENTS - Business combination marketing agreement (Details)	9 Months Ended
	Mar. 31, 2021 USD ($)
LifeSci Capital LLC
Commitments And Contingencies [Line Items]
Cash fee for services as percentage of gross proceeds of IPO	3.50%
Cash fee for services on gross proceeds of IPO	$ 2,803,164
Percentage of fees payable to service provider	75.00%
Ladenburg Thalmann
Commitments And Contingencies [Line Items]
Percentage of fees payable to service provider	25.00%
Percentage of fees that can be allocated to third party service provider	33.00%

XML 42 R31.htm IDEA: XBRL DOCUMENT

STOCKHOLDERS' EQUITY - Preferred Stock Shares (Details) - $ / shares	Mar. 31, 2021	Jun. 30, 2020
STOCKHOLDERS' EQUITY
Preferred shares, shares authorized	1,000,000	1,000,000
Preferred shares, par value	$ 0.0001	$ 0.0001
Preferred shares, shares issued	0	0
Preferred shares, shares outstanding	0	0

XML 43 R32.htm IDEA: XBRL DOCUMENT

STOCKHOLDERS' EQUITY - Common Stock Shares (Details)	Mar. 31, 2021 Vote $ / shares shares	Jun. 30, 2020 $ / shares shares
STOCKHOLDERS' EQUITY
Common shares, shares authorized (in shares)	30,000,000	30,000,000
Common shares, par value (in dollars per share) \| $ / shares	$ 0.0001	$ 0.0001
Common shares, votes per share \| Vote	1
Common shares, shares issued (in shares)	2,421,106	2,156,250
Common shares, shares outstanding (in shares)	2,421,106	2,156,250
Shares subject to possible redemption	7,590,195	0

XML 44 R33.htm IDEA: XBRL DOCUMENT

STOCKHOLDERS' EQUITY - Warrants (Details) - Redeemable warrants	9 Months Ended
	Mar. 31, 2021
Class of Warrant or Right [Line Items]
Public Warrants exercisable term from the closing of the initial public offering	1 year
Public Warrants expiration term	5 years

XML 45 R34.htm IDEA: XBRL DOCUMENT

FAIR VALUE MEASUREMENTS - Gross holding gains and fair value of held-to-maturity securities (Details)	Mar. 31, 2021 USD ($)
Debt Securities, Held-to-maturity, Fair Value to Amortized Cost [Abstract]
Cash held in the Trust Account	$ 20,494
Assets held in the Trust Account	80,110,005
U.S. Treasury Securities
Debt Securities, Held-to-maturity, Fair Value to Amortized Cost [Abstract]
Assets held in the Trust Account	80,089,511
U.S. Treasury Securities \| Level 1 \| Recurring
Debt Securities, Held-to-maturity, Fair Value to Amortized Cost [Abstract]
Amortized Cost	80,089,511
Unrealized Gain	8,086
Fair Value	$ 80,097,597

EXCEL 46 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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

WZ=C&=W2\!_A\/\]7?5OCXZ)Y1,;19)&U3F[-WR30W?*BP M)QXK%+(UZ+D772! [B[-NP^2@TW&*SY891H-T(P/=K(?3[@[G*%C]= MC/X#4$L#!!0 ( .>#L5) Y UO"0, '<+ 8 >&PO=V]R:W-H965T M&ULM99M;]HP$,>_BA7MQ29UQ XD0 5(+67JIHVALH?7AACB M-8DSVX%NGWZVDZ8)A! JC1=@._<__\XY?#?:,_XH D(D>(K"6(RM0,KDVK;% M.B 1%AV6D%@]V3 >8:FF?&N+A!/L&U$4V@Z$GAUA&EN3D5E;\,F(I3*D,5EP M(-(HPOS/+0G9?FPAZWGA@6X#J1?LR2C!6[(D\GNRX&IF%UY\&I%84!8#3C9C MZP9=3U%7"XS%#TKVHC0&.I058X]Z\M$?6U 3D9"LI7:!U<^.3$D8:D^*XW?N MU"KVU,+R^-G[!Q.\"F:%!9FR\"?U93"V!A;PR0:GH7Q@^WN2!^1J?VL6"O,- M]IFM.[3 .A621;E8$40TSG[Q4WX0)0'JG1 XN4J63D^G7^=ULOIS=@=N;SS?SZ0PL[V>S M;^#M G,2RX!(NL;A._ >O $V$(%:%2-;JIVUWE[GN]QFNS@G=OF">0=TT15P MH(-JY--F^:;6-6[U'V0WZ;M#B(;NR-Z5PSFV@X5%A;A;$'<;B159LPIJKT#M78::)0W J0P8IW^) M7X?<.SHQ!,WG@/F\707:+:#=5T%3(=)Z8+?A%6>H31852*^ ]%X%J6YG(7'L MTWA;1^J=)6VRJ)#V"])^(^F419&ZH]OD:K]=KIXUJW ."L[!!9RM$G5P=%9= M6)NI+0PKS,.">7@Y\^D\'1YA.#T'(>@=X-;8(==SW!.T"+X4&'@Y[YF4S5V> MIZXS;,0NU474&ONB2E'=[Z4DH?]4DU#;HM3"L,K^4IQ0)8) MM0%EFWF5._XPED:;+ R[U!7IEE0U(5L:"Q"2C1+!3E^=!,^ZO&PB66(:I163 MJNTRPT!UQH1K _5\PYA\GNC>J^BU)_\ 4$L#!!0 ( .>#L5+33W9S 00 M !X0 8 >&PO=V]R:W-H965T&ULO5A=;^(X%/TK5K0/ MN]*VB?,!205(0#+:2ENH"K/SG":&1$ULUC9E]M^O[80 B0G=F6I?2C[..?:Y MOKXW[NA Z!O+$.+@>UE@-C8RSGY!@]4\#V91G3?V:H((>Q 8WC@Y=\FW'Y MP)R,=O$6K1#_NGNFXLYL5-*\1)CE! .*-F-C"A\B.)0$A?@K1P=V=@VDE5=" MWN3-8SHV+#DC5*"$2XE8_+RC.2H*J23F\738V? .D:!/O"_Y"#G^@VI G]1)2,/47'"KLP#% LF>5>!"V,>3T:4' "5 M:*$F+U3T%5O$*\YX/')?+D(H\4J"L%J/5U'3]%BO0+++V#Y'+U, MUX_+Q0K<@:^K$/SZRV\CDXL1)<],:O59I6Y?47? $\$\8R#"*4HU_*B?'_3P M3>&TL6L?[<[L7L&GF-X#!_X.;,N&FOG,/TZW-/3PY^C1#T_^(AA.L_:.TG.O MZ%4[36U7G )1>ZBXPUN0$,:9;K$KN8&2DQ7H?0)AX =B+N_G,>S"K$M$J!&R MK!8HZH)LRW,\KX%=F'8;TVZOZ3\)8V!#27DT3+#6:Z7BG8U^IS7;Q;7-ZI2Z M;C6H/KM>8]=31.>*W27/$ 4Y3DB)'GIR9M#H#7K#]X@YHHAQ@&**D<@:+*H1 M?4,\?BT08"C9TYSGB($,%:D8%ZRI*&)@FB1DC[DNT(..<>@./;L5YBZJ'>:; MB$@S4N %CC[ PR8@P]Z +$0S+T1.Z:P-=2OO02=HF1O>W#!=A"Z'=./YWG!@ MZRWZC46_U^(+2I'X/)$++-*H%$LNVE+RUI--0:,S"Y[U9]AKZ)OZU!%.XG=1KK;"0Q8+@T!\]#$NZK8LV&33LS"U"]C) M#=^R LN%;1^W@9=.[),3N]?)+&9YHEI-FA=[:0G7>P>(2MPXD/:T#NQ;NV1^ M&Q+>AD2]D$OOITX+^UOM@N [^I^W$3PU->A^SD8Z]0WH_7!=JZF#6X4MU ,[ M=4L+ZRE<\-2M8'^[^JS=HVL=@16X?CL#-4!_Z'4LAQ\%1MJAH6/Y5SX,X*EQ MP?[.];/[L5+WSQ?-NK>\=D1N-[?;D$@_6+LDF6?GH!+1K3J ,J!*>W5&:)XV MA]RI.MJUGL_@0U@=54\RUB@ !@ !X;"]W;W)K[FH?[5FG#W'R.5UQ+M#7=1BE9[V5$)LW_7[JK_C:2U_'&Q[)ORSB9.T) M^3%9]M--PKUYKK0.^\2RG/[:"Z+>Z#3_[CH9G<9;$081OTY0NEVOO>3;6Q[& M#V<]W'O\XB98KD3V17]TNO&6?,;%Q\UU(C_U]U;FP9I':1!'*.&+L]XY?C.U MK4PAE_@SX ]IZ3W*MG(7QY^S#Q?SLYZ5><1#[HO,A"=_W?,Q#\/,DO3C2V&T MMU\S4RR_?[3^+M^\W,R=E_)Q''X*YF)UUG-[:,X7WC84-_'#>UYLR,[L^7&8 MYC_1PT[6L7O(WZ8B7A?*TH-U$.U^>U^+0)04,*U1((4"J2B008T"+11H5<&J M46"% FOKDETHY%OO[_:>!V[B"6]TFL0/*,FDI;7L31[]7%O&*XBR0IF)1/XU MD'IB-+ZZG$PO9],)FMV>WTX_3"]OT=4[-'Y_?OG+=(8N+N7W5^/?WE_]/IG> MS'Y&TS\^7MS^A4[0Q]D$O?CIY6E?2"\R6WV_6/'M;D52MV*\7LL*F8G8_PQH MC\W:Y_-YD%68%Z)K+YB?!!$:>YM >"%@:])@R_>WZVWH"3Y'$[X(_$ 1J9F M([>QMG9?YF"?"+)/!,GML!H[;[W0BWR./('$BJ,[O@RB*(B6V1<3[K]&>/ * M$0L/H8@;36>]YDVZ\7Q^UI/-).7)/>^-$!3[9[(S>28[TZ?;.<@%W>>"'I>+ M%[+)'7@EK-WR^F24Q[-]QFDN#:#$Z>5QTU2!QX/]AX/_K^.8#3= MH2,\DYW),]F9/MW.02[/.RL^J4W"'8.;S>QX50V6?"!BX[%)L 8E#W *W5 M1T#=4>!.MQ19!"KEVAP-HKN&;8?8=V&P/;)';HN\(K_@%\ MQ0JPV$S8BS3=YK&+%\C?W4VGV=)(Q&BVB:,T3L!D$VMI[H^:8 !PTIJHT6Y/OW[")8ATQL\XT$A& 4:Z6.K/0H5L* M8X0=T5]F?-.0)M:F=%F[TM7%9.GJ^P>LT2&IBX B*3&3M+F_-$<#(*&Q:!4+ M2:>)M6-_<=HD"4 EE*1V0S!HK;Z_*.R2(^?@SOU%9[0Y58K4Q/T!_45ADI@Q M:;HQ(3K_3K!K#QP";YHJ_M%._ -N3S!X)@:0CY%*95*=539V'9L,*[4)",KM M.>7M[>( 6;2RU[ F#HI_M/.@:;A)@6,"38 $8\NI<4Z1CQY_K-S8VPK;YB9" M@1$1:"* &-3I(6OUG9Z63G2?YTBW.28ZBHU-A"H0EB1<)J-F/*4 XEV+7&E8='^A7=D7PT'&%0FH>6L?EJ3W=WOW+?9%- M[QO)I^!.;BKA<[[>9/_# T.O#Z\G TN$ ?AT+9O12A2;Y0Z=4_!DQYS2E@X X2[, M@%-:NTHFIE/5MEQ,!W:%38#@B8L=HD4!,IB]W)HP*$RSIQ[5-H<$(*?M,-NM MZ:%,L9/1[P\F5OIGIGE,?6)'8?JX6FTG3!\OL65C6NTE-7*LII$PQ5YF9N\S M-A*F4S?WL<9%!5)F!JE,Z8('8IOD6'H7;R.9]X*GH!_Z 'J"[6K@=7Z69 X] M5>AD9G2:/&V,G@Y0Z34=UK&"*2XR,Q>-71@\984*L%GPT#V%,M;YI+7-X%)8 M-0]S@! \S &"\# '630-<[:"I=UYJ.TZS-G0.2LTS/5+CVUE3^5)RW(J25'( M%U+3>CV0)I+=@VZ[#R+>Y$]RW<5"Q.O\[8I[LKHS ?GW11R+QP_9PV'[QPU' M_P%02P,$% @ YX.Q4A!% P) @ (04 !@ !X;"]W;W)KV=Z\JLA K+ M#M\"TSL%%Q56.A0;5VX%X-R"*NKZGG?M5I@P)XYL;B'BB.\4)0P6 LE=56'Q M?0B4UWVGZQP32[(IE4FX<;3%&TA!/6T70D=NRY*3"I@DG"$!1=\9=.^&/5-O M"SX3J.7)&IE.UIP_F^ A[SN>,004,F48L/[L8024&B)MX]N!TVDE#?!T?62_ MM[WK7M98PHC3+R179=^Y=5 .!=Y1M>3U! []6(,9I]+^HKJIO=&*V4XJ7AW M.JX(:[[XY7 .)P#?.P/P#P#?^FZ$K,LQ5CB.!*^1,-6:S2QLJQ:MS1%F_I14 M";U+-$[%H_ELG,S29(S2U6"53)/9"LWOT6@RF'U(4O0PT_GYZ'$R_SA.END; ME'QZ>EA]15<++("I$A3),'T;N4I[,8QN=M =-KK^&=T 3;G&2Y2P'/)?\:[N MH6W$/S8R]"\2CB'KH*#[#OF>[\E2VY,76(/V> ++&OS7X[D@'+;"H14.SPBG MF +B!5KLUI1D*+4-H2O"4-/;JT?>4/8LI9G&?7SK>>^]L!NY^U>\]%HOO7_R M4F,A,%-_M='[PT;0#:_#7OB;#??DVE8@-G8X)?J&!B!]E6, M?P!02P,$% @ YX.Q4E#Y>)I9;QDSZ&>6"GTVVAJ3GTPF M.MZRC.I/,F<"WJRERJB!6[69Z%PQFA1.63HAGA=,,LK%:'%:/'M4BU.Y,RD7 M[%$AOHH"<^8T%P* MI-CZ;'2.3R[)W#H4%O]P]J(/KI$=RDK*9WMSFYR-/(N(I2PV-@2%OSV[9&EJ M(P&.?ZN@HSJG=3R\?HM^4PP>!K.BFEW*]#M/S/9L%(U0PM9TEYJO\N4SJP8T ML_%BF>KB%[V4MF$P0O%.&YE5SH @XZ+\IS\K(@X<(([;@50.Y%@'OW+PBX&6 MR(IA75%#%Z=*OB!EK2&:O2BX*;QA-%S8:5P:!6\Y^)G%YH3__^.MT8B"A=9O$5?"+,CCI".ZC M.RG,5J-KD;#$X7_9[S_O\9_ 0.O1DK?17I#>@'=4?4(^_AL1CW@N/,>[XQXX M?DV^7\3SN\BG>HMNH)(T6BN9H8><*6JXV*!SN[JYX4R?].29UGFF19YI1YY[ M: >IU-HU@Z5G4'C:FM\OQMCS@)S](2\NJV@6!J2V^P78K 8VZR7@//D!2QRZ M@M'(2&@+L10Q3QD2%6+[U%['EJF=9@GB LF:)GH434&-)NBEZ588II@VB%$E M(!5T&6AMS\S0%4#2+-ZI(A?:LK0 \J0 /S MN>_F-:Q'$O8OK"T5&P#Z*UE:,^"9B@2EG*YX.DA<5*>+>HE[5"RG/$'L)ZB+ M9LYU%@U2T;88XYGO3R,W%_,:W+P77#4]&N7TM9A(2P"-8[5C_8CG+3R.PF@; M19%//#=D[#5=V1NLV,$U[VS(WB#/#I,Q"3T_ZEAT^$!+\(?ZV:W80SD=W\\P M:3*1@5*UD6WC0')=,G5,/591>]EIFXPCSYM[4]S1['#3[K'_L5GE-4$#L^H/ MXVZ;#.%NY -//S2O-UQ0Z-/'SVNC!W@VT$EDS%A2Y=$4RM7.K\PR:,:P&8J? MG?3,ANEIFX31-(H"KXN=1C5POVRX,3\JOJ>&H>]4*0KMQXE[6!\<)B3R<>3- M.V W$H'##\#.X8=K+=4K$A)@CT&,4\"?0-M4YM6)/AQ&WS;!X>RPB_X*OA$< MW*\X7T%P7M_*_W>P#\N1PV3<"[X1)-RO2(\E=&VQR_6:*5M)L=0=BZ0M,2VH M;9,QF07!O ,J:72('*E#P/&>PR8B1.0DZ4#9B1OK%K&BO8W3!-EP(H-6) M<5BY'":D>[F21K5(OVI5\. ;K M;6WJ<_+7-0A)V\]?($^F7IWLIQ@7(9K]A M]W@?52G2J!3I5ZE; <%HBN(4]M1\S6-:'$F\4RJD=ZL?+#;V&R:';QEN-Y^* M)2S+K;F3R6$A%P;1KHALA(_U"UE3*GJ:[EO+^SGB&!:XR>?]IV=V[ M&H$C_0*WS*4 4>B;\49O2/2_[H!((PYD0!Q^:P=4!0T&:G]R<%"4,;4ISL\T M*O;+Y9E1_;0^HSLO3J8FC7EYP'='%;0KC5*V!E?O4PB3K,HSL_+&R+PX=EI) M8V167&X939BR!O!^+4&KJQN;H#ZY7/P'4$L#!!0 ( .>#L5+G_J252! M )(Q 8 >&PO=V]R:W-H965T&ULM5OO<]LVD_Z>OP+C MR]W8,XPLR7;JM$EF'#>]>J9-,G%[[\Q]@TA00D,2*DA:T?WU]^P"($&:4MQV MW@]M) H_%KO/[CZ[H%_OC/U2;Y1JQ->RJ.HW)YNFV7Y_?EZG&U7*>F:VJL(O MN;&E;/#5KL_KK54RXTEE<;ZEU)7)V]?\[-/]NUKTS:%KM0G*^JV+*7= MOU.%V;TY69R$!Y_U>M/0@_.WK[=RK>Y5\_OVD\6W\VZ53)>JJK6IA%7YFY.; MQ??O+FD\#_@?K79U]%G025;&?*$O=]F;DSD)I J5-K2"Q#\/ZE85!2T$,?[T M:YYT6]+$^'-8_2<^.\ZRDK6Z-<6_=-9LWIQ7^E5^]'J()U_,#$Y9^PI+E=ANQE#_*1KY] M;@#'Y5G0SA=D5'N&XM?->8U;W]\?W_[^>[3;WOGOU?WQ33Y\_.V]6,S$W]CLV2\Z5_>I%C?IGZVN-;O1W9VX M-78[$Z?-1HG_^H_KY7+^PZTIM[+:\[?%#V=B)VNAJQ3CC)6-RO!%_*@*N9-6 M"4.?4U6NE!6+:[+AXM5,_(;5_#(\G>(-)N(?01MM6ZQ58W(N5-4HJZLU%FV, MD*)4=JUL(NH-K:Z^IAM9K54B9%TCJ,E>=@QI3/J%UL*8&D.L2N56-[+0_R?= M"*L0X&3EOPOL;K ]HI@N=2$1 =H:"JYKT5A9U=*%EIUN-CB6HN&E@1!AE*KI M$03&_OA\*H/"WH5E<.25KGBSH+W9LYNBV9AVO>&3!Z7H6E2F$04$(8WRT;?2 M-CIM23!=98@6=D\;KI596[G=: !$K4E"4J-784TZ3$W%8;@A/4HQ)4XRW!U* MK[*:MLT-XA)9,3[E5EFW&"S]P5CHXP9VT:FD![301DF<*B43!5&'1L?Y9"64 MM,4>=D)"P-=,*+(NK;N&K/Q#U64=%0>>E 5;7 M7VI"A4DU@Y+-]K0-83V8A56'V)-NNN SW'LC,S82)B%QI=B#GGKE0.4S<0-Y M.!/I9H^IELT\7!(V*R ?ZSI:G."Q^.X'YQD.G20OC= 5\"4+6'A5P.8FSYV# MG'JTW?G?/[G?/_K? ^ 2L0-4-J2Y3-6IU2L(OJ)\G? 6.B,$YWN'E4;"W9K. M$(2L:0"-?%KCY*2;M:I('2I6#1:VZD%5+4[=8B_H*(>3\^%HHT(Y;\P/8E4V M/)BL"5LUP[W#EN1!U8L8JUA/:,I" 7!-R=R0"T!A"KFBZRCO86>$I\QGRPP_FP473 MY9P1-)^)C_'32_=T@-0N *CLV E(']?)?/XJF5\N7(3U\:,L^3043^-,X.?? M\\A' *O2HLT(V:1-BEW847U5-M4([:L]/V_!$>S.:K(_6:/!A@_*OH GFX8U M9[:L2F\V69J6'N;BRHLYD(&A\7PQG\WG H8?_)@$9'A_!Z@Z&V.]Y]?S9/YJ MGEPNYE,>PI$..+Z8/;O7)5B@K)1IZV+O @MCMS"UU^(1)2='+5/+@M/>1;*X M?)E<7ET""1;)!WH9*!Z0)*_ZE_^QR\4X/A(%0C&O\GP^>^45,9Q Q^%Q_'!; MR-3!%$$HT("?39%!7*CTEU]N!YO?;R&TL;V]*9)3UD.@SG-=N'@;UKEU.9=6 M^98%ELDUPN(U#'O, I=PM"@=IZ:&@#0D5ZKF(/A\>?4R>0G=89*C!%V8Y?UFSWXR0.B.'CS=]$/W M]8[*ZNMA'"'##!88(8TC$P,FG^BQL[*GCL8Q,"CC5?DI&^4^OVC"% MLVU+=-);II.4"^]5R0@8PO M.@?$Y78+I,M8I"G/^2>. 3T'(@]&BLQ?T5+(#Q$I'>SIR''CP *!5\J)R=\0 M];.G\/8!]>ET%2CBI*U*TCXV>U3'>*X7$7W&:V/PE$+@1H*!2)%+;0-0'V31 M CA_MMB,^#$ MJ&)V%8<@+GXIS%^1]KU1O?2(,P1)RNCBP30ND(8X&P9Y (0R>$<\K5M4$AP; MB[3GJ_% F^.I=0L"D.K >*%6*@(M#AGOVR'!PW@<42(P^IL,4 MS)6M>Q)HMELDI[;BBH\.F@$J+@90Z40_]D%(VU&"KK'JH%X'6[// M)$[@D77=.LQRBP!AMNR4%5V5#+D%N.[8YH'KX6-%A#!3\'#='(B//I)#SH@+ MUJZ*"[[;E2/K5$*KEPCXY]%7QSZ6/ ]FW8GRH4! MB\?"8-]TJ3F-(IBM-;DT-_X<[D+V>7Y%41S_+9RS4-OHJ4R&6TVC/0F4]20J M$V:&?YC #,>AUM?0B+C4'4*X-NWSDGS0Y= :[: I8%W+7 M490@EW'DHU6F5B2K=9W.K@=:J#6L9Z%0*"YYY*D)&;9NI4N"A(<; M1ZA9DL^*6Q^9N%7 ?D[4BU/17=R M[OLD1ON^]_U@$K74-4>[?W\[+$)0JHZ6SDS:4J*)XCEF49U,18+I(NX1 M.G:7)U#T3CU0DUH>#&5\JJB*A55'%NT*D\ZB;$@.GV;52%U-+_ZWK.G/WX>U MNBL88:,_VFJ0,[#3USW%3Z3ZQKG-V&)NB#-5%UZ^:57&_-,\;SJ;'6YM^Z8% M"^-4$DCR(-*?IB XKME6[-W,45OU/AK>M5T<-29:R!$3U:AS+9<=?C*.S?CT M<,HE3\[56&AJ7'E,TJ&'R83#MLM=Y2!P' Y@XG1U%H@7= 0H-KRP-^JIZ\P1 MBH>2/8$BN%/UQ.!P2D9Y6[A=*?KZK4?9Q#408A@\V:HS<9.YDIBR8X*,AUU\ M2WS :9"M^%;X&SE;6U\[P: D>)<$ M?+M9K0VW_YZ<7+YAY,EH'R+J7XNFHTB5]#6?LT 5=?9(*F?22&1VK+UW+%"4 M.AAOMS'EX^%T^Y.&"R2(G!)"C:L&@K^MK6FWWL'&+A/:/HN+T^SL].)L(AMT MF:#K^UQ?T(Y8;+N'G(<>C5= MSH2BZ5NU:M2G>[S%1+JA:>=-[39Q)8?D[C% M3CV6VN6^?F,T]OFJ0 M/1]W7?>$Z#%KS3>8D[X[PN2_@\%?* ,2T4?L,<4/'12P<4#0;P[L9IH*U:[= M5[6,''>HZMBI7.>]CQ_.8 $ 5#-_)<]M=3T5;VO?@Q*67I"I^=)VD%_[DS#I MHU$N,J>*;).WUO$5#3*4.13%#<6:XR=P=#9LYKC^'NF=J1,G0?U$E.1=*Y\# M57_TP19LO1&#LXK>A.*9\2%'T;EKRZT,=?4P-P//2QMC<9I0 CDGXWMDH.K! M%+"[M/N!(ORZ5L&HTMT,%Z0=,+%!M[4O<;WXNG+Y,26/\W0]+MVHJO.=#?*\ MM)"Z=#=_4(8F0;LS>9;J6#(EJ('F7>T<79TRJ-6!NA/_+[*(+J\47\%&2I^0 MQ,7(F,[= KD9G/OG_J6#OF=4\_75F)]I>FM%/P2"%J'=XW8BF M/R:R(R:32UW43\M)1_-%Y+V>Q'J>Y6[*D+Y#[W7*R?YR&>I:ACO"(K$M1 MW\1/N3_>Z#*ZWAMOV;M21#)#$B%?&U'-H=HB[G8TR=)5#=\VQ9.]V_I+]L?A MF%0VW9*<),%3Y5Z@\)WF9^+GX+%Q9375)#N,NS' 'GN3=Z+L'\#,](G$\[.# MH)L]NZ/QF:N"H=8F "'<31SLGPW50 VJ/M) 'V#-GD4-Z%7N0JI[BIRJ*E>D M^9#'(?X!&O=MM5K9!_ +RF#D@M3S*FM$%3V#HE._' M+39JA[8UE3;C%_#BKD5W$<+4J4U5W. $]H]<^[%ND'8G^IJ> [I.\5@E,"%R M*+U.LJ?B@EXH25ONKKG0YTIC3.+@!],0%I.>-H7T%H9]T7P=+5R#AYZ4AEX M.](N[8=ZP?J[BL<7<4@L5=053T.)(D M*H7Z"NCB8 4T'-X7!;^".AMV=:\*>G&K<2&37OL(VO>ZYQ#AK#-Q_<:7#"X2 M!LPZ,N@6ZZZ0!D(QA2#NY$R:[R>0D;7J &LA\)+6J7G#Y-=X3H*5G9?3[:3S M\1#4B2Y[7SB$K2VM637=?1H4[Y. ?R&#WVK1MCQ+CD4"%74*N_=7#T0'3E=A M8A(0T(>"J'?:O^&+8H2O3O^F6W[+)6=3[V>?1^_)\UO#]-< M> )[I7Y[FGW M!P(.$KXT9LMOW:],TYB2/VZ4A EI M '[/#?*)_T(;='^&\?;_ 5!+ P04 " #G@[%2-7]JBB_FX52E7C)TMQ\.%A4U?+MR8F)%RJ3IE\L50[?S(HRDQ7\6^"UQ8?C94;\A MV4&6J31J4J3_TDFU^'!P<2 2-9-U6GTI5G]35IYSI!<7J:'_BQ6_>W9Z(.+: M5$5F%P,'F<[Y7_EB]1 LN!AT+!C9!2/BFS+;0 T_D*BT M&IC3.1KEL2KA6PWKJH^/7S]_'G_Y'W%_(QYO?[F[O;F=C.^>Q'@RN?]Z]W1[ M]XMXN/_M=G)[_?C^I(+]<-5);&E?,>U1!^U+\;G(JX41UWFBDO;Z$^#3,SMR MS%Z-]A+\+,N^.!U&8C08#??0._7"GQ*]T_]CX5N;G?G-SFBSL_\73>^G?7?_ M="U&??'Z/7I7TF@CBIEX*)51>24Q2'I/"P6!$A?94N9KG<]%GEAJ(+%-EQ%SEJI1INL;OU;+BM17P\C6GO1]Q'^)VG*E2QU(<_N=_7(Q& M@W>_C,.RTG&JQ 6R\D7-ZY3)/A[_-SY!,H_7D[Z8J+("0&QM#;S-BJ+* MBTJ)1)LX+4P-JA\EK6J'T4K/2RF$"0#H4"&T6)-NR+,;$!']-UA*O6(BE HLH)(T RJ]VV M$9PJ0'X5*V,@(=!N4J#SI0J4M P<$YEJ&%@61N/3"%@Q +_$,^2IDB6(4.A8 MFH680 M+A+C"*ND_V^$O%D4=9J PPDL!] K8<&W.N=\ZP-KPJ0QD(9OWN'>A5E"4JZ9 M+0V4;B',D?A#/4UU+.YG,T5JDO"*3F%_3PR]$HC?%<\JFZI2C$XI&PPB?'>E MT!!FYZX3T#QP#5&+SFN0"$7XA0WPOT>OV>W<[P;Z_00FH\>SO'B M+.%47RU*I6A=#N@M,DZ-"E.C@,0&;N R&_L#!)'S"4WHD #N80GC',%M ,$, M)E OJ%,TE=UOK62)Y%&/O]:PX^G DBN77.EN"_Y65N*]+<54;H&<,9H>RJI>T#JF-!L.1 M.,0%EKE?[Z\>\4N7*-A\N@(8 ,+R.Y@E>0942O%A.(5& ;0I@!"*9/9O5@C+ZM]'0N[6' MKS'$P%>1F-85O9SJC**S*B+Z>ZH"5O Q0^@Z3&V)6J*G@?\#T@,R*7S3\A3D MY)F&B)"0+(S%G): H!IGN+/!F;>;+*<2['!\_Y("_I/M@'H=PPY-GA,%[#6W M&09XD)0U4,5Q34Z-/ /6\+:8.C'AD3L"BZ4-6C0;P,?+.H A-N:FK3A VLPO MBI0V13S.IYI# RRO30&P^XR)N ;,0X"$:YO@8 MBA]9RGA18_J2:]X9;01X^XR^@R4.+43DO:E+](W(:W4X&!U.CPZ'/B:0+&,0(?I%BE/8.F@XT.R7.UP<19&,6. M3)4'"KJ 1" W8MGZ'&?GQG( "'%*]8P"O(\9VDI70!!%J 92:TCXZA@50HIY0Y8_YRL(5?MITRBA,^90ZT!8=*8D,)1,4;8'8E M?UWI3.V(@A^N1]6"Q)AA,LPPM+0$J/&%W&:%LK/&XJXIWY%$UE;C&DMH3=]W M"XT5Z+ZOF11:H:#VR]H<,^S\1PZ,=M,QE"*H!IU!56HTYKZIBF5M?+FR!'S- MJURS0-FPQ3:%79R@1X1:\KVSF2K6SUT: N25!E#$ BCYSD4;C&VFM_J9(XO0!=&Z -"I$H:3 H2@@%0:"V\RY!" MR=WL7AX_6:4"75<6"$?] M7*)L[XWN0]TR* 7+%,KTX1HL"-4+ M[M4JZIVDAII:Z/#*ZIB8U_FSLOVM R600@.8 %,9MK,84:15['-L>P-RIEBB M4RY8UM#E2,,9&5H6ZD]5PT@[&R4Z"0H!RJ_MUQ'F8;_-W@DD#-N= 4A>9!D. M:;!Z$X_U])O-T0_.[;ZHQ%:/+5U88&K:U)@)41D(^= 3\OY;>D)=4Z9YK?D) M?#]N@._1 ]^$>AZ;_-R4:_PX\4.NIV().>#L8N"ZFT\\::BU62"IWP+$($] M4U?KONO$)AU"9,A!A95P*(7A"HS;,,RK'I'6=F)& 4)IW&#V1SBC2*,!!IBJ MABICXD*6!EU(7V74'[4T>NB;G?9SBN&9HI&)";DK<>1N8QQVMUD0=6UC#S&U M+%(7[+9T1ZQHY [HU%$G?N.\-E7]*9(E2W9[&:;^=QN?K2M M1, 9 %F<]2BVC1A7%&^,]BT.."TY\V:0 */*XI&2&5L7%S3,8KKBPV& MN::@JJ$0/PVCB_.+Z.SR0JP4^LQ"EG.FN4>G/MSLR#?0;Q<7O=L<7E;B2;ZH MS<0%-!#S/-0&=26/N'=.;?!,X7%B4?7-F4?5<",_Q>+"P)<_V$=@J=:JU&R' M+^%%$']G9]EFAX?LM%N%N_7%)P7BB(+0%9T24$YJJY)+Z2MPNE2M[ MZL!5=6M<%DZI81O6.%5M@6 HM1]XPB)7@UMF6&U]\4_(/G9ZDZ;%2C9K00?@ M6! 72<2UB1^_1S8GU! WB;-#8 #+(DO88H+GX*G^ SH7,=Y1F[2Z5#LIV=Z" M[( >]$*5&T3H3Z>7T6 PB'R7A@MG-9CC>5M /&0 !$7$FTO,T-A>=Y'L]W:F M"AZ5X[RAI5!L@S.>1ENX(B%I>*Q,Y=ZR0?U4UO#,UCB[NG>0P)VEMIPWS@DA%33X?R)07QH+Z_7O CCTO90 MNP5L!EOX*KK[7SD.6$'N^D.5A7, CH1@T.F],."+-K,=!^>VEL:"@ZJIT]N(.GZ.!3=+K@"9\CX>[]@N: HN--/^J,1N^@<&OVSM(3+TV:GB MYBS5WS%6 /UR-P^#KPR\(ND@@_*7>I'@N!R$4XH80O@:=N9Q9;NK\7L;3 AE M34:S\4/3;0#*U$XY?5ZN\X9E!FPGD#1=O@C\4RK.]R[/R9W=?,!QY(]]M[EZ M9<_5DEF'D(**E"O),P_^UN \@B>Y.$53*TXXW.$V&2><*KCA>L0\RY1:302W MDB9,0(9-0C%"9PG6Q"W(H_$%[HCI5_K[%]+W(/7#ISU8--/T#;!BP=>_.XX:4.-X4W M88T[ND+K?P,H-(FV-QW\^%DWC>H>42EY[P:[8%Z2%(J[)([49JY3%17BO>>^ MVS6IW' &1?#GH4KQ;.?](">07*GTV8'GEM,%5FT%2:#N*;K -P2*;2L:S7TZ MWD@AQ[F#Y/P;]!GB 7AP0P6H=!5]D^(W2RK(N47!;\CW77DVQ:'&LZ8&-W/9S='9^YIF;;72MMKZ7:>RNRJ#+ MZI3TL5-CD=4[YS4[4+1=@6?9]J5N7MK1M[=:2S\5I>@REA4ZU/!D5^X^ _RE MCXE-S-W-(5-54GY:6_$R!=Z2["ZB=G6$P8RV=6'%13SFU\TK'UY)[$]H\K9# MO&(.A:&9TY@PTRE.([DDJ%;%,9^OL2#;V_4%>K:K_K8L!=4]GA_3*)M,&A%_ M7?,=C 7K"1O14+E[$T$9J629<^^P54U&/%0,&H<9&#!>H*OP#:\&;Z-71%@7 MP_MBK3/D.]6")W=_334.+*S<#MEMA>4ZIP[:KU' /M;V*>%?FR2M3U+EX2X! MN$7!#!]\X71 5/#,?9!%9>/ M[/\KZ3(18XF_3.)G*E!*@SGW&<=%)RZ[*1@.'IE7OFUDO.2MT^N\-4OU0S?R M#'YO*?%&H5ZB(BQ8_MC]&7!F!;9\Y"*28WZ&9[=F%^)N>623?[8RUB'PD0!M M68*_J1?,?@'^V%+QZ&WOQIKU@7RA1X56 M^_G09]FC'ET6;OW_B4=:/5]U_N 3UJ3M_PUZ7QK;ALU$HG((6?2W01N'6PQ0.CWO L>G,^ZE$>&+WK#2^C\\M3_Z>=*J$E;CQD M/4%5#@KDHW1LH[1+EH[GD;CR_O.) M_:=W$0T&E]'@;.BWW'[B%'FRM;R3@TTY,"R[W@U,YBLSD!FJW& %?N/X\&4: M*'=P'@U/+T-U7YQ';WX& QP.<3)R%"KCU6K?8->Q]:K]]IMLKR*ZO]MENF%T M>3F(+L\NX-/%FW/<'9\-3Z/!Q7GP##G?8;I]G!P.^H/S(_QG"!+=08OSMF,2 MMHU(%D 19&A>(3%.",U*90<5FWDJN!,4S+5MU6:+G,VZ+)Q'X]$@ $]>-;<) M)D!>5^*+-M][-\$5YCMAFB_US+5LS5? M^MUE9T[SS=G !5[[M8<# 9.?FXE5<]FUF;6Z=%R6=+?:35I*U9Q,N6G!C^Y@ MMTYS0(YF&MN,^709GMGS+?,^0!EZ8GC>_% 6>8&'<*S0VUR,ZSF6&'R[F7S) M:V7G.?55@9>D#@]NQH]7!T?N9M?.5[\NZ>CI\&#\^!5>Q2V.!S]'X*732ASS M/]1Q0C2"BQHW#+RG\ZU[>]GF\+&>5GSV_69P/!H<:>*K6_V7$_2JW!^(!P8OA^?$9$"0.'7_ *7DLCD9FZ]8M6>S! MW/'E+M_IBX".4'AA-V]\P5Y$SXI$I19.[(D2 %IXLXEG(40\;FN& "-XYDM+ MJL+X"SZ)"3V:3F19'FV92;SZA(FA(;4%']+T-Q66+*H]ZK-G=^XP.O;F&_EIVF6\-E8U'FIS;AVQE/ZG&=0D.O$8+W2;P@KFGV&[&50LEX!$/M4\&7P%_]LY^-7_U 0[ ]C[1Y MRGH'Y"@^0R\)(%,[C$Z:N_9K++J=IJ/VS]="!"6) J$3ND89A>+(9CSM.N'= M]T9>>YFQO^M'B2?!3T'QKB?]X)5NB^45_RK4/_6_J1WS3TF;U_D'N5"R@:6- M2-4,E@[Z;\X/^'*(^P/ DWY8.BVJJLCHXT))@!1\ ;['WWBY/W #_TOCC_\+ M4$L#!!0 ( .>#L5*O5YMI: ( $<% 9 >&PO=V]R:W-H965TS0 MU*C=2F&H$NQ,VL:V)A1Y$%4J3I/D.*Z$U-%\&GQKFD]-PTIJ7!/8IJH$/2U0 MF786C:*]XU9N2_:.>#ZMQ1;OD._K-3DK[BFYK%!;:300%K/H?'2VF/CX$/!3 M8FL/YN KV1CSX(U5/HL2GQ JS-@3A!O^X!*5\B"7QN\=,^JW],+#^9Y^&6IW MM6R$Q:51OV3.Y2PZB2#'0C2*;TW[#7?U''E>9I0-7VB[V-%Q!%ECV50[L/N/QP(3I)7!.E.D(:\NXU"EE\$B_F43 ODHQW-3T*I0>V2D]H?RAV3 M6Y5.Q_/U_>+[:@DWEY<7MZOKK].8'=0OQ=D.L.@ Z2N 4[@RFDL+%SK'_+D^ M=LGT&:7[C!;IF\ K04,8CP:0)NGH#=ZXKW <>./W5/B,..F)DT",A_ ?ZL&[(-D(SL $N$59:LA0*ULU&R0QNB@))ZNT@+"Y-50O]!-:H M'$X&27(Z2":C?>Q=*0CM -I29B5(G:DF1QN$M:! Q4>D3%J$S5/P-^X J27) M2!9,X7V2P/Q!^B24,NQ:D<'4H9FD#A)1F<8["SAZ>7O!(*!N*"M=YT!-,D,? M_7&4#),$:J1G@N%+AQ,?7.X*:1M:V$+F=^[N>>_M7XGSKCG^A7=/C+M:6ZDM M*"R<-!E^/HJ NK;M##9U:)6-8==X85JZEP[)![CUPAC>&WZ#_NV<_P502P,$ M% @ YX.Q4L[?J;,Q P # < !D !X;"]W;W)K&ULI95-;]LX$(;O_14#H89SY(CE:=TG>F0K1P7PMIUD%E;?,ABDQ68T?S<'3;-HI.2\1FFXDJ"Q6 ?;^8?=TME[ M@V\<.S,9@\LD5>K.3:[R=1"[@%!@9AV!T=]/O$0A'(C"^'%B!J-+)YR.!_I' MGSOEDC*#ETI\Y[FMUL%Y #D6K!7V1G6?\)3/F>-E2AC_"UUO.R?CK#56U2"Y"1(?-R](Q_E7\RRS4JK#K2S)IH;^%2]FH+CTAW* MT6K:Y:2SF\/-U;?M[1X.G[>7^^O]E]M59 GK-J/LA-CUB.0WB NX5M)6!O8R MQ_RI/J)PQIB2(:9=\BKPFND0%O,9)'$R?X6W&'-<>-[BO^7XA+D''E-EXI)5*T1#W0C; 6V0LB$,ER6H H_O9+<7X2P9UGU@L$- MX#WJC!N6"@2K'B%*(IB*:0_*5%W3,Z87D=WY .6@FWJ;S\.S/M:NYX=PU5?K M4M4-DP^0*S0@E77 1B!%PF#74EW1&&>4VX$) BM.XX*-&BE;FWU)ACW7C\H.W/].BR-_"':=-_ MJ(\Y46__H^4:J3D2E12L:H2*9!<,+DE!;= MJ9P;JWG:.I-)/K>:>A!LLTRU=%;^)E) S226YUF&OWI=T:1#U:A+WX<->&K? MK,;5L=5O^P[W:-Y_)Z@[E)Q"%%B0- [_/ OZE(:)58WO=ZFRU#W]L*+/%6IG M0/N%4G:8. ?C!W#S+U!+ P04 " #G@[%2%!N*R6D( "6%0 &0 'AL M+W=O&DBP;3K; [7VQ]<(9SLLSSPQU MMG'^6RB5BN*^,C:\'94QUC]/IR$O527#Q-7*XLW*^4I&W/KU--1>R8*%*C/- M9K.7TTIJ.SH_XV=7_OS,-=%HJZZ\"$U52?_P3AFW>3N:C[H'UWI=1GHP/3^K MY5K=J/BO^LKC;MIK*72E;-#."J]6;T<7\Y_?G=!Z7O!OK39A<"W(DZ5SW^CF M8_%V-".#E%%Y) T2?W?J4AE#BF#&]U;GJ-^2!(?7G?9?V7?XLI1!73KS51>Q M?#MZ/1*%6LG&Q&NW^:!:?Q:D+WI=T98_H.A6_.1O+ M(-[;0A6[\E/8U1N7=<:]RYY4^)OT$W$\'XMLELV?T'?<.WO,^H[_1V=WE)_T MRD]8^+";B<9U'O[H&4?;BII1>A:,O5OQ3V@9U)5*\9F,1 M2R4N755+^R!T"(TJA$0=K-=>K654PJU$-IXO7HZSQ4P$UD//QN4S<^+U$XHO8ZYUV?98OQ M;#:;"%A]H^JHJB74'L\ZPS_IE;K)M?C@3*'M.HA/GRY%]-*&E?(>;F3SQ?AE MMA"[%I$EE[@JL/T')4TL>@SU^]$3VK05$M?=32F >A[I7/-2(-,>V%NU/^)[QP[+QP M-4L$EVPBU;;AR,/F/9\WKC$%'#&\SYV"]GFV3AAGU\H_DE,* =DY M> 17=\$R$1=Y[CR%R#P EXR>0]Y">$,_&ZJ!O*V[%IM1YF908%P@$/7\=0OXC MY:^^-]($VH!"I8H@GLVS"?BV)N20C'B.O,OB=_1ZP%\KF]#2%]I'0=3C?%MC_&P=_4=+'G)2$IS$5.*H4E29R;(O[ M%>,^('_$$H#^8UJ&7;;?&<[*H;S1WQM=M!*5\FO:LT7(/;HCB(3,<6Q!0'$9 MZ5.(9&*TA,9$2-22!!BL\Y?UE @+".X5\:JV M%$*;B(56C8<(@PV?P *EG3BQ";?'H,I_1Z,+ERR#DL#E(@AI"+7-@IP%*4_1H0P33JR@]=;>0 M8C5!8238PD>5>@5*1W6P5C0_"TR_2'DW_NZ-Z5@S"KMB988E+^#O> 2>)20U1ZGP,##$-N!Y\D2 MREYC95-P.T >"EI7X*1DI*60T,DD3(ZN4,9H4@Z-[;.+::2<9V_$M3*2)*\P MQ#SP%(L.+.:G3\^PC66(XJ;>ZK6D=V\8'8ZO>R9T\^N8!M30R%3E6];?UC2- M0DOGF8%XY-L=;S&GY+I&=F4%NHL)):_:"9=J8=_WC:3QP?ZDN38"T:'T3+1( M(K HET9U-#U?)-;>0R3<1C_H"KTSE60$S41160I'VZX*4+,MDBW#J:S+4>+H M>,#2@2ML-69 J9&!N-,7GQ[A=HO[)"5V/')@>J./E(G9ELP2J%HR;@A M">8N)/(#SFP[ZK'/3W%S/U4_4>'<"PX12RILGRJYP(28X] 0< !'72V;**A_ M4T-S<'G-_D0WQF H[4YB5@AQ2*TLZBJAE/Z)6R*W8KKE"1"JJ3UZ- X>2)^W MZ/WJ_#>*YF7J\REB'88GXKT$; ^M:4=YJ%0\0>14G*"[_8$[T6.=,)/P8XCG?Q[K0@9B2Q5*=/5O,$BMA@] \XF ?,IB$T3YV MS68C/: 3^]*I 9[#;0'=2 .#E(G!&74V.4TTWRJ: ."I%]WQ1%#R^H,*"\<' MA,@5HG9)C(QMP,'8"IU@< )"/M* 6"J3IGBDB]_<>LR&?%1H$DE1&:8CX\& M)&CB@+*KLJ7N76U]:IO X/TSW0DF?6Q[<8(6^ ;+6@:^\OJ."NUKNQ1G'4[% M;E?CNF+*WY[^A]$J94&.[+ 6,S%_%M@2UV%;#WW5F0Z^E?$@1E\$:8) --)G ML_YI_]'Q(GUKVRY/7RSAREH#?T:M(#J;O%J,TLS5W417\Y>WI8O157Q9*@F; M:0'>KQP*K[VA#?I/L>?_!5!+ P04 " #G@[%26"XH& (( #J% &0 M 'AL+W=OY?@='MO6//J'KY M$;MV/).XZ=0S<>*)G>8S2*XDU"3! J!D_?M[%@ I*J;2I/T0AR*PNV MK;5YLDLB)YZ+O+2O!TOGJE_&8YLNJ9!VI"LJL3+7II ./\UB;"M#,O-"13Z> M329GXT*J?%*+I>,7X^NK M2B[H@=SGZM[@U[C5DJF"2JMT*0S-7P_>3']Y>\+[_88_%*UMYUFP)XG63_SC M-GL]F# @RBEUK$'BOQ7=4)ZS(L#X*^H3/0*S*##SN(,AC_)7Z>3UE=%K87@WM/&#=]5+ YPJ^5 >G,&J@IR[OOEX M=W?[>/?NP^/#U=A!(;\>IU'X;1">[1&^$'>Z=$LKWI499;OR8P!IT%/WQ\?"?. M1J*CY."3LD]6R#(3G\N4C$,..47VX$Z62 B$OA,I"%9E358X+6@E\UHZ$FY) M0A450EKHN?]U\_&/VU__]Y_SV>3B^5):UI/F-4X)NZ43ZZ7* MH<()99%:TNI2)OE&5-I:E>04-K'>E3(U2]14$C2?$R,H P(- M0.6&,4Q?75HQ5Z4L4R5SUJI""I;96*,BD#3I4J"B0)N39D'LIY<>>E6VHE3- M@3[Z")"E=@PT4T"9D2.#7)",%+Y%"C)F)CYOC5N'UTSE2#SV+XA,4S"@ D? MN1$R^Q/9Q^LVL%%P?@.#1;Z+N=&%-X0Z!^C1+G#6[4%N1@>?:*&L,[)Q7CPX MG3XM=9Z1$;[^V8/[VMA: @7.5T)]1\+X'4(N# 6@^$<&1PCMFFG_H%=4)- U MF_B4F03Z@H&6E]]T7;+!AZ4$>H^#7]\;M6+&ODAC)'O)"^RY#?N"TW(C$@2* MM37LUA6,(I)6T,X 8> +:JXJ%^)&5LJ!U?=:EE8<>EUY+KSE?,,[+*6U41S? M1ZAQ6(->.*1=LA*U 1CK#CG@3 /S6T;J*SECIV!/S8,5'()X(3 M_.C6&G%4P([=!GL,X0B%N'(2AM.4<#6R$DY4C= _:8.X!26NYU"*EE.-RGV-#)BHPAA6?XBA^PQ<< M])YV5:-T^[!)-E W%(?J*/!>:./[!OPO*>96#]=B-]?:=A']9X70V(TC9?9K MLQVS<^Y)AZ='8@-.[;9$AS;%B]T.T<]9LWI;(KQ0SN[K)$2J&YU,UV5BC%R6D<33($FZX\%:VG MW^$?AV,3>;& 3X?3V>EP,IFTM6 K%CL==J7HD& !?WY&.]*AGP^%\LDS;&)Q MGU44V91$SEF\XQ2O9[R,.0I2W-S!IBSZ>GPXO3B*Z8,\?T- M9R=74N5^KN+I;&L%:1O9@(Z?II,1>$<4M6I\(.P<^AJ3"MQ2X$;:93]W7MED M--O5Q9"&'+D_38=GD^GP?'+.M9#YD M$'J9/&AWTU5>!^\,3?2-$>1*F4K6=7-[?^*-\+S,JD]HL4#UECKJ#5B*+ZA)*N/6D(W$8<[UO9U@Y MXCR4V4HA!VU?(>_O#WX&1!39W7$$\MSAV*V"O'NQ87%.=Z8D'_',;1T#MM*. MQQ\XUVNMF03C")[$/3% <>C.J*1V'$&8.(W.ZI1V@'$@MB84QD* ,7&>XMJB M_+QJ76AF,9K"*/.R 73FMN\F;+B'+IWP"."GSLX0*:O*:%RA?&RSQ%Y6>K2V MA%>&)>+T%+*_"I$;.G,O_'W6>B:""B7R!V)3AOR:4TC9.+&:%7+5AH']^^<3 M1LX%I?#)B0D'IG'&QZ/3_S:%;&%P100'.B7*[-^V)<[B&3+X>#@].T%OIV?< ML"QWM3B_X$P@$2J.\G-S$W[PR,:)-ER]$O(W+?##VX\"L:\"-.\V477%ZR7RO57I)#HSD^;IUG _%&Q$4YE3&R>\-9 P4GHZ$FM37V<> I MDX6"[QW4,54X>WR53V3Y9)FY[5TUEI(-7IDBW%6]@E15TI<[@-C;.GTV]J8) M7$7NSOWU+'2Q)DKX17_ ]GU'&7>^/Q6$8L)?V?Q7@]*%3U'MV_9#WIOP_6J[ M/7P%1 5?*(PF.?U_4$L#!!0 ( .>#L5+CQYAN:@0 $<* 9 >&PO=V]R:W-H M965TNK'C3V.MZQWW=UU OWUG5D[)K20ZEH)8GMWYIEGGIE]&:^,?7 EHH?'2FEW M-BB]K]]'D3,9A;&HG M8]-X)35.+;BFJH1]ND!E5F>#9+ >N).+TO- -!G78H$S]%_JJ:6OJ$?)987: M2:/!8G$V.$_>7QRP?3#X5>+*;;P#9S(WYH$_;O*S00(Z%:)2_,ZMK[/(Y9+S, M*!=^8=7:IA0Q:YPW5>=,WY74[5,\=CIL.!S';SBDG4,:>+>! LL/PHO)V)H5 M6+8F-'X)J09O(BIII6M:%^E6P$_"CF _&4(:I\D6 MO/T^S?V M_^?TWP!>]##'@38@_^IWG:4S[?W5W T@DVT'[X[3I.CTPYS9TJ] MBM9B#C-OL@<(T^DIW)<(EZ:JA7X"Z4 TOC16_DEVWM" :Q"281S'_ ^N%!8= MF +J'LX%N)7T)0BHA86E4.1$-M_'(W)*H$;;>K96KLE*:GLG%UKPNG)#6!HO M]0*$SL'XDLPM+P47!MI(J#,*+!QU[A/,D?P]6NIF(E!84X&G=ZOJ? "DHN"VDNO6BI&(Q<#@39K M0$&Z=*#;=4J'!S22Q._>HMYI%0K\+-80\#%3#;_"T?#P)!XF)X=O0;AF_CM5 MC5G6QCDY5TA[>HY5S4TTVODJK!6:FJ;3G"6?6KD4E$T_MY)*4?L0,.7]B#:3 M3C"0\,"E"=W#4:G=F!0%9PD585@FM)OL!8F>D&H@"A[E^4P9%\Q;Q6^T]%(H MF#9S)3.X+:AMPK2%W72O]:"VYT,LG"OD)N"B(0ATCNLUE^W*.*6>,TN9EU6O*@44?FAB[FB@UCEB0<"&<:1?]ZR%'.Z^6JFZHW>BTS-?+>4:$ M'&G8U?!%_?ATADRX4K&$=,C*EITC9%[_5BX@Z MH=#]2V&'(/ERD!F;"W)MU^G'F\]WYW#74,3#)(EW%WN[QWN[YWM#WL24X=W. MO4B+_KBN%$KZ3CO*G=:UHWE*0F,A,XJNR&85*N/^J=KHM2,IVCC<*[2+<(7A MC:#1OCWG^]'^EG3>7@Z>S=LK%NT!"TET%!;D&H^.#@?M7KW^\*8.5X6Y\73Q M"*\EW?30L@'-%X9VE^Z# _1WQ\E?4$L#!!0 ( .>#L5+.JW>W\P4 +(. M 9 >&PO=V]R:W-H965T?"\+[4[[N??5\7#HDAQ*Z0:F HUO,F-+Z?'1W@]=94&FK%06 MP\EH]'982J7[9R=\]L6>G9C:%TK#%RM<79;2/IY#85:G_7&_.;A6][FG@^'9 M227OX0;\7?7%XM.P14E5"=HIHX6%[+0_&Q^?[Y$\"WQ5L'*=WX(B61CS0 ^7 MZ6E_1 Y! 8DG!(G_EG !14% Z,:WB-EO39)B]W>#_IYCQU@6TL&%*?Y5J<]/ M^X=]D4(FZ\)?F]4'B/'L$UYB"L=_Q2K(3O;Z(JF=-V541@]*I<-_^3WFH:-P M.'I!81(5)NQW,,1>OI->GIU8LQ*6I!&-?G"HK(W.*4U%N?$6WRK4\V?O9Y?7 MXNOLX]U<7,UG-W?7\ZOYI]N;DZ%'(^_]?@Y_ M#O3I\^U<' [$"X"]VQQ$)I452UG4($PF/)YIZ MCBI2(T *MG@,DC*H+\"O #2&9!]PE%72>I4H]);B#]Z7(%UM.5R18H@#U8Q"S<&"7MU M]!E]DOC:XR3%?&;6E"B1 H[?E%QVIK8)N#=LF\"5?@9>ZRWP2GNP.M"A+BN* M%0-8X(06.1)]6\9"@2NK$G@AXC<#P6PT!8YU2E== &8O9$C;60I"S>E>9LR$8*K:URE>1=$@>+ MK>N;RB9):ALXZNHLPU(1*3(+WVK0R2.'N31%70)EH;)FB:YS;%0=I'HN[+:QJR8@]Q_C. M\=A8#[*VD1C\Y1ZBQD17FCIL+^Z )WLS/F*GXP5ZS/)="F;'D"FG. M0P&0%3%-3N10I+O>[&*AZ?0QI#O!WL"% ($\LYL+<6LJE8CI9"3ZEWJ)(Y^" M^P>$V%;]"1W M.-H1H\.CG?WQ>"#>K3>8SRT JVM<*Z(,WVBT4M)G?G8KE>*"IG8ASJ16K@0= M\B9!NE!S&QPTO*.>A1/8O-X,GCL+T^689=U1%+;0MH^8F+.V=>/RYNIVMS)B M4.5K:]MA1B*;H46>I3@N/+BGFWV]KF)[TW'P+XZ#;F)JI"12Z'(=2[0([V_L:UWWM/"%\)H;<906]S M"JS[4KQF,,[$V^%T2,)O>N/>JQXR(A*"'O#WVWAX=+"S?W2P[;MWV+E'E&#O M^;;D!%%/QK61A M/-YQ^&>.ETJP)(#O,X,3/SZ0@?::>O8_4$L#!!0 ( .>#L5(@:B@L2 , M ",' 9 >&PO=V]R:W-H965T5T40598BY"[!BWOE,[7@GCJ=T5H/ J50+4IIN/Q M\Z(6VF;+>5J[\LNY:\EHBU<>0EO7PM^OT+AND4VRP\)GO:LH+A3+>2-VN$&Z M::X\SXHCB](UVJ"=!8_E(CN?O%Z=1?MD\$5C%T[&$"/9.G<;)^_5(AM'06A0 M4F00_-OC!1H3B5C&W<"9'5U&X.GXP/XVQ^:D75(GN9@<)2M(8^ MN^X=#O$\BWS2F9"^T/6V$S:6;2!7#V!64&O;_\7W(0\G@)?C/P"F V":=/>. MDLHW@L1R[ET'/EHS6QRD4!.:Q6D;#V5#GGHAOF Y1TW3@Z;5]%'"2^%SF$U&,!U/ M)X_PS8XQSA+?[-]B?,!Y=N0\2YQG_Y.WQRD^?+Q>PZL M<"],*P@5U\TVX%V+EGB1OP&$54!>V"#2%0] E2!P4K;>,T"4A)[7D.^M$58B M]'6NF [:!LBES31-R#AKK6B5COZDX_.T@4>EM@S7PD @-JZ3\PX]@@ZA197# M2D2[MN$ZHTH'+M<]U\\('%-&"8+K+W"U!.GUEBVWL1N,DL-#H$HKL(Y LU/2 MY3W$Q5]C3D([UQH%E=@C>[IK=8I6?>-RB=K >68+TKC01HWVKP++GWRT<"GN MX7E_ 1^J9 N,WK3E['%4YSN/"9<.XXK3#*Z$2_0[CKO35,%&:HRYG[T8P7LK M\Q$(5M"SE8Y+G-DX;8UW>ZVTW0U5CS[T> &-$13;;SPP(26& )(ODY:LVV- MX665)X4&4ZMC!5'SR=7@@XJY_,:],+$TT1W#!\LANJ=L1$[>5LZHZ#_=+]X. M@G0H!R9.;B>XD_H(ENB)._]PSKUR[NT0^G>?]\<-/8:2X!@R5#Q_F+9QGXOB7W$W)-:H-;1RPR M#2M^Q=!' ]XOG:/#)#HXOHO+'U!+ P04 " #G@[%20\4HYT@5 #(00 M&0 'AL+W=O[5^-7[P9G^$">N-? M6JUL]%D@*5-CON*7V^S5_@@Q4KE*:P0AX<^CNE9YCI CS\=T/VP)RZ,/WOH M-T0\$#.55EV;_-\ZJQ>O]B_V1:9FLLGK3V;U#^4(.D=XJ[S>3G0#?R^I8G(X3,1E-QCO@G08^G!*\T[_-AQV;G87- MSFBSLX'-WDBKK3 S<5FJ*I2S7NIR+II1-IFN5 MB=0 ]TL+GV:ZE&6J92XL+%-@9K45"_FHQ%2I4H"!+V4%[^F28%49O*U ->L% M?6_*&B$O*PU EKFR8JY*5X#V%[5:A*IU(<_.=_ M7$PFHU]_N[JZHX_C7P\%^!E86,,;182D+MG_D!V7O6CA5KJT==60N5M1&X%V M*\8C!#ZZ_/6_:>E55>LT5^("4?FDYDW.8.^/_@>?()C[=]?'XEI5-3BUSM: MV\R8NC2U$IFV:6YL ZP7);Z!M ,[\B9CVGM9O(NQR(=(!JVP8%M3Z!JXF(AE M4]E&EC62A[A6#7(?":L"+38B9("A@(:I4(;'XHK0@(_Y.L%5:Y$9H*CVQ B@ MS'&W*P3/"J!?ITR:S'K#*CO^&R=N%:?(,%$Y@2$>MA 5?FI)#9C"L:P:-AC1^_BON;>P2 MXFK#:&F = MFCL#OFBE$"?%Q-E/$)@FOZ!SV#\!0*P'X!_.HBJFJQ.24O/@H MP7=7"@5A>W>]!LX#UF"UJ+P6@9"%7S@#_V?R/;N=A]V OV]!9/28(\GH6#R0 MIK.]>$EXUM>+2BE:5X(K%@6'-(4A34! C7P$8GU 8S(ZX0F[Y"!W\,LQ"N" MWP",&42@GI"G*"JWWUK)"L$C'W]O8,?3D0-/G@ATK 1=:U / \Y./8YWA*GS M$*;.=\:7=^"HY[CW;[ 0V.GDT1>H?@H0Z:W[+#0JO' A0?D%^\RO,F!/ RN#^T4-!*\TU5:DV(4)M,S#4NF:WKE]Z98@BE4M?C8 M5.)-8P&>M1BHJKI9TCJ$-AF-)^( %SCD?O_XYAY_]#&+-4G7X)$ L/P*&I(] M@HL&[X3K4Q=(U),JENR>9Y4IQ",HA0$#"JX8/OW9Z,I99KV0-6F17"[!H.04 M8A:HB0%$P*FPD3%;D,;P-NIZ($=1FX2^3U6$"CYF M;[Z.HVRFEJCT8(H0=,!)*GS3X12E!S,-QBDA;EGG_CH$ FN\X,Y&9T%NLII* MD,/1QZ<<0A')#J W*>S0AEQA8*^Y"W: @Z0 ABQ.&[(OQ!G<'F^+41QC+UD& MH%@Y_X%B T_VM(X\(@MS4U9LJUWD%R:G33$TE%/-5@J2U]9 !'C$',&40RCA M)I#;IU\1"@@4A%R91W"?&&O &N;X&/(P6&64$KO\1=0>S+5J( M0>"FJ5 WDL#5\6AR,#T\& >;\(KKR+,[%(6HWJT*)51,C<#K:Z( T5UN,X<8J5F1*@I#0!<0DN6'+3N:D80.]'K^R MQ!=JY$UY-*P%Z",0%]M : N%=(0/.&T-,?G1D']BRKQ#7X#+I36 )XJ@2P:# M'*:#LZI"R=*AO%J /US E3U!9.TXKC&;U_3[,-&8#._ZF4&A% Q5@D[F&&'GWU)@ ME)M.(2M"-N@"$F2K,?9-52H;&S*G)?C7DA).+^B4XMN ]P%>[LJ(GH6,Z-G. M1.8S(_ .ZH("-:DO%?HQ")0#<578*1%^H(#!-[ RT_4Z*B2=T=NH3D(3).U1 M?G5BYZYEE.=LQ_%[W&$GB%>* >R MP8$UO M:Y79M%!&)ZX;0 5-19>,0P!0:> 7FWU1>V=H$R^?&>^_E5\H7 A\& MN 6!LDK!$(75\Q*2QQ0K[R]--L<7H"@E#PA$Y$I:#$P2#!(\X5H$M26&DLJ[ MO8(/9R93;8DB=F4@&$,3F@W ,^*CKM*F0&U.?9Q03QBSLN]DH"]2(^*HO,V4 M:T6@^E#S )B"J9)'%LM@K ]=,'0=G1++$HB8!7"9D]*28FUA0.ZN'$&=A/2/ MN/R(,MQN-&!'MJ&2FHL@WHK-.68XL-,E89@@!)GMLN?GP9Z?[[3&:RRO46_H MPSO0 %3A48*L! MS9M$C#6H*SV!Z3G6+!0[Q' 1Q'"QFW>F*+ %APFQN&^F7US:<^>MZ)/*7$+>)YC_-^ = M4;E TG8X4@9$:3OD+P%0L/4J !IJ4,X;S4_@]ZLV4-V'0'5--:I+5GR#].K^ M.O1''\P28O;9QE:P&-;%>'_O*^7J B (QJ+%RB:FP MG#%SV8QY4/#>:]=L)6=":9?%; U=/WDEZGV!)C60%5Y[]T8]4H2O"JIG.QP] M",5I]SGYNYFB;IN-L:MPX.+\(>SNLA;DM?-3&'\JDWO'Z$HM]*LMW1&\9FE< MDS%-J=.4DD]MRE#!/X8*S)I9"#X9 A*V"17+1ES5Y XX M+<,4D?J/$0^V8$2UHW5;!F@/O=A$T (S/6$#3)7LQWV<8*\"N1P^&$H[/<^I MP&W9/,12%RUZ0P1@T'4^R8^98-0B[6-[LDG*,$^Q7(R3LTVB^Y*UJ;G3CX6.ZK6Q_0'J1];OA:\I?O7M;J0P5W.9)U$BG7!AO,*"&=LZ MRB5;K*^\'HP7!8QI6F6:.;N[#@\X20F*E4&ZE=;D#R#Q8/7"-0-]Y&.Q@3!G M@)3C&?'+.+DXOTC.+B_$2J'6+F0U9Y@[I!H,WLTK(@D/8;%#CN-1.W(=[93$ M;0D;*O$@G_HKB!]8OI%< !GH^$.\B8HA'A'UMAIQ)G=_[4++\[,06N*-0NN5 M,\F0+V/QB[E])[5W;2D)+X($>MLA771X2$6[U;C;L7BK@..YCB/2432\$79VK_E_,I#U< S ME^CU!V8W-^="/(-ZR;4VJ6%,?@YDU0[7HW!,HXNC9NG?0P!N -!BWRHDF%1; M$O_ ("N65^!K:6*[=$5W/X%M-Q9?177_F7':"@+X7ZHR7@'8$J+N?-#"""_: MS)6H'. ['(L&MT,\VT._B!X1,XFTTE,T'F+#O.2N%=)@,;RP 'P.S+ZEKF%) M$U'0HJ---A MU.@V_0N-7W;V$ 7J[%1Q-9_KKV@KX/U*W\2%GRR\(FGZ1B%4/4E07#;"*5D, M>?@&=N8>>[?R#'M;# A50T)S]D,C&7"4N6O-A]2@*5N4V6%[@J0=TD7 G[*! M&'O(.+K#_E;U[\--;G\LX\\&^SVF#(Y+%SY[ M<.$'8#N#I6,CW)]Z:N)-X4U8X^>M*/TOX IMIMU)H3 ST6VUOH-4"M[]SBYJ ML&5&<:G(EMHV FM3H[\/V ^K)J4;7J#H_+D+9Q[=D KH!) KE3]ZY[FE=)%4 M.T82L7N**O %'<6V%*WF9@6>Z$+%V97^1B<.QSOSUP\0X/^ @DW< 1V^.P,) MN^K-A7\2UA[^DN,O2ZI1N&[$7\@6?;HXQ4;8HZ:N0^E7N/,!*SK1B5D$,!R' M^65#1T6HL]W"LU1'8@?'9[)M_K8]$:-0$]74G4XP^(1*TK$<#"CF2,>4C,AV]L="]1LGXUN20JJ#3R$0;,8$FE"^ TUW= 6G"9L6$/M MST%%::V25%#2&\R]8&37Z0+3C^ M_CG6>&?AZ/:1QF5\OI(;@/T]#-B%VBXF_'L3I--)RH3\21J_*!I"@4[.YWB4 MAB=)DXMQ,CD?#7D1+H<19*3K '6F-)]&8^^ H>H(Z[*:TUG6_Y7TD9%]23B1 M%=I,D-J#.'<)QULG+KLQ[ [N&5<^/6@#Y9TC(&6GP1TZH:09_-Y2X@EAO41& M.&?Y;?5GAS,S6(*2BDBV^1D>@+!]'G=+(]OXLQ6Q#@"/#&#+"O1-/6$TCOR/ M2UT/7^S=.+'>D2[L4>+7GG"\2/8FH_$E8(IE%Y_'[W[Y@&68^WP0HO[A'AW: M[_S_@;M\>R$+_L8GS)&[_QOM?6IE&\]H]GYQ_WUH"O3&IGHAW@'G@:TT-3.A M3S($X-:[+6Y@[8W/DN?GDSV* Y-?]\:7R?GE:?CJNEPHB9O@LA[DT]X!KSL, M;Q[PRO8!.ASE4 L/A_Z^5:6AK L)"E9ZY:QTB):!YXEX$_3G+>O/WD4R&ETF MH[-QV'+[B6?DR=;R00PVZ4"S''HW$EG(S(!FR+JC%?B+QR.D:<#S?0-=C]9W[;=;9#L9,?Q;G^C&R>7E*+D\NX!/ M%\_/<7=\-CY-1A?GT3/$O$=TNS Y&!V/S@_QSQ@H^@ EUXN!SMRV1W(.%)T, M]4\DV@EYLTJYQLEFG(H.UD6M?I>UN21G,R^+6_0[2XQ)6V),OC'S!>=5UNV1 MFFM 4=?BD[9?>ZN,GP>W=Q/=4O$344=\*'#S=1LGHX* CA)&H#G.,FPH4+_& M4QG) WK70N<<!G!.U@YT+O//@)CL1DN_;=F-[O+YM ME/OA9 A8]K<41_Z&& 7@N,&?K>\L? M:6+[T1WV.[AOIC6?)WD^.IJ,#MV5&&HPZ$>7%O]#973&\PB!@:-*^=#A.\"I M7O^7%1]7I3MD$@&\&)\?G0% PM#C!YB2=6.G;;;NW!3 $MH?">C3YF,1P1$* M+RV4K7:Z>T&%R53N7*\;4$(\BD]6X9.YJ*CQO$K:.RN;9]EI+& Y-=&S(T>, MRGSKA"Y(Y?F0\+I8Z7A2];LL&SPHPJG1A*D,-^6HQ\%UH)M!TME'=[FH4K6[ M'(>0,*="EXVV"%3BA8W,5<% *U_J!)A@8*0-\+B[]Q@+>NZMA?$!Q@4;CE*# M]DF\)*-IE)"PE&+*N(-&U:_ABS#??0MSXQ(FU'/;[6T7TYUV0#SG4R$5.YLX]J!$441T1D?)DY@CSO3O^$ )U6+6N^9Q^>AG^FX(HOY[>O\[]Q !DW2-J*7,U@Z>CX^?D^'[CR M7\!YTE7]J:EK4]#'A9+@4O %^!VOW/HON$'XQQM>_Q]02P,$% @ YX.Q M4H,R\)BC P 3 D !D !X;"]W;W)K&ULI59M M;^(X$/Z>7S'*G4X@Y9H78($>(%':[B%M*2KT5O?1) .)FMB<[2R]?W]C![)T MM^%66D5*[/',/,^\V,[H(.2+2A$UO!8Y5V,WU7I_[?LJ3K%@ZDKLD=/*5LB" M:9K*G:_V$EEBC8KLEVJC<"?C/9LARO4S_NEI)E?>TFR KG*! >)V[$[#:]OND;?*OR5X4&= MC<%$LA'BQ4SFR=@-#"',,=;& Z//%YQAGAM'1..?HT^WAC2&Y^.3]WL;.\6R M80IG(O^<)3H=NP,7$MRR,M=/XO G'N/I&7^QR)5]PZ'2[7==B$NE17$T)@9% MQJLO>SWFX#R/*N@"S+6Z;99"3% :31)F]F8$.UUD0NXZ8H*RUI M-2,[/5D]/SQ,G_Z&QWM8S3\NYO?SV72QANEL]OB\6,\7'V'Y^&D^F]^MH+5F MFQQ5>^1K C;F?GP$N:E H@:0(3P(KE,%=SS!Y*V]3X1KUM&)]4UTT>$#DU?0 M"3V(@BB\X*]39Z%C_75^.@L7P+HU6->"=9O JOX'L06=(L0LC\N(2Y#KPEO*W+:B1G?@3;U-#O+ M;!'UDV2@E7%(R#>3R@-\C7&OK5*UR@I1$X4A$-GG4K$8]N\G2PHIM.8, T.L6T[MK?>O,E,E+O4H6Z)4],N_S,R MS?3V%3A/F" =@R91LRK:E1;QB_/K\5F4!4JFA;R&.R8YI54!HP3'UD0+:'(P MYQHE*@US3FE$)^QZ_5[D_/;+( JC/YQPZ/6&G7I:*=E*W$O&XS13"&OVZK0J MNW:MV:HLOPH65#$\4JN%3=];Y().F2J@S_9(HZ)/OU",.VR,I4'NP4W=/[=5 M_S@#+PB&7M -:\CO):=$^M^9-S+X-HZ%X+\WZ9Z5S.3FD^EFBKE4Y][-RHF' M3:%I>DINT//"SO \W8.>U_] !6B%%$C0/D_&#Z?]&[HG6C^$=[ED%Q/1O/9> MZ4)O. R\87= HT&_9]"-+.QXP:!W)C/,WRG=)2:MX"KHMUS1 42'2G79U=+Z5V%:W9!?U:O_#-KONXPKR'%+IL%5O^>"K.[N:J+% MWMZ7&Z'I]K7#E'YW4!H%6M\*H4\3 U#_0$W^ U!+ P04 " #G@[%2XD;" MV7(" ?!0 &0 'AL+W=O[+#&/5F_R2-%S0L*2V0*RHX2,PF_JQS,^_9?)?P3/&@3FRPG6R%>+'.0SKQ M0RL(&2;:,A#S><5;9,P2&1F_:TZ_*6F!I_:1_<[U;GK9$H6W@OVBJ75E[S5]W "&(9? *(: M$#G=52&G\CO19#J6X@#29ALV:[A6'=J(H]S^*;&6YI0:G)[>S1Y6\#Q[W"Q@ MN9C%F]5BN?BYCN%B3;8,U>4XT*:*S0V2FG%>,49?,(Y@*;C.%2QXBNF_^,"H M:R1&1XGSZ"SADL@V=#LMB,*HXYYMX7S'$UV2 R M($JA5J!SHH%(A *)*B6F8/R,4 FOA)4(=B[-;">EE)3O['Q1]=F5GZ\[*X34 M] -3;\/-9C)GWB-+K];B:DET*:E^]Q[Q%9EW*Y3V?IAM]>ZLC&":&/CBW0O(G3/U!+ P04 " #G M@[%2!=+G^%8% %$P &0 'AL+W=ORL[W*5! <&J$D[GJ.,^@FF++.^,;,+<7XAFZC92>Z(YO4KPE*Z*^I$L!HVZI):0)89)RA@39W';NW ]3 M[UH+F!5_4K*7M6>D75ES_JP'L_"VXVA$)":!TBHP_.S(A,2QU@0XOA5*.Z5- M+5A_?M7^T3@/SJRQ)!,>?Z6ABFX[PPX*R09GL7KD^]])X5!?ZPMX+,U_M"_6 M.AT49%+QI! &! EE^2_^7A!1$W#]%@&O$/#.%>@5 KUS!?Q"P#?,Y*X8'J98 MX?&-X'LD]&K0IA\,F48:W*=,QWVE!+RE(*?&TX?5Y'&V?)HMYFCQ$2T>/]W- M9W_=F?'=?(KNOZQF\X?5"BV6#X]F>H7>H[LPI#IL.$8SEB>?#N+%E"A,8_D. MEGQ93='%+^]NN@I0:EO=H$!TGR/R6A#-^>X*>?XE\AS/:1"?V,4_8W&%>FZK M^/1\T==KT;?*UI*&%+;4)5KAF""^02O%@V?T]Q^P%,T4 M2>0_%D.]TE#/&/);#"T%#P@))=H(GB!9F%H*NL.*H*]8",R4;.(SUSLP>G69 MV(V!MUV=LN,5WK#G#IU1N>X LE]"]JV0#_BX1$^ 4.*\'$RX; 1[[Q]!<8?] MH3\:-D/IEU#Z5B@3+".4L9"(O8#,9ENT(:010*ZG7PA+C$TR1*$MUM!MCIU M-I@*J#CB&9K0#L<905@BC%(B L(4] 8=0D /TY(HB2(":B@S4T\"*ABZ"P*> M,=6T&>VPALZ5X_QJV1S#TK_AF?X=PH9&*!5FH:9\QTW<)0DRG0)$OOJEL-B" M[XJC-3@9?,NH("%:OZ 4@O1>U;(VX$F*V8M>JA]C O2M,PE@I-0S:\I,H6QB MPNY _Q03HY*)D5715^C")L%P2A64;YFM_X46K"%CQC*8B6E"&V,U:D@]!_Z: M4\]UJ@[D6"%]+E*.:9(QV])U7"93EAI:F3F6&(Z+H-R_TCJQTUK8KJ,VH!VW M!7:M<;H_E5/+;!W3 *TB#._K_$+6D"0U3NRIBB#WC">3/&E^DR@5E ND"Y B MN=>D>=><0.:=2A:WZEZN9R]+X,LV)[[P@"0_>$@W"&!2]8)"#D/&597\N#%. MZ*)>09J."-,3L%SGI(M5WW3MC;.*8[E50_P"?11B40L91#;-_9;&[T;4=DM] MH]@&NNJB^% M[4ZES$C8>&8<'/7=H>.,'+]M'U>MS[4W&9/&>N\%1*=D'MY&"-?'9X^VXEV#\)+O7.;SJ\&4X:D0R/D!1DM.&IVH-K[P^+'1'O<1QSE1P5G\,#<%7? M/>=M\\FK:K)GKWSGYU.AJ'_0%P[2*=_2I]<=0JW="^PE[.RT*_25?2\ M4[>%_%ZPC'% =*31?S_>%6P!J>J4Y[]Q[*NRY=F/\%7L]\5EQQ;^XV-\S_4' M?M]O8;8J:9Z]I#U\A[9&Y6MH:W :<>3*AO7+UU7+M\]XYK M7/-5KUO[Y* _$,&]>4N91#'9@*1S=0W4BOR;2SY0/#5?(=9<*9Z8QXA@N'#I M!?!^P[EZ'>@/&^67K_'_4$L#!!0 ( .>#L5*[A2&PO=V]R:W-H965T[4LBR7SX/"1M4I.CD+=J MCZCA/DNYFCI[K0_O75=%>\RHZH@#[:6LXG(=B7&F156"C(&.\_*?W52). %[O&8!? ?R7 KH5 MH/M20*\"]&QFRE!L'A94T]E$BB/(PMIX*Q8VF19MPF>\J'NHI7G*#$[/PLWE MY?SZ"UQ=0+C\N%I>+(/YZ@;F07"U6=TL5Q]A??7W,EB>A_ .@I0J!7,(1):9 MFH5:1+<0YMNOIHB@!:R%4FR;(EQCC-G!%O9L@9JR5+TQ^$VX@+-7;R:N-LH+ M?C>J5'XH5?K/J%R)NP[XO;?@$Y\TP(-V^"65'>AZ%NXUP!?M\+]R;N"DB=TU MZ:YS[M,[YHR6GKM6Z]%\[B;#?MCXHW[$_?N-'5/[4AM\4APKQ;<:QT[ J1 M4%HUO2ZEB\$)JS?JCWKC43-WO^;NMW(O,$$I,09-[\&\ZZB;4M-_0MX=$_), MV(.:>M!*_9FF.2U;86J:,>41@MG$+U(T>%*$%D7#6M&P5=&21R)#2XSW9LXH M;*(>/DD&^>T-:;-X)&Q4"QNU"CM/$K3CPFJ35".<4044#B@CY+JIP03M+DF' MD-=-G>$_PQY%-*XC&K?ZV7")D=AQ]J.J]!8Y)JSQW0_&_YKQ-HM'^CSR:TR0 M_Z?03.Y(YN;0W$& <8VFMV@P?<54@]-4,VP,HJ)KBZ+5I S#/1E\Q37%-/H= MXPI23 R&=(;FDY#EY"\W6ASL+-P*;2:K7>[-;0EE86">)T+HATTQ7NO[U^PG M4$L#!!0 ( .>#L5(;DYY!R 0 $ 4 9 >&PO=V]R:W-H965T1+WMY1]YVN,!7B-HX1?M-9" M;+ZVVSQ8XQCQ<[K!B;RSHBQ&0IZRYS;?,(S"C!1';=NR.NT8D:0UZ&?7[MF@ M3U,1D03?,\#3.$;LQQ6.Z/:B!5N["P_D>2W4A?:@OT'/>('%T^:>R;-V:24D M,4XXH0E@>'71NH1?I[:C"!GB5X*WO'8,5"A+2K^KDUEXT;*41SC"@5 FD/Q[ MP4,<1)X2*-O)!3KBY;? B%>H302#W0[ MQ45 GK(7T(AGOV!;8*T6"%(N:%R0I00)*IV%X+)NT3RQ&#Q='M[^? ;N!N#Q6PRGXUGP\OY([@<#N^>YH^S M^03/:0>'45>Z4?<2I$0[.@0._ -N"/0U]:*;?(K:CVU!# M'S5^NFUIZ-=F^@)O)-TZ2A\W=UY'GWR,/GUWZMJRLLKRLLORLC-[SA%[EXD@ M(8E2-:# @>55=>5K_? M2,-@)G#,_S"XY91N.9E;[A&WBI*5W15\!V*-!-AB^12>+O^4,Q4("J0JK# 1 M*<.Z).;6O7@>U#VY,)?]%XY99>N<9D/> 02V5:1KCL*>6@(5ZOM.P9 MXYTE0L;'=]VK:ZG<0*<6$G2[GEU&E-?N(?NTX98<>8 MNSE-SGX^?]W2>M>8/S7X(CGP=*.L>Q#.&;2LO:"'W8.*D2@/.KVWN)'&FF]Y MKO,6=JV%[:W5(69_K1JY/M6Y[GO=CJU?,;_,J6_,:6VU@EH[&E:K5UKN_<-] M!*U*+JV/=E)AP3.WTE0'.]X'L";H\(2'F4"C) 1CAI)@33@&C^A5ZRK45(#. M5QW.X&PE#]"L#^]K6UC->6@>]-^R=U>I,^@%,_DN#KB2$P[D6SP7,D529I3B MU OP"[A"G 19 D=*NG"H3=VA!OB6U;-XG2(HY M!392.7=!J8BU$;BG!L3X-&1R&C(U0M[&7@D:-"N:*ASVTQ,$5G("_PT]@96@ MP'UEI("9)M%IR%3_L".#V*XDUS9+;JT%MHA)T17<].U4^WCZ7WT] MV96LVF997>0=@7=^<)($6'Y(8<* /(S2;&MK2],H!$OU+B+(V2X0W?>4?:B1 M#G0[KN?N+4V[MM.A]M;D]^HS23B(\$HRK?.N-,'R[:K\1-!-MOFQI$+0.#M< M8Q1BI@#R_HI2L3M1^RGEIN'@;U!+ P04 " #G@[%2.$@!S2 " " ! M&0 'AL+W=OT?"@TF_;HP 6L&IO9)K3__6Q#6"8M>5D>P&??[^,N9X*&BU=9 M "CT5E(FITZA5/7HNC(MH,1RP"M@^N3(18F5#D7NRDH SBRHI*[O>0]NB0ES MPL#N;448\%I1PF KD*S+$HOW.5#>3)VA<][8D;Q09L,-@PKGD(#:5UNA([=G MR4@)3!+.D(#CU)D-'^=CDV\3OA-HY,4:F4H.G+^:(,ZFCF<, 854&0:L7R>( M@%)#I&W\ZCB=7M( +]=G]J6M7==RP!(B3G^03!53Y[.#,CCBFJH=;[Y"5\_$ M\*6<2OM$39L[&3DHK:7B90?6#DK"VC=^Z_IP ?"'5P!^!_"M[U;(NEQ@A<- M\ 8)DZW9S,*6:M':'&'F3TF4T*=$XU28[%>KV>XGVBQ1$C^OXV4#=M%.9MRK^%94O:,69*B1Z8AED M?^-=[;BW[9]MS_V;A"LL!F@T_(A\SQ_NDP6Z^W!_@W;4=V-D:4?_W8T;8N-> M;&S%QE?$EI"!P!0MH.*2*"[>4O6]H'2VLNW2GT)Y[^ M!>[ITHY[,14EB-S.OD0IKYEJ!Z3?[:_7K)VJ/^GMW=3MS@F3B,)10[W!IXF# M1#OO;:!X96?LP)6>6+LL]"<"A$G0YT?.U3DP OU')_P-4$L#!!0 ( .># ML5(8EVL?=@( .(& 9 >&PO=V]R:W-H965TKV,.W!@4NP8C"S3=+]^]F&HE1+ MZ*1M+^"/>\X]QQ=?)DI,@MN."G(#C>H'HNUT#.W88EIAKFD/ >!R=1YW[V9C4V\#?A"\2A/QF"< M;#G?F\DBGCJ>$80,(V48B'X=<(:,&2(MXT?-Z30I#?!T_,P^M]ZUERV1../L M*XU5.G5&#L28D)*I!W[\A+6?ON&+.)/V"<:K/ MX030[5T ^#7 _U- 4 ,":[129FW=$47"B>!'$"9:LYF!/1N+UFYH;JJX44+O M4HU3X?KQ]GXQ@]5\_N%AL?P(;^]0$)3]TP.]=@>_YWAGXK!W^F8@.!%T+[[Z$N]IA8]-O;/J6KW>!;Y%310F# M=;EE-()5DJ"@^:Z%.6B8 \L<7&#>E%M)8ZIOP!5L"$/@"6P4C_;P[5Z'PD)A M)K^W).HUB7JM%I9EMD5AZ$MM1@*5LL3X7&4JGK[E,;?X$(X\;^SU]$$>S@CH M-P+ZK0+6@D8(A=9@/XISF2N"P4GFKG<^Z:!).FA-NCJ@N":,<:5;AVHYQF%# M./R_]1HUB4;_J%ZCW^K5?UFNZL:\&O9"YKB1.?[;JHY?KZI[TH%,]]?W=T=S M"0P3#?(Z0RU;5!VUFBA>V*:TY4JW.#M,]4\(A0G0^PGGZGEB^ESS6PM_ 5!+ M P04 " #G@[%2,>$S*:D2I#3)M$IMA9I^/$Q[<. &K )F MM@F9M!\_&PBC*\DR:7L)MKGGW'./S74F)66O/ 80:),\!A!4H3W3*,D9YBDFG>I%KSF3>AA4A(!CY#O$A3 MS+Y?0T++J69J^X4'$L5"+>C>),<1K$ \Y3Z3,[UE"4D*&2^,D2IE3>FKFMR$4\U0BB"!0"@*+!];F$.2*":IXUM#JK4Y%; [ MWK-_JHJ7Q:PQASE-7D@HXJGF:BB$#2X2\4#+S] 4-%1\ 4UX]8O*.M8>:R@H MN*!I Y8*4I+53[QKC.@ 3.< P&H UJD NP'8IP*A-$2 M,14MV=2@,K-"R_))IO9])9A\2R1.>/[#S?/L<8G\V]E\>;>\?T1G"Q"8)/P< M?41/JP4Z^W ^T85,I0!ZT-!>U[36 =I[NAT@R[E EF$9/?#Y)G .)9E'$(,("4%ZP();G&>6,!-#G8,TTJIC4U[WUI%/;KDGO M(RS7-EUCW,:]$>FT(IVC(GU&MDJBG^ 9 L0Z ?:K[U@QG FCE@Q;+,,_Z_G MHS;1Z&@Y]T6Z!J;HRUH\1X3S L*^4U]3#3N6VJ8S&ULS5AM;]LV$/XKA)$!+9!%(N6W%(Z!Q$[:#&EJQ.F&8=@'6J(M+I+HD51< M _GQ.TJRY-02[60-MB^V9/,>/G>\>X[D8"7D@PH9T^A;'"7JK!5JO?S@.,H/ M64S5B5BR!/Z9"QE3#:]RX:BE9#3(C.+((:[;=6+*D]9PD/TVD<.!2'7$$S:1 M2*5Q3.7Z@D5B==;"KLF0C%D4&"7C\ M78"VRCF-X?;S!OTJ2G2HNX, 8&,4_R;_JM",26 6DR((4!.=3 *PR\[PR\?H-!NS!H M?S]#K\&@4QAT#J74+0RZAQKT"H->MEAY=+.E&5--AP,I5DB:T8!F'K+US:QA M17AB4G&J)?S+P4X/[RYOSN\OQVAR?G?_.[J_.[^=GH_NK[_<3M'/Z$JD2< D MFH94,H7>C9FF/%+O!XZ&J0V XQ?37.33D(9I?J')"7+[QXBX!*L,K@9D9 >9 MLN4)\MP,Q&T$&1_"!.<@7Z=C].[H_?@(.2@';(2]M,..F0_8Q$'$.D01/\A^,B#H@KE;*@+LDZ.]$@;8*QVRU9Y'E4,PYW MNJ3CUK/MEFR[+V<+S5!IF@0\6=11[AY(N6: _;0Y@2#.VP'?K &=:_!1AS!]PC6GT:;(OLSG3)J! MT%2RK<(CB]8H9%& 9FO$B\'9@H8B@D#5RJ^=*'%/7/Y8TKDM(MR%I\%8+Q3\ZTR\*R,/95 J-R0N2JBDNEX7,.*5CD"2SU_B3' ME59C[VW3'%=2C.U:_#S1-[&6:$4E3*LANT&K@4HB-)HQI T7R&K)@F-$E>*+ MQ#PI2%]C)6%+#'(>H+D4,6+*!SZU6PH[J<[>I*XD'MLU_CX$ATQUH274H@!F M0-,XHT7IS,83XP%LZB,H]+6)!I0TE[4Q*2O>%_$R8MG2Y 9E6<]2!524,D-F M/*%F3&TH[/R["$I!A]:\JCH(MK>0J:FHHM=JR1<+X\6>.-2X7WAJ?(<1QZ\. M1[;]"$ ;J51F>?*YWIMM0+E_K U9[F5_J]8Q.>DT%'K5K+"]6U6I @')!#Z@ M:Y4E3&V$BAW5;H#^142>T+C6XUZ-NC7X6_52W#_07U\DBOFI:5#_0]_[.[Y[ M3;Y7[1W;V^:.J-\Q<\]@''^YL).JQ1+W;86=5$V4V)OH?R/L>TCM%7:R=7"R MM^7I$I(6F#VA@W>9I&K Y(T;,*D:,+'WNM<DE9>Y7\>F\LOUXE MOYY=Z5Y3UB.OYA"3E?5WH7>V[B?-!?=G*A<\42ABPP9A>B: ?#_7 B]>3&WH.7-_? ?4$L#!!0 ( .>#L5(<_>C' M! 0 *T/ 9 >&PO=V]R:W-H965TBK4E M(X'4BT&!;SFVW;8"RL+:L!\_FXIAGV^5ST*<"I#;(*#B<(L^WP]JI/;Z8,;6 M&V4>6,-^1-(0^NLJHH/IOAW?H^T:3]N.?5&DMLVF Q^M7[9_BX'4P2RKQ MCOL_F*G>NA'[+-$X-9Y/'T6(RANEH MMO@3%K/1TWQTMWAX?IK#'S#R/&8ZC/K PF1.3+_=C%%1YLL/6N3;? PWOWWH M6TH[8U1:;FKX-C'L7##\Q'=U<)J_@V,[=@'\K@KH "T%#21-B^NM1B\*#PD#^76*HD1EJQ(::%PU%]*!Y4P%?021XP*3DX@ A M5ZA;4:1^1,:/HJ(DVMNQ=L/INZ$.?W><]W,)TFG9=BYVXG6&R>6DSHG4JTCJ>9E_[J9?]UWE1G^ MA9'KBJTN$Z:AE!2DEUGM7;?RQ,Z/"OO=!?B76 MG*2*6B6'ZMLB]ZE(\=%\&D/.BZ17&L-7^L*";0"^*0"X/-RA4&SIHZ8OQ6%/ MAY*J[A[GLM[[Q?,WA!*WK:-KA;G(ZN_.-=.Y]'&E47:]HTLJDKMALE$\ MBF\:2Z[TO25>;O1]&H41T.]77,]FNC&7E^R&/OP/4$L#!!0 ( .>#L5(X M,D/OMP( +,' 9 >&PO=V]R:W-H965T[YYY[SMR-MTJO38Y(L!.%-),@)]I!P\,2SG-Q! M.!UO6(9+I"^;A;:[L$%)N$!IN)*@,9T$-]WKVX.O'+?F: TNDY52:[=Y M2"9!QQ'" F-R",Q^7O 6B\(!61K?:\R@">DKPOA?V-:VG0#BTI 2M;-E(+BLOFQ7ZW#DT!V= M<8AJA\CSK@)YEG>,V'2LU1:TL[9H;N%3]=Z6')>N*$O2]I9;/YK>/L[G#\_S M^\_/2[B )\RX(=OH#4$L#!!0 ( .>#L5*GE!T)(@, #<* 9 M>&PO=V]R:W-H965T$;R/23A(N4*#T5*U=N!)#8@E+F^I[7=U-" M,VNQ63$<\5H!M<"R3Q-B7@\!\9W8P<[3S=NZ&JMS UW,MJ0%2Q W6VN MA9ZY%4M,4\@DY1D2D(R=,WPZPST#L!&?*>QD;8S,4I:S)!*FG'VAL5J/G=!!,20D9^J& M[SY N:# \$6<2?N/=D5L,'!0E$O%TQ*L':0T*Z[DH4Q$#: 7V@SP2X!_**!; M KJ' GHEP*;:+99B\S CBDQ&@N^0,-&:S0QL,BU:+Y]F9M\72NBG5./49'HU MGU_'(]%DK]'Z9)O.\COG2#?\[T&^+0=/B>B@[K8PG$#?-8._YAG&NXUJ;LZ M957>_"IOON7K[LL;3U.J3'8D.LMB-.6921ID$06)OG[2X>A"02J_M8AU*[&N M%>NUB.EW9*%X='^"%FLBM,99KM9M@," M7WCN59Y[K9YGD( 0$*,$ &U H#RCJLEI01/6#'@=OUD[J+2#P[3S>CU;(^21 M+!DT^2@H^S4?N._AT N;O?0K+_U6+Q=ZV90P=)TO&8W05:*M:37>;K4Y<036U$242GS1@/GPU<&0L\; M>CW<; ![SSW3^R,+9*N[X[ZZ*KGJ-OHX& ;#/2YJG1NWNKC:@GA+&..V!EKV M&#\W-?P?NAI^;FNXO:\=OI7X=9L*7FYEF>S?QKVT^MS-<'L[N],&T4;0J'F/ M>Z^;QZ]E[M8^TN9(I3]H*YI)Q"#1(*\ST*9%<4HI)HIO['=[R94^!=CA6I_L M0)@ _3SA7#U-S%&@.BM.?@)02P,$% @ YX.Q4F@^H<+Q @ @ @ !D M !X;"]W;W)K&ULM59M;],P$/XKIP@DD*!Y6]L- MM976#L2D%:IUP ?$!S>Y)M8<.]ANR_X]9Z?-BK2&%XDOB5_NGN>YLW.7T4[I M>U,B6OA1"6G&06EM_28,359BQ4Q/U2AI9ZUTQ2Q-=1&:6B/+O5,EPB2*!F'% MN PF([^VT).1VEC!)2XTF$U5,?TP1:%VXR .#@NWO"BM6P@GHYH5N$3[J5YH MFH4M2LXKE(8K"1K7X^ R?C.-O8.W^,QQ9X[&X$)9*77O)M?Y.(B<(A2860?! MZ+7%&0KAD$C']SUHT'(ZQ^/Q ?V=#YZ"63&#,R6^\-R6X^ \@!S7;"/LK=J] MQWU ?8>7*6'\$W:-[3 -(-L8JZJ],RFHN&S>[,<^$4<.27S"(=D[)%YW0^15 M7C'+)B.M=J"=-:&Y@0_5>Y,X+MVI+*VF74Y^=C+[.)]?W\W??KA;PFN8;@SM M&P.9JE9<,I\X.JU[M%P6P J-2$=BX<456L:%>3D*+:EP6&&V9YPVC,D)Q@N8 M*VE+ V]ECOFO_B&I;T-(#B%,DT[ .=,]2.-7D$1)_&EY!2^>O>R 3=O,I![V M[ 3L#5_C,N,P8S6W3,#-S:P#]:Q%/?.HZ:E\JZKBUN70P*7,84:YH-2BS#@: M^'I#YG!ML3+?.LCZ+5F_,X09,R6L$8&^7C"HMSPC$F:@1IV1!/KL0*VAT(J. MO-8J0\R-6[E>?'SJ8+O9TEX_>MZA>M"J'OR#:KJ(?ZRSP1]X?%>6MI/D/$KC MP=DHW#XA;-@*&W8*6_R2-5)(8M@#6PD$JPY*G;XMSU$_):P;?]CO19T9/&^% MGG=?79:C7&UT 7ZU+TGY/]&X+D=]F.CVIH_+=: M;-DWET;SIS51A"RX-"%R3:]0;4B'03;MK)E;5OL6LE*6&Y8#L5+>P$*G40( 'L& 9 M>&PO=V]R:W-H965TB#K1_BUSG'YYXJ-]&:BZ7, 11Z M*%@IATZN5'6!L4QS*(CL\0I*?3+GHB!*+\4"RTH R2RI8-AWW1 7A)9.'-F] MB8@C7BM&2Y@().NB(.+7)3"^'CJ>L]F8TD6NS :.HXHL( %U7TV$7N%.):,% ME)+R$@F8#YWWWL4H-'@+^$9A+;?FR%0RXWQI%C?9T'&-(6"0*J- ]+""$3!F MA+2-GZVFTUUIB-OSC?H'6[NN948DC#C[3C.5#YVW#LI@3FJFIGQ]#6T] Z.7 M!K) Q:JYF)S<:R=36T-/]BHH0^I9JGXN3N=O3I^O;S^&J:O$177^]O M[GZ@-VBBPP0A($.)XND2)3D1(-&K,2A"F7RM(2\01M)N1UAI)T8/I^VME\VM M_H%;OQ#10X%WAGS7]_;01\?I'^M2TUU+=W?I6-??A>!W(?A6+WA""$=D@TXV ML++] [)_0VQR.FM'1&J5_ >F3T)V_$ZZ+P.GIG^[@G]0>YWH, ML>,R[%R&SW.INZI4I,QHN=AG-3QI]1BBL8JW6H-IR_K-6]!2(@9SS7%[YYHL MFE;7+!2O;+>8<:5[CYWF^NL P@#T^9QSM5F8!M1];^(_4$L#!!0 ( .># ML5)0A5M(P ( "$( 9 >&PO=V]R:W-H965T:V\7#BS'9:-NW'[]H)6>F+ M1S\D=GS/N>?<.+Z-%T+>JQ1 DX>,YZKOI%H71ZZK)BED5+5$ 3FN3(7,J,:I MG+FJD$ 3"\JX&WA>Q\THRYU!;)]=R4$L2LU9#E>2J#++J/Q]#%PL^H[O/#ZX M9K-4FP?N("[H#$:@;XLKB3.W84E8!KEB(B<2IGWGHW\T[)EX&W#'8*&6QL0X M&0MQ;R;G2=_QC"#@,-&&@>)M#D/@W!"AC%\UI].D-,#E\2/[)^L=O8RI@J'@ MWUFBT[[3%D!8 T)KM%)F;9U030>Q% LB332RF8&MC46C&Y:;MSC2 M$E<9XO1@=',Y_'QV^>7D]'KTGIQ^NSV_^4$^D*'(,BSR2(O)/1FE5((B>R>@ M*>-J/W8U9C9X=U)G.:ZR!%NR?*6R14+_@ 1>X-\)#>^(2Y2EK:X;*(>[*2_* M'"D]2^GMIG.Q)DUA@J8P@>4/7U&8';1A0QM:VO86VKJPEY\N7HO"'QBH-T8:+_&0$$EF5->@A6>",ZI M5*0 647LD[_D_\O99*C*UEW2Z;50I+]BY]FP)V:BQDST&C-SW)E+XE&[V:N; M5$=KU=VBI-,HZ;QA7S"ERN?W1&=-3- .?-_KK-1P0YP?=8)HRX[H-M*[;Y". M'4-IFBA>CUM5["X=X*9YXGDY8[DB'*:(\5I=!,NJ(543+0I[ MIH^%Q@YAARGV<) F ->G C=N/3%MHOE7,/@'4$L#!!0 ( .>#L5(;5\KZ M40( %<% 9 >&PO=V]R:W-H965T%)N.A>KB2Y-I*1,\TFMJ5!EH4D M*>*DT_D82\95-!X&W\*,AWI+@BM<&+!;*9EYF:#0U2CJ1CO'DF\*\HYX/"S9 M!E=(#^7"."MN43(N45FN%1C,1]%%]WPR\/$AX#O'RN[MP2M9:_WDC:ML%'4\ M(128DD=@;OF#4Q3" SD:OQO,J"WI$_?W._2O0;O3LF86IUH\\HR*4?0Y@@QS MMA6TU-4E-GH"P50+&[Y0-;&="-*M)2V;9,= != M%PHL9XS8>&AT!<9'.S2_"5)#MB/'E?\I*S+NE+L\&J_N[Z;7EW*DZ;@I.Z8'*D MX!>XU8H*"W.58?9O?NS(MPJ2G8))FU'>@&O=P1O M*IBUH/-=#T ;"'<5?MZX4+@BE/;7B4+]ME _%.H?*;38K@5/7UN-SVA2;D-_ M"8V$W&@)5""D0ENN-IZ4-[GBQ)F L@;0>8[&'1_Z%Z<9=.$%F3DA9=!*&?RG ME)(;%L;.*SG$[#3@(#"SAZC%>Y==HMF$D;:0ZJVB^MZWWO;5N*B'Y36\?G+< MU=EP94%@[E([9Y\<*5./<6V0+L/HK#6Y00S;PKU\:'R .\^UIIWA"[1OZ?@O M4$L#!!0 ( .>#L5(*Q.V,WP( *P( 9 >&PO=V]R:W-H965T\"IK M+]U=0U+UX[N[$(>F!BE5I;S@VJ[Z7:KT\]7T5 MIYA151-+S,W)7,B,:K.4"U\M)=+$.67<#X.@Y6>4Y=Z@Y_;NY* G"LU9CG<2 M5)%E5#Z?(1?KOD>\EXTQ6Z3:;OB#WI(N<()ZNKR39N67* G+,%=,Y"!QWO[>(ZZ7N!980<8VTAJ'FL<(B<6R3#X\<6U"MC M6L==^P7]PB5ODIE1A4/!O[)$IWVOXT&"#*_<)Z>S?P M("Z4%MG6V3#(6+YYTJ>M$#L.(=GC$&X=G!#^)I!C.:*:#GI2K$':VP;-&BY5 MYVW(L=Q69:*E.67&3P\NHNLQ/$0WTW.X/8\FT_'Y[?F7^PF,+R M!2Q,@170/($Y91)6E!<(8@XI\N1$BQ.C3R&9?@:%L348*C@:H::,J\\]7QNJ M-J ?;VF=;6B%>VC=4EF#.CF&, C)=#*"HT]O4'R3:)EM6&8;.MCZ'M@1SC1, M2H;'7'I:0)0)J=E/3& HE(9OT4QI:?Y)WP^0J9=DZHY,8P^9 M(56ITP]8#CI%N)>FWA#%L2AR7:79!J_E\.SKMAJ$0:/;Z/FK"AJ-DD;C((U( M*=3J?40VB,T=(IV D" (FM5?-(=?<(,KY$",-;;;TC2" \EWRX#=CZ\$ M"5X;8'"X%G^@5[:JX)W2DYWN2PZ+GQOAN8M^:3IL9712$;W3VA/YM1.2\&#D M5XDK@X9_M1J3FYG,"I;U@SN="Z)>%G7#E!\K@-U!+ P04 " #G@[%2MA\1)0P# M "-$ #0 'AL+W-T>6QE3'.>ENM+UP];.H;%TC^ZY1W?GR'32Z@VG MUTM*=;"NN6CS<*EU\S&*VL62UJ0]EPT5!BFEJHDV4U5%;:,H*5IPJGDT' S2 MJ"9,A-.)6-67M6Z#A5P)G8=);PK<[4N1AW'Z/@P#V[.+8_NI!<["R$LZ>@+I^%Y.".0B&A>12!=J4R(B)P=+>.SAV,ZA>QU,S M(96-[2*X[WFW_ C8SD @X[P7. R=83IIB-94B4LSL8NM\0$4=..;36,45HIL MXN$HW#G8FPDREZJ@J@\3AUO3=,)I"7(4JY9PU[*) -1:UF90,%))0:R&K4Y5=0 U%?W0".J&CL9-@'^?S7'OT6;/H@T:=B?UYY79 MC;!SZ!5ZI6C)UG:^+OOX&'N,LY.FX9M/G%6BIF[O3PXXG9"M7["4BMV;:- I M"V.@*@SNJ-)LL6_YI4AS0]=ZVTWK$M<\?(6:_VZ>*RJH(GQ?M&G]EYSE9RM. M/OPKR?9'Y5BP5V-W7+UTD:/7(#)]D2*C[@=][]0X.#-Z:P!G,:R:ZV9(5!14/C@Y#K\GTP, ,3M;O X1BYM)KCO'S(S'ZP.'Z?S%S^G699DJ0IEM'9 MS*M@AN4M3>'/SX9I P\L#D3ZLUSCU<8[Y/$^P&KZ6(=@.\4[$=LIGFM _'D# MCRSS5QN+ QY8%;#>@?C^.-!3?I\D@:IBVK G&$>R#$.@%_T]FJ9(=E+X^.N# M/25)DF5^!#"_@B3!$'@:<013 !HP)$GL.7AT'D7;*NQS $P( L !?3T\$MP>:4#M.*2VBZD8 M_1!2:5K5N %(MB6/:( M7->=I3W;+T]!;X"O.DQQ0FE(2S,.\,W2?S+W\PPU1>5*(Y5;&GC3Y?YVX$G1 MH2)8%II%R=.B':5_'E)JJ\;*;^BOYM:Z&%P,.9XW^OI[8$U5/\F MCTS8EIU4#36VJ/8]?52,5OK F&GJ7M3O#WH-Y2+X_.DRUE+UW((T;&NX%+:R MK5AS]J3_:V^+Z!O7?,-K;OX9!MU]S0+4<,$;_IU5PZ ?('V03U.I^':U86I$#9LH>3IRL6^'L;/H.=/HXG"YGH-XK_Y/&.5NQ[=L)+>GA@ES MCJ-B=0LH]($?=8 $;=@PN'1!5%2("&.#A%)Q'LKV;6=J'YU6YUD;B^O$4-US MVZ#2J@/W!YDLLA')"C)"#WB&LX2@8DI(ZF0+6,RQ=F$%,B!O ,@[]X0\J_(@1P MD(.W@<3%%(UG"P?R/0#YWB_DB!1)GB[+=)%U2S&?X"S]$W=EG(T_ MD,5J/L?Y8PM8I),L':<)ML'$2;)895=_G(\ Y$>_D,O5PRQ-+..8Y&DV<3?M M/K1K]SUCY>G:KCZTG.&D6X,N&*@3SS[)R%5*4B^3+=#$;D;SX!9'?5VGYZ+)!X@@]FV.,TQRM M\6Q%T)S@8I639Z&#E!%Z=D:Q>BALP-I=F*Q_!(,T$7KV!+B[7C8% MC!F[F) J0L^N>&45HAN;]]=,NYB0+$+/M@"]>_72(\@>D6=[P"_]UL6$7!)Y M=@F,>>=B@A\IGH4"8PY<3$@RD6?)_)#)H)L1,Y37^E<7$#)-Y-DTSW*:EQ$A MVT2>;?-Z=H/>H;%T,2'W1)[= V+BRL6$W!-Y=H^3B5FNG.VY-JKKUAV9N)B0 M>R+/[KG&7(F*J2?%#1=[A/>*N9B0>R+/[KG&?#AI+IC6:"N;#1?TZK $V+?[GD9,Y%-8Y>GFV7&D'MBW^YY&?,/JA05QLV+ M8O"(S+-[7DO?WJ&)DOH*$S)0W!FH=SFZK=C.KO$JLX_0MGY+Z^U2H?9R_LB\ MO6N3P=VIKA-;MQ S2:O+2?#E%/OSOU!+ P04 " #G@[%2C-]?K6X! #= M% &@ 'AL+U]R96QS+W=O]Q]:N[RR3>9676_;\4G1#4WFQ^50ZC[+;UEI-<=QHH?7 M&>IX>)T9G1^]_<_$KBBNN?WL\N_&MOZ/P?JG&VZNLM:KZ)P-I?6ITO=ZONWT M=*'5.%E%ITNJAM.%E X=Q!#$X8,,!)GP06L(6HC-J#<+T)L7/]L"]&;4FP7HS:@W"]"; M46\6H#>CWBQ ;T:]68#>C'JS +T9]68!>AO4VPC0VZ#>1H#>!O4V O0VB\,2 M 7H;U-N\4V_G'[5U<\]SC?N_DVH_OFOG[:?E\^;BZYUPUG":>?P%4$L#!!0 M ( .>#L5(&5T)WCP$ ' 5 3 6T-O;G1E;G1?5'EP97-=+GAM;,V8 MS6[",!"$7R7*%1%CIZ4_ BYMKRV'OH";;(A%$ENVH?#V=<*/U(I&("IU+K$2 M[\Z,O=)WR.1]:\A%F[IJW#0NO3>/C+FLI%JZ1!MJPDZA;2U]>+4+9F2VE MB M8C0:LTPWGAH_]*U&/)L\4R%7E8]>-N&S4[J9QI8J%T=/N\+6:QI+8RJ521_V MV;K)?[@,]PY)Z.QJ7*F,&X2"F)UT:'=^-]CWO:W)6I53-)?6O\HZ5+%-Q9S? M5N22?HD3&751J(QRG:WJT)(X8TGFKB3R=97L1 ?]SC[<,.V>_&K_3J;/,%3. MK38N3,S2Y7:'D;3=0Q.$R'K5?\2C8Y"^^GS43CNG_$SO<+V?VBZ[>3C6+=?? M\?<9'_4OS"% #L5('04UB@0 +$ 0 " 0 !D;V-0&UL4$L! A0#% @ YX.Q4G',HG7N *P( !$ M ( !KP &1O8U!R;W!S+V-O&UL4$L! A0#% @ YX.Q4IE< MG",0!@ G"< !, ( !S $ 'AL+W1H96UE+W1H96UE,2YX M;6Q02P$"% ,4 " #G@[%22O'<"0\$ "$#P & @($- M" >&PO=V]R:W-H965T&UL4$L! A0#% @ YX.Q4J"; M0/?B! QA !@ ("!4@P 'AL+W=O#L5) Y UO"0, '<+ 8 M " @6H1 !X;"]W;W)K$ & @(&I% >&PO=V]R:W-H965T M&UL4$L! A0#% @ YX.Q4@R<1"3J!@ >B@ !@ M ("!X!@ 'AL+W=O#L5(010,"0 ( "$% 8 " @0 @ !X;"]W;W)K M&PO=V]R:W-H965T&UL4$L! M A0#% @ YX.Q4N?^I)5($ DC$ !@ ("!TB< 'AL M+W=O#L5(UP&7_I10 M '4\ 8 " @5 X !X;"]W;W)K;:6@" !'!0 &0 @($K M30 >&PO=V]R:W-H965T#L5+. MWZFS,0, P' 9 " @&UL4$L! A0#% @ YX.Q4A0;BLEI" EA4 !D M ("!,E, 'AL+W=O&PO=V]R:W-H M965T#L5+CQYAN:@0 $<* 9 M " @0MD !X;"]W;W)K&UL4$L! M A0#% @ YX.Q4LZK=[?S!0 L@X !D ("!K&@ 'AL M+W=O&PO=V]R:W-H965T#L5)#Q2CG2!4 ,A! 9 " M@55R !X;"]W;W)K&UL4$L! A0#% @ YX.Q M4H,R\)BC P 3 D !D ("!U(< 'AL+W=O&PO=V]R:W-H965T#L5(%TN?X5@4 43 9 " @5>. !X;"]W;W)K M&UL4$L! A0#% @ YX.Q4KN%)R(^ P BPD M !D ("!Y), 'AL+W=O0<@$ ! % &0 @(%9EP M>&PO=V]R:W-H965T#L5(X2 '- M( ( ( $ 9 " @5B< !X;"]W;W)K&UL4$L! A0#% @ YX.Q4AB7:Q]V @ X@8 !D M ("!KYX 'AL+W=O&PO=V]R:W-H965T M#L5*C;25PBP4 ,47 9 M " @52D !X;"]W;W)K&UL4$L! A0# M% @ YX.Q4AS]Z,<$! K0\ !D ("!%JH 'AL+W=O M&PO=V]R:W-H965T#L5*GE!T)(@, #<* 9 " @3^Q M !X;"]W;W)K&UL4$L! A0#% @ YX.Q4F@^ MH<+Q @ @ @ !D ("!F+0 'AL+W=O&PO=V]R:W-H965T#L5)0A5M(P ( "$( 9 " @4BZ !X;"]W;W)K&UL4$L! A0#% @ YX.Q4AM7ROI1 @ 5P4 !D M ("!/[T 'AL+W=O&PO M=V]R:W-H965T#L5*V'Q$E# , M (T0 - " =W" !X;"]S='EL97,N>&UL4$L! A0#% M @ YX.Q4I>*NQS $P( L ( !%,8 %]R96QS+RYR M96QS4$L! A0#% @ YX.Q4@[M.%&9 P 21< \ ( ! M_<8 'AL+W=O#L5*,WU^M;@$ -T4 M : " #L5(&5T)WCP$ ' 5 3 " 6G, K !;0V]N=&5N=%]4>7!E&UL4$L%!@ J "H 70L "G. $! end

XML 47 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 48 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 49 FilingSummary.xml IDEA: XBRL DOCUMENT 3.21.1 html 91 244 1 false 26 0 false 7 false false R1.htm 00090 - Document - Document and Entity Information Sheet http://www.lifesciacquisition.com/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 00100 - Statement - CONDENSED BALANCE SHEET Sheet http://www.lifesciacquisition.com/role/StatementCondensedBalanceSheet CONDENSED BALANCE SHEET Statements 2 false false R3.htm 00105 - Statement - CONDENSED BALANCE SHEET (Parenthetical) Sheet http://www.lifesciacquisition.com/role/StatementCondensedBalanceSheetParenthetical CONDENSED BALANCE SHEET (Parenthetical) Statements 3 false false R4.htm 00200 - Statement - CONDENSED STATEMENTS OF OPERATIONS Sheet http://www.lifesciacquisition.com/role/StatementCondensedStatementsOfOperations CONDENSED STATEMENTS OF OPERATIONS Statements 4 false false R5.htm 00300 - Statement - CONDENSED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY Sheet http://www.lifesciacquisition.com/role/StatementCondensedStatementOfChangesInStockholdersEquity CONDENSED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY Statements 5 false false R6.htm 00305 - Statement - CONDENSED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (Parenthetical) Sheet http://www.lifesciacquisition.com/role/StatementCondensedStatementOfChangesInStockholdersEquityParenthetical CONDENSED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (Parenthetical) Statements 6 false false R7.htm 00400 - Statement - CONDENSED STATEMENT OF CASH FLOWS Sheet http://www.lifesciacquisition.com/role/StatementCondensedStatementOfCashFlows CONDENSED STATEMENT OF CASH FLOWS Statements 7 false false R8.htm 10101 - Disclosure - DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS Sheet http://www.lifesciacquisition.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperations DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS Notes 8 false false R9.htm 10201 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Sheet http://www.lifesciacquisition.com/role/DisclosureSummaryOfSignificantAccountingPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Notes 9 false false R10.htm 10301 - Disclosure - PUBLIC OFFERING Sheet http://www.lifesciacquisition.com/role/DisclosurePublicOffering PUBLIC OFFERING Notes 10 false false R11.htm 10401 - Disclosure - PRIVATE PLACEMENT Sheet http://www.lifesciacquisition.com/role/DisclosurePrivatePlacement PRIVATE PLACEMENT Notes 11 false false R12.htm 10501 - Disclosure - RELATED PARTY TRANSACTIONS Sheet http://www.lifesciacquisition.com/role/DisclosureRelatedPartyTransactions RELATED PARTY TRANSACTIONS Notes 12 false false R13.htm 10601 - Disclosure - COMMITMENTS Sheet http://www.lifesciacquisition.com/role/DisclosureCommitments COMMITMENTS Notes 13 false false R14.htm 10701 - Disclosure - STOCKHOLDERS' EQUITY Sheet http://www.lifesciacquisition.com/role/DisclosureStockholdersEquity STOCKHOLDERS' EQUITY Notes 14 false false R15.htm 10801 - Disclosure - FAIR VALUE MEASUREMENTS Sheet http://www.lifesciacquisition.com/role/DisclosureFairValueMeasurements FAIR VALUE MEASUREMENTS Notes 15 false false R16.htm 10901 - Disclosure - SUBSEQUENT EVENTS Sheet http://www.lifesciacquisition.com/role/DisclosureSubsequentEvents SUBSEQUENT EVENTS Notes 16 false false R17.htm 20202 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://www.lifesciacquisition.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Policies 17 false false R18.htm 30203 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Sheet http://www.lifesciacquisition.com/role/DisclosureSummaryOfSignificantAccountingPoliciesTables SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Tables http://www.lifesciacquisition.com/role/DisclosureSummaryOfSignificantAccountingPolicies 18 false false R19.htm 30803 - Disclosure - FAIR VALUE MEASUREMENTS (Tables) Sheet http://www.lifesciacquisition.com/role/DisclosureFairValueMeasurementsTables FAIR VALUE MEASUREMENTS (Tables) Tables http://www.lifesciacquisition.com/role/DisclosureFairValueMeasurements 19 false false R20.htm 40101 - Disclosure - DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS - Additional Information (Details) Sheet http://www.lifesciacquisition.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetails DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS - Additional Information (Details) Details 20 false false R21.htm 40201 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Class A Common Stock Subject to Possible Redemption (Details) Sheet http://www.lifesciacquisition.com/role/DisclosureSummaryOfSignificantAccountingPoliciesClassCommonStockSubjectToPossibleRedemptionDetails SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Class A Common Stock Subject to Possible Redemption (Details) Details 21 false false R22.htm 40202 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Net Income (Loss) Per Common Share (Details) Sheet http://www.lifesciacquisition.com/role/DisclosureSummaryOfSignificantAccountingPoliciesNetIncomeLossPerCommonShareDetails SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Net Income (Loss) Per Common Share (Details) Details 22 false false R23.htm 40203 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) Sheet http://www.lifesciacquisition.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) Details http://www.lifesciacquisition.com/role/DisclosureSummaryOfSignificantAccountingPoliciesTables 23 false false R24.htm 40301 - Disclosure - PUBLIC OFFERING (Details) Sheet http://www.lifesciacquisition.com/role/DisclosurePublicOfferingDetails PUBLIC OFFERING (Details) Details http://www.lifesciacquisition.com/role/DisclosurePublicOffering 24 false false R25.htm 40401 - Disclosure - PRIVATE PLACEMENT (Details) Sheet http://www.lifesciacquisition.com/role/DisclosurePrivatePlacementDetails PRIVATE PLACEMENT (Details) Details http://www.lifesciacquisition.com/role/DisclosurePrivatePlacement 25 false false R26.htm 40501 - Disclosure - RELATED PARTY TRANSACTIONS - Founder Shares (Details) Sheet http://www.lifesciacquisition.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetails RELATED PARTY TRANSACTIONS - Founder Shares (Details) Details 26 false false R27.htm 40502 - Disclosure - RELATED PARTY TRANSACTIONS - Additional information (Details) Sheet http://www.lifesciacquisition.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails RELATED PARTY TRANSACTIONS - Additional information (Details) Details 27 false false R28.htm 40601 - Disclosure - COMMITMENTS - Registration and Stockholder Rights (Details) Sheet http://www.lifesciacquisition.com/role/DisclosureCommitmentsRegistrationAndStockholderRightsDetails COMMITMENTS - Registration and Stockholder Rights (Details) Details 28 false false R29.htm 40602 - Disclosure - COMMITMENTS - Underwriting Agreement (Details) Sheet http://www.lifesciacquisition.com/role/DisclosureCommitmentsUnderwritingAgreementDetails COMMITMENTS - Underwriting Agreement (Details) Details 29 false false R30.htm 40603 - Disclosure - COMMITMENTS - Business combination marketing agreement (Details) Sheet http://www.lifesciacquisition.com/role/DisclosureCommitmentsBusinessCombinationMarketingAgreementDetails COMMITMENTS - Business combination marketing agreement (Details) Details 30 false false R31.htm 40701 - Disclosure - STOCKHOLDERS' EQUITY - Preferred Stock Shares (Details) Sheet http://www.lifesciacquisition.com/role/DisclosureStockholdersEquityPreferredStockSharesDetails STOCKHOLDERS' EQUITY - Preferred Stock Shares (Details) Details 31 false false R32.htm 40702 - Disclosure - STOCKHOLDERS' EQUITY - Common Stock Shares (Details) Sheet http://www.lifesciacquisition.com/role/DisclosureStockholdersEquityCommonStockSharesDetails STOCKHOLDERS' EQUITY - Common Stock Shares (Details) Details 32 false false R33.htm 40703 - Disclosure - STOCKHOLDERS' EQUITY - Warrants (Details) Sheet http://www.lifesciacquisition.com/role/DisclosureStockholdersEquityWarrantsDetails STOCKHOLDERS' EQUITY - Warrants (Details) Details 33 false false R34.htm 40801 - Disclosure - FAIR VALUE MEASUREMENTS - Gross holding gains and fair value of held-to-maturity securities (Details) Sheet http://www.lifesciacquisition.com/role/DisclosureFairValueMeasurementsGrossHoldingGainsAndFairValueOfHeldToMaturitySecuritiesDetails FAIR VALUE MEASUREMENTS - Gross holding gains and fair value of held-to-maturity securities (Details) Details 34 false false All Reports Book All Reports lsaq-20210331.xml lsaq-20210331.xsd lsaq-20210331_cal.xml lsaq-20210331_def.xml lsaq-20210331_lab.xml lsaq-20210331_pre.xml http://fasb.org/us-gaap/2020-01-31 http://fasb.org/srt/2020-01-31 http://xbrl.sec.gov/dei/2020-01-31 true true ZIP 51 0001104659-21-068146-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001104659-21-068146-xbrl.zip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
+YGW!S#70SR%>8LW+PI!2S@3W.O4'.5/0%1CZ)69($($-P5#"1 M_RJ(3,Q$A<$(X_B\>0;CJH>[G%HC?@6#="R0+GNE.T)OA,G5\ QP+-)Y@4)P MN$/O&65>2_#6]B'(WC1!=[">XVN.I* ^<(F_H\X!#Z92 !HS] MS R.#\5PYEL;:"9%),!RUXG,#PV+39D\0'W,MF/S )=T&>4#GN W;XD*M[-=H/ M_>'%^Z')A51X4&$]93Q+'/\+ S.-)\^/7\DW"J[Z$W"$+\=G@\E:" MD.*K(*&4:!P'<"&.PG',0SL@@,V<$MU=G.5LR_NV,]&;Y9DB8C-9VN!5]!KB M;ME+%I\Y1OA5OP:T?V9/>%)OS,1PFJCDVK*#228G._2$R<1;6C>\!XKWS6W\ M50P6\T_Q/$B<*<"V/R(WLVIB0LLQU5HW;1Z&,\5$_L@$]Q* 71+YJ7'35NQ9KZC_7Z?G!-33M^V$%PD2':II46-K^S##.#,!C[MW8,T M(F&7BX!?ZD&(P+LTBC@[UO?YE)]"',F0FFVY! P/E+%7A&_1]<2BRUUQLJPL MS?JZUDMBN9&=#-,%BX/EC T(BSISQ)9PCFEC^\*_0.=V?=F0&Z%N MZYDG,4T![>($=I8"Y<4^)C_>4H[P;-3>Y")M4SB^<*PL\F=)AQW3_>18*)G- MO(F[,NY@2*]<\.M">9&4SS9'G6A4F]BP&W0,"ZA MT.$@013&*.C+: ]![_B M(,EDGZZGB#E-G(B@LC,*[JG%ZX?>2&56WBY,QR\8TBT>.M&NX2Y39,>F,\Q: MZERE/72B&BOLIN5[09,[Y=@!2ZE#X\Y!GRV;DG#$S@,W0CD3DW+GS2K.X!\C M+^=E+!OH$@>77T#4S]S7I4ZC\0<;)>;5":JI=@BRDX1])<(+R+=GG,,>\ACC8 B-@XT MF=ADW8@L'[A72HI4(SEG,SPZE+A8VH\],(IXDRB?,Y(J+27R9N@,5-8">/M[ M&M";^MH#BHF9W-/(RO!LV$_QID;2=Z&TDRO\Q+8G?U=#UC2:Y.+40;-XG=X$3YG#? ML)U@N35\[JJ:AV%BXR?V)CQB PR^^#AK)M2L[ #B1S'\GE]24 4U21MFCQ$HNP,[%1RU)2VA/,M4XP$H B&^27!8*)N,;IQ0J)EW\2 MDKN%S'.MQ!O@A =U[>\Q>,G.BSQ/_&Q1G)2Y:4T3"F:M(7E>NL(*BWZF'+[V M.NR> .L5$L/B[C20F3 6]?A4>^8)1);'Z/Q.L?:!48F@M&A/8G3W^=+)OX79 M\TI#XWAIHZ7\"<1)'$S #)]LDPH=N+S&"5XAH2OOH3B+R_90T^)SG,3C,1$: M$&]KX])!LOL>#Y2B +T>D]>99/=G
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end